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 1 
Summary 
 
 
RNA polymerase II (Pol II) is the central enzyme, that synthetizes all mRNA in 
eukaryotic cells. In this work, I solved the structure of the complete, initiation-
competent 12-subunit yeast RNA polymerase II at 3.8 Å. I also solved the 
structure of the Pol II subcomplex of Rpb4/7 alone at 2.3 Å resolution. These 
structures reveal the details of Pol II assembly from 12 subunits and give 
important insights into the initiation of transcription. The refined, atomic model 
of the complete 12-subunit Pol II enabled homology modeling of the two other 
nuclear RNA polymerases. In Pol I and Pol III, 65 % and 77 % of the Pol II fold 
are conserved, respectively. Together with a recent structure of a Pol II 
elongation complex, these results show that the basic mechanism of transcription 
applies also to the two other nuclear RNA polymerases.  
 Chapter I 
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Macromolecular assemblies 
Most cellular processes are carried out by assemblies of proteins and not by freely diffusing 
and occasionally colliding proteins. These complexes are organized into networks, which 
cover the whole proteome, and are its functional units (Gavin et al., 2002). Specific 
complexes are referred to as molecular machines because of their modularity, complexity, 
cyclic functions and energy consumption (Nogales and Grigorieff, 2001) (Figure 1). There are 
currently about 12,000 known structures of assemblies from different organisms, involving 
two or more protein chains, and these complexes can be organized into around 3,500 groups 
based on sequence similarity (Sali et al., 2003). The most comprehensive information about 
transient and stable (cohesive) complexes exists for yeast, which has ~6,200 genes. It is 
estimated that in yeast around 11,000 protein-protein binary interactions occur, which 
corresponds to ~9 protein partners per protein (Bork et al., 2002). 
 
 
 
 
However, our knowledge of this multitude of interactions between individual proteins and 
macromolecular assemblies is not sufficient to describe their biochemical and cellular 
functions mechanistically. Such mechanistic insights can be obtained by structural 
characterization with a variety of techniques and approaches. 
Methods for structural characterization of macromolecular assemblies 
Methods for structural characterization of protein ensembles vary in efficiency, accuracy, 
resolution and completeness (Russell et al., 2004). We can group them into genetic, 
biochemical or molecular biology methods, structural or biophysical methods, low and high 
resolution methods and last but not least experimental or computer-aided methods. The choice 
of the method is dictated by the question we want to answer, the amount of material that is 
required for the experiment, and several other factors. 
Figure 1. Macromolecular assemblies. The figure shows four examples of macromolecular assemblies for which high 
resolution structures exist. In (a) the nucleosome core particle (Davey et al., 2002), in (b) 20S yeast proteosome (Groll et al., 
1997), in (c) 50S subunit from the archaean Haloarcula marismortuii (Ban et al., 2000), and in (d) structure of 10-subunit 
Pol II (Cramer et al., 2001). The figures do not represent the real size proportions between the structures. 
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X-ray crystallography 
This method is the most powerful method for structure determination of complexes, because it 
yields structures of macromolecular assemblies at atomic and near atomic resolution. The 
technique is based on irradiation of the crystal with x-rays and obtaining patterns produced by 
the diffraction of these x-rays through the closely spaced lattice of atoms in a crystal. The 
patterns are recorded and then analyzed to reveal the nature of that lattice. The spacings in the 
crystal lattice can be determined using Bragg's law. The electrons in the atoms are the entities 
that physically interact with the incoming x-ray photons to diffract them and so the electron 
density can be calculated and attributed to protein. Currently (March, 2005) there are 29,956 
structures deposited to the Protein Data Bank (PDB) out of which 25544 were solved by x-ray 
crystallography and the remaining 4,412 by nuclear magnetic resonance (NMR) spectroscopy. 
Out of these deposited structures, 27,283 are of proteins, peptides and viruses, 1,242 of 
protein/nucleic acid complexes, 1,418 of nucleic acids and 13 of carbohydrates. Over the last 
decades, x-ray crystallography developed rapidly. In 1,972 there were 2 structures deposited 
in PDB database, in 1990: 568 and in 2004: 5,501 (Figure 2). 
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Figure 2. The growth of Protein Databank (PDB) from 1972-2005.  
(www.rcsb.org/pdb) 
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RNA polymerase II 
Two major steps have to be made in every cell that the protein is produced, first the genetic 
information, which is encoded in the DNA, has to be copied (transcribed) to mRNA, and 
second, this mRNA has to be translated into the protein. The process of transcription is carried 
out by multisubunit RNA polymerases. Bacteria and archaea have one, whereas eukaryotes 
have three essential, nuclear RNA polymerases, which were discovered between 1965-1970 
by Robert Roeder (Roeder and Rutter, 1969a and b, 1970). RNA Pol I transcribes 18S and 
28S rRNA, RNA Pol III snRNAs, tRNAs and 5.7S rRNAs and RNA Pol II transcribes some 
snRNAs and all mRNAs. Pol II consists of 12 subunits of total of 513 kDa. Sequence analyses 
showed that two big subunits are highly conserved and are the only polypeptides present in all 
types of cellular RNA polymerases (Allison et al., 1985). The high conservation of these 
subunits reflects the function, various biochemical (Cho and Kimball, 1982, Carrol and 
Stollar, 1983; Riva et al., 1987) and later structural studies (Gnatt et al, 2001; Cramer et al., 
2001) have shown that they contain the catalytic center responsible for DNA-directed RNA 
transcription. It was also shown experimentally that several human Pol II subunits could 
substitute for their homologues in yeast (Khazak et al., 1995; McKune et al., 1995; 
Shpakovski et al., 1995). This suggested a high degree of both functional and structural 
conservation in eukaryotes and allowed for the assumption that results obtained in a yeast 
system can be applied to all eukaryotic RNA polymerases (Weinzierl, 1999). 
Yeast Pol II is so far the best characterized out of three RNA polymerases, both biochemically 
and structurally. Pol II is associating with general transcription factors, coactivators (e.g. 
Mediator), elongation factors, processing factors, RNA export factors and others (Woychik 
and Hampsey, 2002; Hahn, 2004 and references therein). The regulation of Pol II underlies 
gene transcription and expression and therefore organisms’ complexity and diversity (Levine 
and Tjian, 2003). To understand how this complex assembly functions, and to get insight into 
mechanistic properties, a major effort was put into structural studies of Pol II. 
History of Pol II structure determination 
The history of structure determination of Pol II can be divided into few phases, which are 
characterized by breakthroughs. The 1st breakthrough came with the refinement of the protein 
purification protocol for obtaining sufficient amount of pure Pol II and application of a 
general method of growing single-layer crystals (Uzgiris and Kornberg, 1983). The key step 
for obtaining large amounts of pure Pol II was developing an immunoaffinity method based 
on monoclonal antibodies, (designated 8WG16) reacting with the highly conserved, 
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unphosphorylated heptapeptide repeat of C-terminal domain of Rpb1, the largest Pol II 
subunit. These antibodies allow for elution of Pol II with a gradient of polyols (Thompson et 
al., 1989). After successful trials with wheat germ and calf thymus Pol II, yeast Pol II was 
purified with the use of this method as well. The amounts and purity of prepared enzyme were 
much higher in comparison to older protocols that were based on several chromatography 
steps. The method of growing 2D crystals on charged lipid layers proved to work for Pol II. 
2D crystals were analyzed by electron microscopy (EM), resulting in a resolution of 30 Å 
(Edwards et al., 1990). This resolution was only suitable to determine the shape of the 
molecule but it was a starting point for further trials. The small amounts of required material 
and the simplicity of the method for obtaining 2D crystals allowed for screening for larger and 
better diffracting crystals. It became apparent that polymerase preparations resulted in 
heterogeneous material, consisting of 10-subunit core enzyme and varying, substoichiometric 
amounts of two subunits Rpb4 and Rpb7, which form a subcomplex.  
The 2nd breakthrough came with creating the deletion yeast strain (designated Δ4/7) with a 
knockout of the gene coding for Rpb4. Polymerase purified from this deletion strain lacked 
Rpb7 as well. Preparation resulted in homogeneous 10-subunit core enzyme, which 
crystallized readily, forming 2D crystals of good shape and quality (Darst et al., 1991a). A 
surface representation of Δ4/7 Pol II was derived from stained 2D crystals at 16 Å (Darst et 
al., 1991b and Figure 3a). This structure revealed the general shape of Pol II. Discovery of a 
crystal form in which the density for the part of the structure was absent, due to disorder or 
motion was the first proof of possible multiple conformations of Pol II. This mobile element 
designated as clamp was rendering Pol II in open and close conformation and was in 
agreement with the structural features of E.coli RNA polymerase (Asturias et al., 1997; 1998). 
2D crystallography identified a possible location on the Pol II surface where the CTD 
emanates to solution (Meredith et al., 1996). This period of studies of Pol II with the use of 
2D crystallography resulted in several complexes of Pol II with general transcription factors 
and nucleic acids with resolution limited to around 15 Å (e.g. Leuther et al., 1996).  
The 3rd breakthrough came with obtaining 3D crystals of 10-subunit Pol II, first by seeding 
with 2D crystals (Edwards et al., 1994) and then by conventional methods. Initial x-ray 
analysis of these crystals failed due to problems with oxidation. With the inert atmosphere and 
better crystals, first diffraction was measured to 3.5 Å (Fu et al., 1999). For initial phase 
determination 18-tungsten atom cluster was used, and the density calculated at 6 Å resolution 
showed a general good fit to the 16 Å molecular envelope obtained by electron 
crystallography (Figure 3b), except for the regions that were thought to be mobile and clamp 
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the DNA (Darst et al., 1991b). It proved to be very hard to obtain crystals diffracting 
reproducibly to ~3.5 Å, they were nonisomorphous, with unit cell deviations of up to 10 Å 
and heavy metal incorporation destroyed the diffraction. 
The search for new crystallization buffers, lacking phosphate, led to the 4th breakthrough 
when the soaking protocol which shrank the crystals of 10-subunit Pol II to minimal fixed unit 
cell was introduced (Cramer et al., 2000). These crystals diffracted isotropically to around 3.0 
Å. Unfortunately, it was not possible to use previously obtained phases (Fu et al., 1999) 
because the new crystals were nonisomorphous with the old ones. The initial phase 
determination was based on MAD with 6-tantalum atom cluster and these phases allowed for 
location of other heavy atom derivatives with the use of cross-difference Fourier. Phases were 
obtained from 10 datasets ranging from 4.0 to 3.1 Å by the multiple isomorphous replacement 
with anomalous scattering (MIRAS) method. The compounds used were non-standard and 
contained mercury, rhenium or iridium. The electron density had a good agreement with the 
molecular envelope derived at 6 Å and allowed for model building of the backbone of RNA 
Pol II. Complete structures of yeast Rpb5 and Rpb8 together with archaeal and bacterial 
homologues of Rpb3, Rpb6, Rpb9, Rpb10 and Rpb11, which were determined by x-ray 
crystallography and NMR, facilitated model building. Subunit placement was also aided with 
eight structural zinc ions that were detected in anomalous difference-Fourier maps. The rest of 
the model was built as polyalanine. This model revealed for the first time the subunit 
architecture of Pol II. The atomic model of 10-subunit Pol II came with further shrinkage of 
one unit cell axis by ~8 Å, which improved the diffraction to 2.6 Å (Cramer et al., 2001). 
Differences between this crystal form and the previous one (Cramer et al., 2000) identified 
four mobile modules in Pol II. Sequence markers like selenomethionine facilitated model 
building. Maps were improved by phase combination and the atomic model was refined at 2.8 
Å. These model phases allowed for structure determination of a complex of Pol II with 
nucleic acids and α-amanitin, an inhibitor of Pol II transcription. (Gnatt et al., 2001; Bushnell 
et al., 2002). The structure of the nucleic acids complex revealed new features out of which 
one is the clamp closure upon nucleic acids binding at the active site of polymerase. The 
transcribing polymerase model was then used as search model for solving the structures of 
other Pol II complexes, described here and elsewhere (Armache et al., 2003; Bushnell and 
Kornberg, 2003; Kettenberger et al., 2003; Bushnell et al., 2004; Westover et al., 2004 a and 
b). 
The 5th breakthrough came during this work with reconstitution of the 12-subunit Pol II and a 
new crystal form, which are described in details in Chapter II and Chapter III. These new 
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crystals diffract reproducibly to 4 Å and contain ~80 % of solvent. The packing allowed for 
soaking of elongation factor TFIIS to preformed 12-subunit Pol II crystals and structure 
determination at 3.8 Å. This was the first ever structure of Pol II in complex with a 
transcription factor at near-atomic resolution (Kettenberger et al., 2003). Also with 
improvement of the crystals of 12-subunit Pol II and structure determination of the 
subcomplex of Rpb4/7 alone, the atomic, refined model of complete 12-subunit Pol II was 
determined (this work). This model was essential for phasing of the complete RNA 
polymerase II elongation complex (Kettenberger et al., 2004 and Figure 3c). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. History of Pol II structure determination. (a) 16 Å structure of Pol II (Darst et al., 1991); (b) 6 Å 
electron density map (Fu et al., 1999) being the first density obtained from 3D crystals in comparison with 
molecular envelope derived from 16 Å EM structure (Darst et al., 1991); (c) Elongation complex of 12-subunit Pol 
II (this work and Kettenberger et al.,2004)  
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General architecture of Pol II and comparison to bacterial RNA polymerase 
Bacterial, archaeal and eukaryotic DNA dependent RNA polymerases belong to a conserved 
family of enzymes designated “multisubunit RNAP family”. All of these enzymes consist of 
conserved subunits that are termed the “core” subunits. Eukaryotic RNA polymerases also 
have common subunits that are shared between Pol I, II, and III. Additionally archaeal and 
eukaryotic RNA polymerases have several specific subunits (Table 1). 
 
Table 1. Multisubunit RNA polymerases. 
RNAP subunits 
Eukaryotes Archaea Bacteria Class 
Pol I Pol II Pol III    
A190 Rpb1 C160 A´+A´´ β´ Core 
A135 Rpb2 C129 B (B´+B´´) β Core 
AC40 Rpb3 AC40 D α Core 
AC19 Rpb11 AC19 L α Core 
Rpb6 Rpb6 Rpb6 K ω Core/common 
Rpb5 Rpb5 Rpb5 H  Common 
Rpb8 Rpb8 Rpb8 -  Common 
Rpb10 Rpb10 Rpb10 N  Common 
Rpb12 Rpb12 Rpb12 P  Common 
(A12.2) Rpb9 (C11) X   
A14 Rpb4 C17 F   
A43 Rpb7 C25 E   
Specific subunits 
Pol I specific: 
A49, A34.5 
 Pol III specific:  
C82, C34, C31, 
C53, C37  
Archaea specific: 
1 more 
 
  
 
The atomic model of S.cerevisiae Pol II core (Cramer et al., 2001) and bacterial T.aquaticus 
and T.thermophilus RNA polymerase (Zhang et al., 1999; Campbell et al., 2001; Murakami et 
al., 2002a and b; Vassylyev et al., 2002) allowed for structural comparison of these eukaryotic 
and bacterial enzymes (Figure 4a and b). 
The general architecture of Pol II is based on five core subunits, Rpb1, Rpb2, Rpb3, Rpb11 
and Rpb6 in yeast and β´, β, αα homodimer and ω in bacteria respectively. The two large 
subunits Rpb1/β´ and Rpb2/β, form the central mass of the enzyme and lie on opposite sides 
of a positively charged cleft. The two large subunits are stabilized by the Rpb3-Rpb11 
CHAPTER I: INTRODUCTION 
 
 
10 
heterodimer in yeast and αα homodimer in bacteria. Rpb6/ω further buttresses and stabilizes 
the large subunit. The sequential assembly of Pol II is based mainly on these “core” subunits 
(Chapter 4). 
Comparison of two crystal forms of the Pol II core (Cramer et al., 2000, Cramer et al., 2001) 
revealed several mobile modules that underlie the dynamics of Pol II. On the Rpb1/β´ side of 
the cleft the mobile “clamp” is located, feature which was already observed in EM studies 
(Asturias et al., 1997; 1998). The clamp was trapped in open and closed conformation and is 
believed to play an important role in initiation and transition from initiation to elongation 
(Chapter 2 and 3). On the other side of the cleft are situated two domains, “lobe” and 
“protrusion” which in bacterial polymerase are designated “β domain 1” and “β domain 2”. In 
both enzymes, the active site is located on the bottom of the cleft at the center of the enzyme. 
Before the active site, long, conserved “bridge helix” spans the cleft (in bacteria “β´F helix”), 
and below the “bridge helix” and active site “pore 1” or “secondary channel” is situated, 
which widens towards the bottom of the enzyme, creating a “funnel”. The rim of the pore has 
a loop of Rpb1, which binds Mg2+, and a second catalytic metal could bind further in the pore. 
Beyond the active site, the cleft is blocked by a “wall” or “flap”. Other Pol II subunits are 
located on the outside of the enzyme, further stabilizing the assembly and constituting 12-
subunit enzyme (Armache et al., 2003; Armache et al., 2005, this work).  
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Figure 4. Structural comparison of eukaryotic and bacterial RNA polymerases. (a) bacterial polymerase 
(Zhang et al., 1999); (b) yeast Pol II core enzyme (Cramer et al., 2000 and 2001); (c) initiation competent bacterial 
polymerase with σ (Murakami et al., 2002); (d) Pol II and proposed model of the CTD (Meinhart and Cramer, 
2004). 
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The CTD 
The C-terminal domain of Rpb1 is a unique feature of RNA Pol II (Corden, 1993; 
Meininghaus et al., 2000), not present in any other RNA polymerase. It is essential for mRNA 
processing (Proudfoot et al., 2002), for Pol II response to enhancers (Scafe et al., 1990; Gerbe 
et al., 1995) and for organization of transcription foci in the nucleus (Misteli, 2000).  
The CTD consists of seven amino acid repeats, whose number is species-dependent, 26 in 
yeast, 45 in flies and 52 in humans (Corden, 1990). The heptapeptide repeat, has the 
consensus sequence Y1S2P3T4S5P6S7 and out of these seven amino acids, five can be 
phosphorylated and it was shown that indeed in vivo phosphorylation is the major 
modification of the CTD (Bensaude et al., 1999). The phosphorylation status plays a major 
role in the transcription process (Dahmus, 1996) and several CTD-specific kinases and 
phosphatases were identified. CDK7 of TFIIH, CDK8 of Mediator and CDK of pTEFb are the 
CTD kinases. The phosphatases Fcp1 and Scp1 (Lin et al., 2002; Kamenski et al., 2004) as 
well as a number of phosphoserine/phosphothreonine phosphatases and Ssu72 (Meinhart et 
al., 2003b) were discovered. 
It was shown that assembly of Pol II in the preinitiation complex and the interaction with 
Mediator are related to the unphosphorylated CTD. Upon CTD phosphorylation these 
interactions are being disrupted and the transition from initiation to elongation, and 
recruitment of pre-mRNA modifying enzymes occurs (Kobor and Greenblatt, 2002; Bentley, 
2002). The variable phosphorylation status of the CTD could underlie the recruitment of 
different factors to Pol II. The CTD appears to be completely disordered in all Pol II 
structures. We only know where the linker to the CTD emerges from the Pol II surface and 
that in a β-strand conformation the CTD could span the distance of several hundreds of Å 
(Cramer et al., 2001). Structural studies of the CTD alone failed, indicating flexibility and a 
lack of secondary structure. The only structural information regarding the CTD comes from x-
ray structures of CTD peptides bound to different factors such as Pcf11, a component of 
cleveage factor IA, a Pin1 domain, a peptidyl-prolyl isomerase, or Cgt1, a capping enzyme 
subunit (Meinhart and Cramer, 2004; Fabrega et al., 2003; Verdecia et al., 2000). In addition, 
a model of the CTD conformation was proposed (Figure 4d, Meinhart and Cramer, 2004) 
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The subcomplex of Rpb4/7 
Pol II consists of 12 subunits out of which two, Rpb4 and Rpb7 form a subcomplex, which 
transiently interacts with the remainder, 10-subunit (core) enzyme. Whereas the 10-subunit 
core Pol II is sufficient for elongation and promoter-independent initiation of transcription 
(Edwards et al., 1991; Ruet et al., 1980; Rosenheck et al., 1998), it is not capable of 
promoter–directed initiation in vitro (Orlicky et al., 2001; Edwards et al., 1991), for this it 
needs association with the subcomplex Rpb4/7. These two subunits were identified in 
S.cerevisiae as 4th and 7th biggest subunits (Woychik and Young, 1989). The subcomplex 
associates with Pol II as a heterodimer (Armache et al., 2003; Bushnell and Kornberg, 2003; 
Edwards et al., 1991). Rpb7, like most Pol II subunits, is an essential protein (McKune et al., 
1993; Mitsuzawa et al., 2003), and Rpb4 is dispensable under optimal growth conditions 
(Woychik and Young, 1989; Sheffer et al., 1999; Choder and Young, 1993; Farago et al., 
2003; Miyao et al., 2001; Tan et al., 2000; Khazak et al., 1995).  
It was very early discovered that Rpb4/7 is substoichiometric with respect to the Pol II core 
(Kolodziej et al., 1990), and can dissociate from the core enzyme (Edwards et al., 1991; Ruet 
et al., 1980). This was a major impediment for crystallization of wild-type Pol II in the early 
90´s, until the mutant ΔRpb4 strain was introduced from which stoichiometric 10-subunit 
polymerase core, lacking also Rpb7 could be purified. Under optimal conditions, this strain 
has the transcriptional capacity of a wild type strain (Choder and Young, 1993; Miyao et al., 
2001; Maillet et al., 1999), whereas under suboptimal conditions transcription is abolished 
from most of the genes (Sheffer et al., 1999; Farago et al., 2003; Pillai et al., 2001). Although 
the ΔRpb4 strain is sensitive towards elevated temperature, ethanol and starvation, Rpb4 is 
not required for cell survival during oxidative or osmotic stress (Maillet et al., 1999) or 
nitrogen starvation (Pillai et al., 2001). The temperature-sensitive phenotype upon Rpb4 
deletion can be partially suppressed by Rpb7 overexpression, which shows that Rpb7 can 
function to some extent independently of Rpb4 even under some moderate temperature stress 
(Sheffer et al., 1999; Tan et al., 2000; Maillet et al., 1999).  
During exponential growth in S.cerevisiae, only 20 % of Pol II seems to contain Rpb4/7, 
whereas in stationary phase and during stress conditions 12-subunit Pol II becomes the most 
abundant form of the enzyme (Choder and Young, 1993). This situation seems to be different 
in S.pombe and human, where the homologues of the Rpb4/7 subcomplex are thought to be 
stoichiometrically associated with the core also in the exponential growth phase (Sakurai et 
al., 1999; Khazak et al., 1998). Structures of S.cerevisiae Rpb4/7 (this work, Armache et al., 
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2005) and its archaeal homologue E/F subcomplex (Todone et al., 2001) were solved by x-ray 
crystallography at 2.3 Å and 1.7 Å respectively revealing the atomic details of the 
subcomplexes. Also x-ray structures of 12-subunit Pol II were determined (this work, 
Armache et al., 2003; Armache et al., 2005, Bushnell et al., 2003) showing Rpb4/7 in context 
of the whole enzyme. The structure of archaeal subcomplex of E/F showed two putative RNA 
binding domains harboring a conserved S1 motif, commonly seen in single-stranded nucleic 
acid binding proteins and forming continuous binding surface in RpoE. Experiments showed 
that both, RpoE and Rpa14 that is an Rpb7 homologue in the Pol I system bind RNA in vitro 
(Orlicky et al., 2001; Meka et al., 2003). Rpb4/7 physically interacts with TFIIF (Chung et al., 
2003). In the Pol III system Rpc17, which is a homologue of Rpb4 interacts with Brf1, which 
is a counterpart of TFIIB (Ferri et al., 2000) and in Pol I system Rpa43, homologue of Rpb7 
interacts with the general initiation factor Rrn3 (Yuan et al., 2002; Peyroche et al., 2002). 
Human Rpb7 was reported to interact with NOV, putative transcription factor (Perbal et al., 
1999) and N-terminal portion of Edwin sarcoma oncogene (Zhou and Lee, 2001).  
Regulated phosphorylation and dephosphorylation of the C-terminal domain of Rpb1 (CTD) 
plays a pivotal role in regulating Pol II transcription and the linker leading to CTD is 
positioned near Rpb4/7 (Armache et al., 2003). It was shown, that Rpb7 interacts genetically 
with ESS1, a prolyl isomerase that binds to the CTD and induces conformational changes, 
which affect transcription elongation and termination (Wu et al., 2003). Rpb4/7 was also 
shown to interact with Fcp1, a CTD phosphatase (Kamenski et al., 2004; Kimura et al., 2002). 
It is still not clear at which point of transcription initiation Rpb4/7 associates with the Pol II 
core. On the one hand 12-subunit Pol II has a higher affinity to TBP-TFIIB-promoter complex 
(Jensen et al., 1998), but on the other 10-subunit Pol II can also bind efficiently to a promoter 
in vitro (Orlicky et al., 2001). The subcomplex Rpb4/7 was also reported to participate in 
termination of transcription and co- and post-transcriptional processes such as mRNA export 
and DNA repair (Farago et al., 2003; He and Ramoter, 1999; Li and Smerdon, 2002). In 
S.cerevisiae and S.pombe Rpb4/7 is in excess to other Pol II subunits with Rpb4 being in 7 
fold excess over Rpb7 in fission yeast. Sedimentation experiments showed that apart from Pol 
II, Rpb4 sediments also with small complexes (Rosenheck and Choder, 1998; Kimura et al., 
2001) and it was proposed that Rpb4/7 could play additionally a role out of the Pol II context. 
Nrd1 in S.cerevisiae and its homologue in S.pombe are involved in RNA 3`-end formation of 
some genes transcribed by Pol II, and Rpb7 was shown to interact with these factors, pointing 
to possible Rpb4/7 involvement in mRNA processing and termination (Mitsuzawa et al., 
2003). Rpb4 was shown to repress the Rpb9 mediated DNA repair pathway and to support the 
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Rad26 mediated DNA repair pathway (Li and Smerdon, 2002) and Rpb7 apparently plays a 
role in mediating repair in response to bleomycin (He and Ramoter, 1999). Rpb4/7 was shown 
to be localized in the nucleus (Farago et al., 2003), which is not really surprising as it is a part 
of Pol II but also in the cytoplasm, especially during stress conditions (Kimura et al., 2001; 
Khazak et al., 1995; Na et al., 2003) where it was shown to be required for efficient mRNA 
export (Farago et al., 2003). 
Rpb4/7 is a component of transcription machinery and a great example of a protein taking part 
in several processes, which constitute the true interaction network underlying cell 
proliferation and development. It is an essential part of Pol II acts in a manner similar to 
general transcription factors.  
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The mRNA transcription cycle 
Generation of mRNA by Pol II involves multiple processes out of which some occur 
sequentially and some in parallel. The phases of transcript generation form transcription cycle, 
which can be divided into preinitiation, open complex formation, initiation, promoter 
clearance, elongation, termination and reinitiation. Figure 5 shows a schematic description of 
this process. 
 
 
 
 
 
Figure 5. Pol II transcription cycle. (Adapted from Hahn, 2004) 
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Initiation of transcription 
12-subunit Pol II is the initiation-competent form of the enzyme but alone it cannot initiate 
transcription in a promoter-dependent manner. A breakthrough in understanding of the 
mechanism of transcription initiation came with the discovery that in a cell-free system Pol II 
can initiate transcription from template DNA only when supplemented with a crude extract 
(Weil et al.1979; Manley et al., 1980; Dignam et al., 1983). Our understanding of the 
preinitiation complex (PIC) assembly came from studies of minimal set of factors required for 
promoter-directed transcription initiation (Van Dyke et al., 1988). In eukaryotes, these are 
termed general transcription factors (GTFs) and together with promoter DNA and 12-subunit 
RNA Pol II they constitute the so-called PIC. These and other studies established in vitro 
assembly pathway on the AdML promoter and identified intermediates that are stable to 
nuclease protection, electrophoretic mobility shift and template-challenge assays (Conaway 
and Conaway, 1993; Zawel and Reinberg, 1993; Buratowski et al., 1989). Intramolecular 
interactions and protein domains participating in them were further studied by binary 
interaction assays and mutagenesis techniques. These techniques were complemented by 
structural studies of independent components of PIC and intermediate complexes of the 
machinery (Figure 8). Crosslinking studies depicted position of GTFs on the promoter (Kim et 
al., 2000; Forget et al., 2003; Douziech et al., 2000 and Figure 6). General transcription 
factors enable Pol II to initiate the basal transcription but not the response to activators, for 
this Pol II requires additional entities like the mediator of transcription which is highly 
modular (Myers and Kornberg, 2000) and transmits the regulatory signals from various DNA-
binding transcription factors to the Pol II initiation apparatus. Pol II general transcription 
factors are extremely conserved among species and Mediator complexes although variable in 
composition are structurally conserved in mammalian and yeast systems.  
Core promoter  
The core promoter can be understood as minimal stretch of contiguous DNA sequence that is 
sufficient to direct accurate initiation of the transcription machinery (Butler and Kadonaga, 
2002). It usually encompasses the site of transcription initiation and extends upstream and 
downstream. In many cases, a core promoter comprises only ~40 nucleotides (nt). There are 
several commonly found sequence motifs with known specific functions in class II promoters, 
namely: TATA box, initiator (Inr), TFIIB recognition element (Bre) and downstream core 
promoter element (DPE). In addition to these core promoter elements there are cis-acting 
DNA sequences which regulate Pol II transcription and include the proximal promoter, 
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enhancers, silencers and boundary/insulator elements and can be located up to several kb from 
transcription start site and can either activate or repress transcription (West et al., 2002). 
These cis-acting elements can functionally interact with core promoter motifs. Core promoters 
are not only scaffolding DNA elements for Pol II and general transcription factors, but are 
also dynamic regulators of transcriptional activity (Figure 6). 
 
 
The TATA box was the first identified core promoter element (Sassone-Corsi et al., 1981) and 
it is located 25-30 nt upstream of the transcription start site. In S.cerevisiae TATA box has 
position that is more variable and is located between 40-100nt upstream of transcription start 
site. Consensus sequence of TATA box is TATAAA but it can vary to various degree still 
promoting transcription (Singer et al., 1990). 
This motif is very commonly found in class II promoters but there are a number of sequences 
not containing a TATA box (Kutach and Kadonaga, 2000). The TATA box is recognized 
predominantly by TBP or TBP-related factors ((TRFs); Berk, 2000)). The initiator element 
(Inr) encompasses the transcription start site (Breathnach and Chambon 1981) and the 
consensus sequence is TCA+1G/TTC/T (Hultmark et al., 1986) with A+1 being the 
transcription start site. TFIID and precisely TAFII150 and TAFII250 were found to interact 
with Inr in a sequence-specific manner (Verrijzer et al., 1994). In addition, Pol II with TBP 
and TFIIF can initiate transcription in the absence of TAFs through recognition of the Inr 
(Carcamo et al., 1991). Downstream promoter element was found as a binding site for TFIID 
(Burke and Kadonaga 1996). TFIID binds cooperatively to DPE and Inr sequences and the 
Figure 6. Core promoter interactions and beyond. (Kadonaga, 2002) 
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spacing between these two elements seems to be crucial (Kutach and Kadonaga, 2000). 
Mutation of only one nucleotide in the spacing reduces TFIID binding dramatically and hence 
reduces basal transcription (Burke and Katonaga, 1997). DPE is located precisely +28 to +32 
relative to A+1 transcription start site. DPE is found mainly on TATA-less promoters and does 
not interact with TBP. The TFIIB recognition element (BRE) is located in many cases directly 
upstream of some TATA boxes and facilitates incorporation of TFIIB into productive PICs 
(Lagrange et al., 1998). Interaction with TFIIB was visualized by x-ray crystallography (Tsai 
and Sigler, 2000). The sequence of BRE is GC-rich in eukaryotes in contrast to archaea, 
which also have BRE element, but it is rather AT-rich (Qureshi and Jackson, 1998). As 
mentioned above, the core promoter is also a scaffold for general transcription machinery and 
was studied extensively with respect to interactions wit Pol II and GTFs. Figure 7 shows 
current understanding of these interactions based on DNA-protein crosslinks. 
 
 
 
General transcription factors  
TFIIA 
TFIIA, in early days sometimes referred to as AB or STF, was initially discovered as an 
interaction partner of TFIID (Matsui et al., 1980; Samuels et al., 1982). It is usually discussed 
when referring to basal transcription although substitution of TBP by intact TFIID complex 
eliminated requirement of TFIIA for transcription in vitro (Conaway and Conaway, 1993; 
Zawel and Reinberg, 1993). TFIIA becomes essential in case of non- canonical TATA 
promoters and basal transcription with TFIID. It is important in PIC assembly in response to 
some activators (Stargell et al., 2000) and TFIIA depletion abolishes response to activators in 
Figure 7. Interaction of initiation machinery with class II promoter. (Hahn, 2004) 
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yeast (Chou et al., 1999). TFIIA enhances TBP binding to its target site in vitro (Weideman et 
al., 1997; Yokomori et al., 1994). This stabilization was explained with x-ray structures of 
TFIIA/TBP/DNA (Tan et al., 1996; Geiger et al., 1996; Bleichenbacher et al., 2003). Due to 
interaction with TBP, TFIIA stabilizes also TFIID interaction with DNA and plays a major 
role in displacement of a TAF domain, that inhibits formation of PIC (Kokubo et al., 1998). It 
also derepresses basal transcription by counteracting various inhibitors of preinitiation 
complex assembly (Chicca et al., 1998; Mermelstein et al., 1996; Merino et al., 1993). It is 
indispensable for efficient transcription from snRNA promoters in vitro. Yeast TFIIA consists 
of two subunits, the large subunit TOA1 and small subunit TOA2, whereas in humans there 
are three subunits, TFIIAα, TFIIAβ and TFIIAγ. These subunits have very high structural 
homology, share identical topology and can be superimposed with root mean square deviation 
(rmsd) of 0.99 Å (Bleichenbacher et al., 2003). The structure of TFIIA shows a β-barrel and 
four-helix bundle with β-barrel interacting with N-terminal portion of TBP and making 
several hydrogen bonds to DNA upstream of TATA box (Figure 8c). 
TFIID  
TFIID, in the early literature also known as DB, BTF1 and D (Matsui et al., 1980; Samuels et 
al., 1982), consists of TATA-binding protein ((TBP) (Hahn et al., 1989; Horikoshi et al., 
1989; Schmidt et al., 1989)) and around 14 TBP-associated factors ((TAFs) Lewin 1990; 
Ptashne and Gann, 1990)). TBP is a universal factor conserved in archaeal and eukaryotic Pol 
I, Pol II and Pol III systems, and although TAFs differ in sizes between yeast, Drosophila and 
human, conserved domains are homologous reflecting evolutionary conservation. Function of 
TBP is specific recognition of TATA core element and directing the PIC assembly. Structures 
of TBP alone from different organisms were solved by x-ray crystallography. TBP has two 
pseudosymmetric domains bent in the middle, creating a saddle (Chasman et al., 1993; 
DeDecker et al., 1996; Nikolov and Burley, 1994 Nikolov et al., 1992; Koike et al., 2004), 
which binds the TATA element (Juo et al., 1996, Kim et al., 1993a, 1993b; Nikolov et al., 
1996; Patikoglou et al., 1999). This platform created by TBP and DNA recruits then TFIIB 
which binds the binary complex with its two cyclin-A-like domains (Kosa et al., 1997; 
Nikolov et al., 1995; Littlefield et al., 1999; Tsai and Sigler, 2000 and Figure 8a). The 
complex of TBP bound to TATA box is stabilized by TFIIA that acts as a positive cofactor 
and this structure was solved by x-ray crystallography (Geiger et al., 1996; Tan et al., 1996; 
Bleichenbacher et al., 2003 and Figure 8c). Structure of TBP with Negative Cofactor 2 was 
determined by x-ray crystallography (Kamada et al., 2001) and explained the negative effect 
of this factor on transcription by preventing of recognition of TBP/DNA binary complex by 
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TFIIB. The orientation specificity of TBP for DNA sequence is not very rigorous and 
additional promoter elements such as BRE have to determine the orientation of PIC assembly 
(Cox et al., 1997). In archaea, the two TBP domains are more less symmetric so it is essential 
that the recognition of promoter directionality is conferred additionally by TFB binding to the 
BRE sequence. TFIID makes contacts not only to the TATA box (through TBP), but also 
additional downstream contacts, which might allow recognition of TATA-less promoters. 
These contacts in Drosophila and humans are conferred by two largest TAFs: TAF1 and 
TAF2 that can bind Inr directly (Chalkley and Verrijzer, 1999) and other two TAFs, TAF6 
and TAF9 were reported to interact with DPE. TAFs are often regarded as coactivators, 
transducing the signals from activators to the core machinery (Verrijzer and Tjian, 1996). 
Several TAFs are essential for growth and proliferation and can have a positive or negative 
effect on transcription. In yeast, there is only one form of TFIID characterized, whereas in 
Drosophila and human these complexes can vary in composition. Some TAFs have a DNA-
binding activity and can bind acetylated nucleosomes. Several have histone fold domains 
(HFDs) (Gangloff et al., 2002) and reconstitution of quaternary arrangement comparable to 
octamer has been reported (Selleck et al., 2001). Some complexes other than TFIID 
containing TAFs such as TFTC, SAGA, STAGA and PCAF have been reported (Brand et al., 
1999) and TAFs in these complexes might form protein interacting cores. Low-resolution EM 
structures of TFIID, TFTC, and TFIID in complex with TFIIB and TFIIA were reported 
(Andel et al., 1999; Brand et al., 1999 and Figure 8e) and TFIID shows globular, horseshoe 
like organization with a central, solvent exposed concave with TBP (immunolocalized) in the 
middle and TFIIA and TFIIB on two sites of TBP. TFIID has a characteristic three lobes 
whereas TFTC has five. Surprisingly, none of the lobes could accommodate the histone-like 
octamer. Structures of TAFs were also investigated with x-ray crystallography especially 
histone-like pairs: Drosophila TAFII40/TAFII60 (Xie et al., 1996) and human 
TAFII18/TAFII28 (Birck et al., 1998) and TAFII4/TAFII12 (Werten et al., 2002 and Figure 8f) 
and double bromodomain module from TAFII250 (Jacobson et al., 2000) and also by NMR 
like TAFII230 with TBP (Liu et al., 1998). 
TFIIB 
First characterized by Reinberg and Roeder in 1987, TFIIB plays a crucial role in PIC 
assembly, interacting with TBP, DNA, TFIIF and Pol II (Hampsey, 1998; Hahn, 2004). 
Binding studies identified this factor to be essential for TBP/DNA recognition by Pol II 
(Buratowski et al., 1989). TFIIB can also autoacetylate itself and this modification stabilizes 
interaction of TFIIB and TFIIF and activates transcription both in vitro and in vivo (Choi et 
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al., 2003). TFIIB consists of two domains, C-terminal domain, referred to also as core domain 
(TFIIBc) and N-terminal domain (TFIIBn). These domains are connected with a conserved, 
flexible region that forms a loop termed B-finger and a linker. The structure of TFIIBn 
encompassing ~30 residues was solved by NMR (Chen et al., 2000; Roberts and Green, 1994; 
Zhu et al., 1996; Barberis et al., 1993) and is composed of three antiparallel β-strands and a 
zinc binding motif (Bushnell et al., 2004; Chen et al., 2000; Hahn and Roberts, 2000). TFIIBn 
is essential for interaction of TFIIB with Pol II (Buratowski et al., 1993; Yamashita et al., 
1993; Barberis et al., Ha et al., 1993; Hahn 2004). Mutations in N-terminal domain of TFIIB 
alter transcription start site determination (Bangur et al. 1997; Pardee et al., 1998; Hawkes et 
al., 1999; Bell et al., 2000, Fairley et al., 2002). It was shown by biochemical probing (Chen 
and Hahn, 2003) and with x-ray crystallography (Bushnell et al., 2004) to interact with the 
pocket formed by the wall, dock and clamp regions of Pol II. This would explain the 
conservation of ribbon domain in TFIIB, Brf1 (Juo et al., 2002) and archea (Kosa et al., 
1997). C-terminal domain was very well characterized by several crystal structures in 
complex with TBP and DNA (Kosa et al., 1997; Nikolov et al., 1995; Littlefield et al., 1999; 
Tsai and Sigler, 2000 and Figure 8a). It consists of two cyclin A-like folds to clamp the C-
terminus of TBP and interacts with DNA upstream and downstream of TATA box in a 
sequence-unspecific and with BRE in a sequence-specific manner (Lagrange et al., 1998). The 
B-finger might play multiple roles in initiation. It can stabilize the interaction of Pol II with 
short DNA/RNA intermediates and therefore play a role at the transition from open complex 
formation to actively transcribing Pol II (Bushnell et al., 2004). It was also proposed by the 
same group that B-finger might compete with RNA on the saddle of Pol II and account for 
promoter escape when RNA becomes longer then 10 nt which would disrupt TFIIB-Pol II 
interaction. A mechanism of TFIIB being a “molecular bridge” defining a distance between 
start site and TBP was proposed based on electron crystallography of TFIIB and TFIIE in 
complex with Pol II at 15.7 Å projection (Leuther et al., 1996) but in the light of new data 
(Bushnell et al., 2004 and Figure 8j) this model seems to be only partially correct.  
TFIIF 
TFIIF was identified based on its strong, physical interaction with Pol II (Flores et al., 1990). 
It inhibits unspecific transcription initiation (Wang and Burton, 1995) and recruits Pol II to 
transcription initiation complex on promoter DNA making specific interactions with the 
promoter, TFIIB and TAF250 subunit of TFIID (Fang and Burton, 1996; Ruppert and Tjian, 
1995; Wang and Burton, 1995). TFIIF contributes to open complex formation by enabling 
entry of TFIIE and TFIIH to the scaffold and therefore DNA helicase activity of TFIIH 
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(Maxon et al., 1994; Tirode et al., 1999). TFIIF remains bound to Pol II during RNA 
elongation, enhancing processivity and the polymerization rate (Lei et al., 1999; Ren et al., 
1999; Yan et al., 1999). TFIIF also plays a role in the process of Pol II reinitiation by 
recruiting and enhancing the activity of phosphatase FCP1, which is required for 
dephosphorylation of the CTD of Pol II and is a prerequisite for the next round of 
transcription (Archambault et al., 1997). TFIIF forms a heterotetramer composed of conserved 
subunits, two large RAP74 in humans or α in yeast and two small RAP30 or β in yeast. Yeast 
TFIIF also contains third, non-conserved subunit-γ. X-ray studies showed the dimer of N-
terminal domains of RAP74 and RA30 (Gaiser et al., 2000) and CTDs of RAP30 (Groft et al., 
1998) and RAP74 (Kamada et al., 2001). N-terminal domains of these subunits form a novel, 
“triple barrel” dimerization fold and C-terminal domains form winged helix domains which in 
case of RAP30 makes unspecific DNA binding and in case of RAP74 interacts with FCP1 
(Kamada et al., 2003). RAP30 through its winged helix domains might also bind DNA on 
both sides of TATA box and compact promoter DNA around Pol II (Forget et al., 1997; Kim 
et al., 1997). RAP74 can also interact with DNA. Cryo-EM of RNA Pol II in complex with 
TFIIF allowed for ~18 Å reconstruction and showed RAP74 interacting with the extended 
surface of Pol II along the clamp and with the subcomplex of Rpb4/7 and RAP30 globular 
densities along the active site cleft (Chung et al., 2003 and Figure 8i). 
TFIIE 
TFIIE was identified in early 90s´ (Ohkuma et al., 1990 and 1991) and shown to recruit TFIIH 
to the preinitiation complex (Maxon et al., 1994). These two factors together stabilize and 
activate the PIC by completing the assembly and then melting the DNA around the 
transcription start site to create the transcription bubble, inducing the transition from closed to 
open PIC. TFIIE stimulates enzymatic activities of TFIIH, a helicase that is responsible for 
unwinding the dsDNA (Ohkuma and Roeder, 1994) and a kinase, which is responsible for 
phosphorylation of CTD of Pol II and transition to elongation phase of transcription (Drapkin 
et al., 1994). This transition is also facilitated by TFIIE, TFIIF and TFIIH, which cooperate in 
suppression of promoter proximal stalling. TFIIE can also melt the DNA at the supercoiled 
promoter. It was shown that premelted DNA around the transcription start site eliminated the 
requirement for TFIIE as well as TFIIH and ATP (Dvir et al., 1997; Holstege et al., 1996; Pan 
and Greenblatt, 1994; Tantin and Carey, 1994). It was shown that TFIIE can directly bind 
ssDNA (Kuldell and Buratowski, 1997) and crosslinking studies showed that it binds to 
promoter DNA upstream the transcription start site (Robert et al., 1996), within the 
transcription bubble or directly downstream of it. These contacts are consistent with electron 
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crystallography of TFIIE in complex with Pol II, which located it around the active center 
(Leuther et al., 1996). TFIIE is a heterotetramer consisting of two large subunits (Ohkuma et 
al., 1990) TFIIEα and two small TFIIEβ. NMR studies of TFIIEβ showed that it has a region 
with homology to the TFIIF winged helix domain (Okuda et al., 2000), which was proposed 
to bind DNA unspecifically in the similar manner as RAP30. The c-terminus of this small 
subunit of TFIIE seems to be essential for transition from initiation to elongation of 
transcription (Watanabe et al., 2003). NMR studies of part of TFIIEα showed a novel 
conserved zinc finger (Okuda et al., 2004), which is essential. Archaeal TFE is a homologue 
of TFIIEα and the structure of the N-terminal domain of TFE was solved (Meinhart et al., 
2003 and Figure 8b). It consists of a winged helix domain which does not have DNA binding 
activity in vitro and was proposed to make interactions with other GTFs and Pol II. 
TFIIH 
TFIIH is the largest and most complex of all GTFs. It consists of 10 subunits of total 
molecular weight of ~0.5 MDa and is comparable in complexity to Pol II and Mediator. 
Active, holo TFIIH was isolated from yeast (Svejstrup et al., 1994) and mammalian cells 
(Conaway et al., 1989). It is the only general transcription factor which has several enzymatic 
activities, including two different helicase activities of different polarities (subunit 
XPB/SSL2/RAD25 and subunit XPD/RAD3) and a cyclin-dependent protein kinase activity 
(subunit Cdk7/Kin28 and cyclin H/CCL1). It plays a central role in transcription by Pol I and 
Pol II, cell cycle control and DNA repair. TFIIH is composed of two subcomplexes: a core 
complex and the cyclin activating kinase complex (CAK). DNA dependent ATPases/helicases 
are essential for promoter opening by unwinding the DNA in an ATP dependent manner and 
this is crucial for the start of transcription. Six TFIIH subunits are sometimes referred to as 
repairosome (Svejstrup et al., 1995; Feaver et al., 2000), because they are involved in 
nucleotide excision repair and transcription coupled repair (Egly, 2001). Cdk7 phosphorylates 
the CTD (Gerber et al., 1995), which is a regulatory step in transition from initiation to 
elongation of transcription and this kinase activity is modulated by the Mediator. Cdk8, a 
subunit of Mediator, modulates Cdk7 through phosphorylation of cyclin H (Akoulitchev et al., 
2000). TFIIH interacts with several transcription factors (Bastien et al., 2000; Chen et al., 
2000) and was also shown to be connected with the splicing machinery. Interaction with some 
snRNAs, like U1 snRNA stimulates the formation of first phosphodiester bond by Pol II in 
vitro (Kwek et al., 2002). Based on TFIIH/DNA crosslinking studies different models for 
DNA opening were proposed. XPB was shown to interact with DNA both upstream and 
downstream of the start site, resulting in tight wrapping of the template around PIC. ATP 
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hydrolysis would then induce conformational change in XPB, which would then open the 
DNA by physical interaction (Douziech et al., 2000). The second model proposes that XPB 
would unwind a DNA in an ATP-driven manner downstream of start site with upstream DNA 
fixed (Kim et al., 2000). Human TFIIH was characterized at 38 Å resolution by EM (Schultz 
et al., 2000 and Figure 8d) and revealed a ring-like structure with a hole in the middle, of 
dimensions, which could accommodate the double-stranded (ds) DNA. Diffraction from 
electron micrographs of the crystals in negative stain extended to about 18 Å resolution 
(Chang and Kornberg, 2002 and Figure 8d) and 3D reconstruction revealed several densities 
whose volumes corresponded well with those of individual TFIIH subunits. In yeast TFIIH 
there is also a ring composed of 3 subunits as in case of human structure. Crystal structures of 
cyclin H (Andersen et al., 1996) and Cdk7 (Lolli et al., 2004) were obtained, and the carboxy-
terminal domain of P44 subunit, N-terminal domain of Mat1 and N-terminal pH/Ptb domain 
of P62 subunit were solved by NMR. 
The Mediator 
The mediator is a large modular macromolecular assembly, which transmits gene signals from 
gene specific transcription factors to the core Pol II machinery. This huge coactivator was first 
discovered as a complex enabling activated transcription in vitro with purified Pol II and 
GTFs (Flanagan et al., 1991; Kim et al., 1994). In Saccharomyces cerevisiae, Mediator is 
composed of 25 subunits, which are organized in four subcomplexes, the head, middle, tail, 
and Cdk8 modules (Guglielmi et al., 2004; Blazek et al., 2005). In yeast, this coactivator is 
required for regulation of the majority of genes (Holstege et al., 1998) and was discovered to 
stimulate basal transcription (Mittler et al., 2001; Baek et al., 2002). The Mediator confers 
many interactions, with activators, Pol II and GTFs and can modulate the transition from 
initiation to elongation by stimulation of the CTD kinase activity of TFIIH (Kim et al., 1994). 
Mediator was also reported to remain bound near the promoter during active transcription and 
therefore facilitate transcription reinitiation (Liu et al., 2001; Yudkovsky et al., 2000). 
Mediator can transduce both positive and negative regulatory information to the core Pol II-
GTFs machinery (Hampsey and Reinberg, 1999). Mediator also shows significant 
evolutionary conservation from yeast to human (Malik and Roeder, 2000), but the 
composition of different species of Mediator can vary depending on the organism and the 
stage of cell cycle. Mediator undergoes strong conformational changes upon binding to Pol II 
(Naar et al., 2002; Asturias et al., 1999; Davis et al., 2002) or activators (Taatjes et al., 2002). 
The resolution of these EM structures was limited to 30-35 Å and provided a gross shape of 
Mediator, but no structural details (Figure 8g). A high-resolution picture exists for the 
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conserved MED7/MED21 heterodimer, which was solved by x-ray crystallography at 3.0 Å 
resolution (Baumli et al., 2005 and Figure 8h). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Structures of initiation machinery components. (a) TBP/TFB/DNA (Littlefield et al., 1999, pdb entry: 
1D3U); (b) TFE/TFEα (Meinhart et al., 2003, pdb entry: 1Q1H); (c) TBP/TFIIA/DNA (Tan et al., 1996, pdb entry: 
1YTF); (d) molecular envelope of yeast ((red) Chang and Kornberg, 2000) and human ((yellow) Schultz, 2000) 
TFIIH; (e) molecular envelope of yeast TFIID (Brand et al., 1999) with TAFs (green) and TBP (red) positions; (f) 
histone pair of human Taf4 and Taf12 (Werten et al., 2002, pdb entry: 1H3O); (g) yeast holoenzyme (mediator and 
RNA Pol II, Davis et al., 2002); (h) Med7/Med21 structure (Baumli et al., 2005, pdb entry: 1YKH); (i) Pol II-TFIIF 
EM structure (Chung et al., 2003); (j) Pol II-TFIIB structure (Bushnell and Kornberg, 2004, pdb entry: 1R5U) 
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Sequential assembly of PIC and interaction of GTFs with Pol II 
Based on x-ray studies, PIC assembly involves following steps. 
1. Binding of TBP to TATA element through minor groove forms a stable complex, 
where DNA is distorted. 
2. Binding of TFIIB through direct interactions with TBP and DNA. 
3. Binding of TFIIA, which stabilized TBP-TFIIB-DNA complex. 
4. Promoter targeting by preformed Pol II-TFIIF complex. 
5. Recruitment of TFIIE and TFIIH through interactions of TFIIE with Pol II and DNA. 
At this stage, transcription can start with promoter melting catalyzed by ATP dependent 
TFIIH helicase. Some structural knowledge of intermediates of these complexes exists (Figure 
8) but the process of initiation will only be understood when the structural and biochemical 
data can be put in context of 12-subunit Pol II. At this stage, there is only one x-ray structure 
of GTF in complex with Pol II (Bushnell et al., 2004 and Figure 8j) and several low-resolution 
EM structures (e.g. Chung et al., 2003 and Figure 8i). From this data, the picture is as follows. 
The Zn-ribbon domain of TFIIB binds Pol II around the dock domain and the B-finger 
protrudes into the hybrid-binding site. It can stabilize interaction of Pol II with short 
DNA/RNA hybrids and therefore play a role during the transition from open complex 
formation to actively transcribing Pol II (Bushnell et al., 2004). This would be consistent with 
the action of σ, bacterial initiation factor that penetrates the hybrid-binding site with its 3.2 
region (Cramer, 2004; Vassylyev, 2002). In the archaeal system homologues of TFIIB and 
TBP are sufficient for promoter loading but in the Pol II system, TFIIF is required (Tyree et 
al., 1993). One can expect topological similarity of promoter loading in Pol II and bacteria 
based on the available structures of Pol II with TFIIB and TFIIF and bacterial holoenzyme. 
These factors bind in the same region where σ was shown to bind in bacterial polymerase 
(Figure 4c). In this region, Mediator was also shown to bind, around the Rpb3-Rpb11 
heterodimer and this region seems to be important as well for transcription regulation in 
bacteria (Davis et al., 2002). After assembly of TBP-TFIIB-Pol II/TFIIF complex, TFIIH with 
help of TFIIE has to join and open the promoter. This step is poorly characterized with 
structures, electron crystallography at low resolution (Leuther et al., 1996) suggests that 
TFIIE binds near the cleft, which is in agreement with studies showing that TFIIE crosslinks 
DNA around the transcription start site in the PIC. There is no structural information 
concerning the Pol II-TFIIH complex except crosslinking (Kim et al., 2000). 
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Abstract 
 
 
RNA polymerase II (Pol II) consists of a ten-polypeptide catalytic core and the 
two-subunit Rpb4/7 complex that is required for transcription initiation.  
Previous structures of the Pol II core revealed a “clamp,” which binds the DNA 
template strand via three “switch regions,” and a flexible “linker” to the C-
terminal repeat domain (CTD).  Here we derived a model of the complete Pol II 
by fitting structures of the core and Rpb4/7 to a 4.2 Å crystallographic electron 
density map. Rpb4/7 protrudes from the polymerase “upstream face,” on which 
initiation factors assemble for promoter DNA loading.  Rpb7 forms a wedge 
between the clamp and the linker, restricting the clamp to a closed position.  The 
wedge allosterically prevents entry of the promoter DNA duplex into the active 
center cleft, and induces in two switch regions a conformation poised for 
template strand binding.  Interaction of Rpb4/7 with the linker explains Rpb4-
mediated recruitment of the CTD phosphatase to the CTD during Pol II 
recycling.  The core-Rpb7 interaction and some functions of Rpb4/7 are 
apparently conserved in all eukaryotic and archaeal RNA polymerases, but not 
in the bacterial enzyme. 
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Introduction 
Pol II synthesizes all eukaryotic mRNA in the course of gene transcription.  The regulation of 
gene transcription by Pol II underlies cell proliferation and differentiation.  Regulation occurs 
mainly at the level of transcription initiation, when Pol II assembles with the general 
transcription factors TFIIB, -D, -E, -F, and –H into the initiation complex on promoter DNA 
(Roeder, 1998; Lee and Young, 2000; Lemon and Tjian, 2000).  In addition to the ten-subunit 
Pol II core, initiation requires the heterodimeric Rpb4/7 complex that can dissociate from core  
Crystallographic structures are available for the Saccharomyces cerevisiae Pol II core (Cramer 
et al., 2000 and 2001), which is sufficient for RNA elongation (Ruet et al., 1980; Edwards et 
al., 1991). In the core structures, the two large subunits form opposite sides of a central 
“cleft,” and the eight small subunits are arrayed around the periphery.  The cleft contains the 
active center, and is constricted at one end by a protein “wall.”  One side of the cleft is formed 
by a mobile “clamp,” which adopts open states in two crystal forms of the Pol II core ( 
Cramer et al., 2000 and 2001), but is closed in a further structure of a core elongation complex 
with bound template DNA and product RNA (Gnatt et al., 2001).  Mobility of the clamp relies 
on five protein “switch” regions, which connect the clamp to the remainder of the enzyme 
(Cramer et al., 2001; Gnatt et al., 2001).  A flexible “linker” emerges from the core surface 
below the clamp, and connects to the C-terminal repeat domain (CTD) of the largest Pol II 
subunit, which is dissordered in all core structures. The purification of 10-subunit core was 
established several years ago and here the refined and optimized procedure is reported. 
Purification of E.coli overexpressed subcomplex of Rpb4/7 is shown in Chapter III and will 
not be presented here. The reconstitution of 12- polypeptide enzyme relies on quality of 
preparations of both proteins and the ultimate goal is to reconstitute stoichiometric, 
homogeneous species of this macromolecular assembly. It will be shown here how this 
reconstitution is done. Counterparts of the Rpb4/7 complex exist in the two other eukaryotic 
RNA polymerases (Sadhale and Woychik, 1994; Shpakovski and Shematorova, 1999; 
Peyroche et al., 2002; Siaut et al., 2003; Hu et al., 2002), and the archaeal RNA polymerase 
(Werner et al., 2000). The structure of an archaeal Rpb4/7 counterpart revealed an extended 
complex, spanned by the Rpb7 homolog (Todone et al., 2001). To understand Rpb4/7 
function, and to elucidate the mechanism of transcription initiation, we studied the 12-subunit 
Pol II by X-ray crystallography. 
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Materials and methods 
Fermentation and purification of 10-subunit Pol II 
ΔRpb4 strain 
For structural biology purposes described in the introduction yeast strain CB010∆Rpb4 (Mata, 
pep4::His3/prb1::Leu2, prc1::HISG, can1, ade2, trp1, ura3, his3, leu2-3, 112) was used. This 
strain has a knockout of Rpb4 subunit of RNA polymerase II and since the stability of Rpb7 
upon binding to Pol II is lower in absence of Rpb4, in purification stoichiometric and pure 10-
subunit (lacking Rpb4/7 subcomplex) core Pol II is obtained. The other important features of 
the strain is a knockout of three cellular proteases namely: vacuolar proteinase B which is a 
serine-type endopeptidase; vacuolar carboxypeptidase Y (proteinase C) and most importantly 
vacuolar aspartyl protease (proteinase A), required for the posttranslational precursor 
maturation of vacuolar proteinases and therefore its knockout inactivates the whole cascade of 
proteolytic enzymes. This strain additionaly has an Ade2 marker, a phosphoribosyl-
aminoimidazole carboxylase that catalyzes a step in 'de novo' purine nucleotide biosynthetic 
pathway and the mutant cells deprived of adenine accumulate red pigment. Due to Ade2 
marker, we have a good indication of the stationary phase since the cells turn red. 
Fermentation of ΔRpb4 strain 
Since no overexpression systems are developed for obtaining RNA Pol II and as milligram 
quantities are required for crystallization, large scale fermentation of yeast was necessary to 
obtain sufficient amount of material. The amount of crystallization grade Pol II that is purified 
in one preparation is quite low and ranges from 6-10 mg from around 600 g of yeast pellet. 
For fermentation two different bioreactors ISF 20 and ISF 200 (INFORS HT, Figure 1) were 
used. Bioreactors have a huge advantage over shaker cultures, not only because it is possible 
to ferment large volumes in them but also to control several parameters like pH, temperature, 
amount of air and stirring. For yeast growth in ISF 20 and ISF 200 these parameters were 
refined experimentally. Table 1 shows parameters used in each of the fermenters. The steam 
and cold water flow adjust the temperature to the set value, and externally connected vessels 
with 2 M NaOH control the pH. Other parameters are set to fixed values and do not change 
during the process. 
Yeast was grown at 30°C on YPD1 medium with addition of 10 mg/l of Tetracyclin and 50 
mg/l of Ampicilin to avoid contaminations caused by E.coli. First, 20 ml preculture was 
started from glycerol stock, grown for 16 hours and transferred to 500 ml preculture which 
                                                 
1 Media, additives and buffers used during preparation of 10-subunit Pol II are listed in Table 3 
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was grown to OD600 of 4 in the shaker. This culture was used then as inoculum for the ISF20. 
15 litres of YPD medium in the fermenter were sterilized (20 minutes at 121°C) prior to 
inoculation and fermentation and cooled down to 30°C. For fermentation 0.003 % of 
Antifoam C Emulsion (Sigma) and proper amount of antibiotics were added. The starting OD 
in the ISF20 fermenter was usually around 0.1. The doubling time was estimated to be around 
3.5-4 hours for this strain and usually yeast reached early stationary phase in approximately 
23-26 hours. This culture then was pumped into ISF200 which was pre-filled with 185 litres 
of sterilized YPD medium and cooled down to 30°C. The antifoam and antibiotics were added 
and the fermentation started with the initial OD600 usually around 0.1.  
 
     Table 1. Fermentation parameters 
 
 
 
 
 
 
 
Fermenter ISF 20 ISF 200 
preculture; 
OD600 
3-4 5-6 
preculture; 
volume (l) 
0.5 15 
starting OD600 0.1 0.1 
final OD600 5 6-7 
total volume (l) 15 200 
temperature 
(°C) 
30 30 
pH 7 7 
stirrer (RPM)  600 200 
air (l/min) 8 20 
fermentation 
time (h)  
23-26 22-23 
Figure1. ISF 200 (left) and ISF 20 (right) 
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Fermentation was finished after around 23 hours when yeast reached early stationary phase 
which was monitored with regular OD600 measurements. Cells were harvested with 
continuous-flow Carl Padberg centrifuge and around 1.5-2 kg of yeast paste was obtained. 
The cells were then resuspended in 3x Pol II freezing buffer (330 ml/kg of cells), divided into 
500-600 g aliquots, frozen in liquid nitrogen and stored at -80°C. 
Lysis of yeast 
The first step before protein purification is cell lysis, which in case of yeast is quite tedious. 
The lysis has to be very efficient so that the majority of cells are disrupted and at the same 
time protein has to be intact and not degraded for example due to heating emitted during cell 
disruption. In case of 10-subunit Pol II yeast pellet was opened with the Bead Beaters 
(BioSpec Products) in which cells are disrupted by 0.45-0.5 mm borosilicate beads. In each 
preparation 3 Bead Beaters were used. The metal chamber was filled with 200 ml of beads 
and approximately 200 ml of yeast cell suspension which corresponds to approximately 200 g 
of dry yeast pellet. Then 1 ml of 100x protease inhibitor mix was added, mixed with a glass 
rod to get rid of air bubbles. The chambers were then filled to the top with buffer HSB150, 
and Bead Beaters assembled. The chambers were immersed in salt/ice mix and the bead 
beating started with a duty cycle of 60 s lysis, 90 s pause to avoid overheating. The lysis 
lasted for 75 minutes and every 10-15 minutes the salt/ice mix was exchanged. The efficiency 
of lysis was always around 90-95 %. After 75 minutes the beads were filtered from lysate 
with a mesh funnel. The beads were then washed with buffer HSB150 until the flowthrough 
became clear (the volume for three bead beaters never exceeded 600 ml of buffer HSB150). 
The lysate was then centrifuged twice at 12000 RPM for 30 minutes. 
Purification of 10-subunit Pol II 
For 3 bead beaters preparation, 250 ml Hepharin Sepharose Fast Flow (Pharmacia, 17-0998-
03) was used. The column was equilibrated with 3 column volumes (cv) of HSB150, where 
for last cv DTT and protease inhibitors were added. The cell extract was loaded on the column 
with the flow of 8 ml/min. Then the column was washed with 3 cv of buffer HSB150 and 
bound protein eluted with 500 ml HSB600. First 100 ml of the elution were discarded and the 
remaining 400 ml were precipitated for 30 minutes at 4°C with 116.8 g of solid, fine-ground 
ammonium sulphate. The precipitation solution was then centrifuged for 45 minutes at 12000 
RPM, the supernatant decanted and pellet stored at 4°C overnight. Second day of purification 
started with dissolving of ammonium sulphate pellet in 80 ml of TEZ0 which corresponded to 
conductivity below 400µSi. 5 ml 8WG16 immunoaffinity column was equilibrated with 4 cv 
of buffer TEZ250 and for last column volume DTT was added to the buffer. The column was 
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loaded by gravity and the flowthrought was reloaded to ensure complete binding of Pol II. 
The wash step was done at room temperature with 5cv of TEZ500 and 10-subunit Pol II was 
eluted with TEZ500/glycerol buffer, 1 ml fractions were collected and checked for protein 
with Bradford reagent. Main fractions were pooled and stored at 4°C overnight. The 8WG16 
column was cleaned with TEZ500/ethylene glycol/noDTT buffer, reequilibrated with 
TEZ250/noDTT buffer containing 0.02 % azide and stored at 4°C for next purification. 
Usually the column can be used around 10 times with high efficiency of binding. The 
subsequent purification step is done on AEKTA HPLC purification system (Amersham 
Biosciences) and is based on anion exchange chromatography. This step was changed in the 
course of this PhD work in comparison to old protocols. The Phenomenex Biosep DEAE 
5PW which was used in a previous protocol (Cramer et al., 2000) was replaced with Biorad 
UnoQ 1.35 ml anion exchange column. The main fractions from immunoaffinity step were 
diluted with buffer UnoQ 0 until the conductivity corresponded to 90 mM ammonium 
sulphate (usually 1:8 dilution). The UnoQ column was washed with high salt UnoQ B buffer 
and preequilibrated with UnoQ A buffer. The sample was loaded and unbound protein was 
washed with 3 cv of buffer UnoQ A. Pol II was eluted with a linear gradient from 0-50 % over 
10 cv of UnoQ B buffer and 1 ml fractions were collected. Column was then stored in water 
with addition of 0.02 % of azide. The peak fractions were pooled and aliquots of 500 µg of 
protein were precipitated with saturated ammonium sulfate for around 1h at 4°C (protein 
solution 1:1 with saturated ammonium sulphate). Aliquots were then centrifuged for 30 
minutes at 14000 RPM, supernatant decanted (some left to keep pellet covered), frozen in 
liquid nitrogen and kept in -80°C ready for crystallization experiments. The yield from one 
purification ranged from 6 to 12 mg of 10-subunit RNA Pol II. 
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Expression and purification of full-length Rpb4/7 
Full length Rpb4/7 was a kind gift from M. Kimura and A. Ishihama. Neither Rpb4 nor Rpb7 
could be overexpressed alone in E.coli. This problem was overcame by construction of 
double-expression system for Rpb4/7 (Sakurai et al., 1999) with T7 promoter preceding Rpb4 
coding frame and second T7 promoter preceeding Rpb7 coding frame followed with a His-
Tag and T7 terminator. This strategy is shown in Figure 2. This strategy is a key to get both 
proteins overexpressed in a soluble manner, if expressed independently they do not have the 
interaction partner for co-folding and aggregate. Upon translation both nascent peptide chains 
emerge from ribosomes in physical proximity and thereby fold properly. The complex can be 
purified with affinity chromatography due to His-tag which is cloned C-terminally on Rpb7. 
Table 2 lists few important facts about both proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table2. Number of residues, molecular weight, pI and estimated charge of Rpb4 and Rpb7 
 
Protein Rpb4 Rpb7 
Amino acid residues 221 171 
Molecular weight (kDa) 25.415 19.059 
pI 4.92 7.8 
Estimated charge at pH 7.0 -15.6 1.8 
Figure 2. Double 
expression strategy. 
Rpb4 is depicted in red 
and Rpb7in blue. 
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The transformed E.coli BL21(DE3) with double expression plasmid were grown in LB 
medium at 37°C. When the cells reached optical density of 0.6 measured at 600nm, isopropyl-
β-D-thiogalactopyranosid (IPTG) was added to a final concentration of 0.05 µM. The cells 
were then grown for 16 hours at 18°C, harvested by centrifugation, suspended in Rpb4/7 
freezing buffer2 and stored at -80°C. For purification of expressed protein, frozen cells were 
thaw at room temperature, lysed with a French Press (Gaulin) with 750 Bar pressure, 
centrifuged for 20 minutes at 16000 RPM two times at 4°C. The resulting supernatant was 
loaded on Ni2+-nitriloacetic acid agarose (Qiagen). The column was washed in a stepwise 
fashion with 3 times the column volume of buffer 0, 3 times buffer 0 containing 10 mM 
imidazole and 3 times buffer 0 containing mM imidazole. Protein was then eluted with buffer 
0 containing 50 mM imidazole. To wash the column and elute the remaining bound protein 5 
times column volume buffer 0 containing 200 mM imidazole was used. Fractions were 
checked with Bradford reagent to detect if protein was eluted, and loaded on 15 % SDS-
PAGE. The main fractions were then diluted with buffer C and loaded with buffer A on the 
ResourceQ3 6 ml anion exchange chromatography column (Pharmacia) were they were eluted 
with a gradient of 0-100 % ResourceQ buffer B. Fractions were then checked with Bradford 
and loaded on 15 % SDS-PAGE. Main fractions were upconcentrated and loaded with Pol II 
buffer on Superose 12 HR 10/30 column (Pharmacia). Peak fractions were then loaded on 15 
% SDS-PAGE gel and then upconcentrated to 7 mg/ml, frozen in liquid nitrogen and stored at 
-80°C. 
Assembly of 12-subunit Pol II 
For reconstitution of stoichiometric 12-subunit Pol II, 500 µg frozen ammonium sulphate 
pellet of 10-subunit Pol II was thaw on ice and centrifuged for 20 minutes at 14000 RPM at 
4°C. The solution covering the pellet was carefully removed with a pipet and the pellet was 
dissolved in 300 µl of Pol II buffer and 5 M excess of full-length Rpb4/7 was added. Total 
volume of the solution should not exceed 350 µl. The solution was then incubated for 1h at 
20°C and then loaded with Pol II buffer on preequilibrated Superose 6 gel filtration column. 
The column separates 12-subunit complex from the excess of Rpb4/7 and the samples from 
the peak fractions were loaded on 15 % SDS-PAGE gel to check visually the subunit 
composition of assembled complex. 
                                                 
2 Media, additives and buffers used during preparation of Rpb4/7 are listed in Table 4 
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Crystallization of 12-subunit Pol II 
For crystallization of 12-subunit RNA Pol II hanging drop method was used. Therefore 1.5 µl 
of the purified protein (solutions contained 4 mg/ml protein) was set with a pipette as a drop 
on a plastic cover slide and mixed with 1.5 µl of reservoir solution. The slide was set up side 
down over a well with reservoir solution and sealed to the reservoir edge using high vacuum 
grease. As the drop contains lower concentration of crystallization agent, water vapour will 
leave the drop and the concentration will increase until supersaturation and crystal growth is 
reached. Crystallization was carried out at 20°C and the plates were egzamined under a 
microscope few days after setting the drops for presence of crystals. Crystals were harvested 
in a mother solution and several different cryoprotectants were carefully screened. The 
cyroprotectants were introduced in a stepwise fashion and quick freezing at 4°C and at 20°C 
was tried. 
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Table 3. Media, additives and buffers used during fermentation and purification of 10-subunit 
Pol II 
Name Description of additives 
Yeast media 
YPD 1.5 % yeast extract, 2 % peptone, 2 % glucose 
Antibiotics 
Ampicillin   50 mg/l of Ampicilin 
Tetracycline 10 mg/l of Tetracyclin 
Purification 
100x protease inhibitor mix 
1.42 mg Leupeptin, 6.85 mg Pepstatin A,  0.85 g PMSF,  
1.65 g Benzamidine; add Ethanol up to 50 ml; stored at -20°C 
3x freezing buffer 
150 mM Tris-Cl, pH 7.5 at 4°C, 3 mM EDTA, 30 % glycerol, 30 µM ZnCl2, 3 % 
DMSO, 30 mM DTT, 3x protease inhibitor mix 
Heparin purification 
1x HSB150 
50 mM Tris-Cl pH 7.9 at 4°C, 150 mM KCl, 1 mM EDTA, 10 % glycerol, 10 µM ZnCl2, 
10 mM DTT, 1x protease inhibitor mix 
1x HSB600 
50 mM Tris-Cl pH 7.9 at 4°C, 600 mM KCl, 1 mM EDTA, 10 % glycerol, 10 µM ZnCl2, 
10 mM DTT, 1x protease inhibitor mix 
Antibody purification 
10x TEZ0 500 mM Tris-Cl pH 7.5 at 20°C, 10 mM EDTA, 100 µM ZnCl2 
1x TEZ0 5 ml 10x TEZ0, 5 mM DTT, 1x protease inhibitor mix, H2O to 50 ml 
1x TEZ250 
5 ml 10x TEZ0, 250 mM ammonium sulphate (3 M stock), 5 mM DTT, 1x protease 
inhibitor mix, H2O to 50 ml 
1x  TEZ500 
5 ml 10x TEZ0, 500 mM ammonium sulphate (3 M stock), 5 mM DTT, 1x protease 
inhibitor mix, H2O to 50 ml 
1x TEZ500 + glycerol 
5 ml 10x TEZ0, 500 mM ammonium sulphate (3 M stock), 50 % glycerol, 5 mM DTT, 
no protease inhibitiors, H2O to 50 ml 
1x TEZ500 + ethylene glycol 
5 ml 10x TEZ0, 500 mM ammonium sulphate (3 M stock), 70 % ethylene glycol, no 
DTT, no protease inhibitors, H2O to 50 ml 
Anion exchange chromatography (UnoQ) 
UnoQ 0 
50 mM Tris-Cl pH 7.5 at 20°C, 10 % glycerol, 1 mM EDTA, 10 µM ZnCl2,, 10 mM 
DTT 
UnoQ A 
50 mM Tris-Cl pH 7.5 at 20°C, 60 mM ammonium sulphate, 10 % glycerol, 1 mM 
EDTA, 10 µM ZnCl2, 10mM DTT 
UnoQ B 
50 mM Tris-Cl pH 7.5 at 20°C, 1 M ammonium sulphate, 10 % glycerol, 1 mM EDTA, 
10 µM ZnCl2, 10 mM DTT 
Gel filtration (Superose 6) 
Pol II buffer 5 mM Hepes pH 7.25, 40 mM ammonium sulphate, 10 µM ZnCl2,  10 mM DTT 
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Table 4. Media, additives and buffers used during purification of Rpb4/7 
Name Description of additives 
E.coli Media  
LB 
10 g Trypton, 5 g Yeast Extract, 5 g NaCl, 1.3 ml 2 M NaOH;  
filled with H2O to 1 litre.  
For making culture plates 1, 5 % Agar (w/v) was added. 
Antibiotics/ IPTG  
Ampicillin   100 mg/ml H2O               
IPTG 234.3 mg/ml H2O (1M)  
Purification 
100x protease inhibitor mix     
1.42 mg Leupeptin, 6.85 mg Pepstatin A,  0.85 g PMSF,  
1.65 g Benzamidine; add Ethanol up to 50 ml; stored at -20°C                  
Lysis Buffer 50 mM Tris (pH 7.0), 150 mM NaCl, 10 % glycerol 
Ni-NTA purification 
Elution buffers for Ni-NTA 
column 
Lysis Buffer with increasing concentrations of imidazole:  
10 mM, 20 mM, 50 mM, 200 mM 
Anion exchange chromatography (ResourceQ) 
Buffer A 100 mM NaCl, 20 mM Tris pH 7.5, 1 mM EDTA, 10 mM DTT                                     
Buffer B 1 M NaCl, 20 mM Tris pH 7.5, 1 mM EDTA, 10 mM DTT                                              
Buffer C 20 mM Tris pH 7.5, 1 mM EDTA, 10 mM DTT                                      
Gel filtration (Superose 12) 
Pol II buffer  5 mM Hepes pH 7.25, 40 mM ammonium sulphate , 10 mM ZnCl2 
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Figure 3. Logarithmic growth curve of ΔRpb4 strain in ISF200. 
 
Results and Discussion 
Fermentation of 10-subunit Pol II 
The yeast growth was carefully monitored during fermentation. The measurements of optical 
density at 600 nm at defined time points were plotted on the logarithmic curve to define the 
phase of growth. These measurements were supported by light-microscopy examinations of 
cells to check for possible contaminations and look at yeast morphology. ∆Rpb4 cells have to 
be harvested at late logarithmic early stationary phase to ensure that the degradation of Pol II 
is minimized. Pol II is mostly abundant in the cell during logarithmic phase of growth and this 
is another reason for which the cells have to be harvested before they reach late stationary 
phase. The estimate of the doubling time for this yeast strain is around 4 h. Figure 3 shows a 
logarithmic growth curve of ΔRpb4 strain. 
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Figure 4. 15 % SDS-PAGE of 10-subunit Pol II after antibody column. 
Lanes 1-5 show fractionscollected from colum; subunits of Pol II (white).
Purification of 10-subunit Pol II 
After the first step of preparation, Pol II cannot be seen on the SDS-PAGE because there is 
lots of other proteins which co-elute with it from Heparin column and this step is only a first 
crude separation based on their ionic character. The ammonium sulphate precipitation further 
reduces the number of other proteins in the solution. The step after which Pol II becomes 
distinguishable on the SDS-PAGE is the immunoaffinity 8WG16. 1 ml elution fractions from 
antibody column were collected, checked with Bradford reagent weather they contain protein 
and 20 µl samples were loaded on 15 % SDS-PAGE gel (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The quality of Pol II after the antibody column was already very high but it had to be further 
purified because crystal setups after this step were still unsuccessful. UnoQ anion exchange 
chromatography was the last, refining step of purification and protein that elutes from this 
column is extremely pure and of crystallization quality. Figure 5 shows the UnoQ elution 
profile of Pol II. 
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Figure 5. UnoQ anion exchange chromatography of 10-subunit RNA Pol II. 
Blue: absorption at 280 nm, red absorption at 260 nm, green: salt gradient 
 
Figure 6. 15 % SDS-PAGE of 10-subunit Pol II after  UnoQ (lane 1-4). 
M: marker 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak fractions were collected and loaded on SDS-PAGE gel to check for quality (Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pol II is then precipitated with ammonium sulphate, frozen in liquid nitrogen and stored at  
-80°C where it is stable for 2-3 months. 
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Figure 7. 15 % SDS-PAGE of elutions of full length Rpb4/7 from Ni-NTA.  
50-200 mM imidazole elutions of full length Rpb4/7 from left to right respectively. 
Expression and purification of full-length Rpb4/7  
Full length Rpb4/7 was expressed in 4l of LB medium to ensure sufficient amount for further 
reconstitution and crystallisation of 12-subunit RNA Pol II. It was purified by Ni-NTA gravity 
flow affinity chromatography. The optimal imidazole concentration of the elution solution 
was tested and determined by a step gradient of 10, 20, 50 and 200 mM of imidazole. The 
elution occurred mostly at the concentration of imidazole between 20 – 200 mM. The 
concentration of protein in these fractions was estimated with Bradford reagent and the purity 
was checked on SDS-PAGE (Figure 7). 
 
 
 
 
 
 
 
 
 
The thin band under Rpb4 is a degradation product and is removed in subsequent purification 
steps. The 50 and 200 mM imidazole peak fractions were pooled together, diluted 3 times 
with buffer C to reach the salt amount below 100mM NaCl (ResourceQ buffer A) and applied 
to the anion exchange chromatography ResourceQ column (Figure 8). The peak fractions 
were checked on SDS-PAGE (Figure 9). 
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Figure 8. ResourceQ anion exchange chromatography of full length Rpb4/7. 
Blue: absorption at 280 nm, green: salt gradient 
Figure 9. 15 % SDS-PAGE with ResourceQ anion exchange fractions. 
Protein fractions were loaded on SDS-PAGE. Lanes 1 and 2 flowthrough 
fractions 3, 4, 5 peak fractions, protein marker in the last lane on the right side 
 
 
 
 
 
 
 
 
 
 
 
 
The peak fractions were pooled, concentrated to total volume of 600 µl and subjected to next 
and final step of purification, Superose 12 gel filtration onto which 300 µl of sample was 
loaded for one run (Figures 10 and 11). 
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Figure 10. Superose 12 gel filtration chromatography of full length Rpb4/7. 
Blue: absorption at 280 nm 
Figure 11. 15 % SDS-PAGE with Superose 12 peak fraction. 
20 µl protein from peak fraction were loaded on SDS-PAGE 
1: a peak fraction and M is a protein marker 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The purity of full length Rpb4/7 after gel filtration is very high, there are no additional 
proteins, such as degradation products or impurities visible on gel and the quality is therefore 
sufficient for crystallization experiments. The concentration of protein was measured with 
Bradford reagent, peak fractions pooled and concentrated to 7 mg/ml, flash frozen in liquid 
nitrogen and stored in –80°C for further use. The total amount of this highly pure 
crystallization quality Rpb4/7 is around 4 mg from 4 l of expression. 
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Figure 13. 15 % SDS-PAGE 
of fractions from Superose 
6 12-subunit Pol II 
assembly. 
1st peak from Superose 6 lane 
1 and 2; 2nd peak from 
Superose 6 lane 3 and 4; M: 
marker 
 
Figure 12. Superose 6 gel 
filtration chromatography 
of 10-subunit Pol II core 
incubated with 5x molar 
excess of full length 
Rpb4/7 subcomplex. 
Blue: absorption at 280 nm; 
Red arrows indicate peaks 
and their content 
 
Assembly of 12-subunit Pol II 
12-subunit Pol II is assembled as described in Materials and Methods. To get a homogeneous 
and stoichiometric sample, 10-subunit Pol II was incubated with 5 M excess of Rpb4/7. The 
excess of Rpb4/7 was removed with gel filtration (Figure 12 and Figure 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After gel filtration protein was concentrated and subjected to crystallization trials. 
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Crystallization of 12-subunit Pol II 
Peak protein fractions from Superose 6, which contained 12-subunit RNA Pol II were 
concentrated to 4 mg/ml with 10 kDa cutoff concentrator. Crystallization trials were carried 
out with the hanging drop vapour diffusion method. Establishment of crystallization 
conditions was done by sparse matrix sampling using commercially available Hampton 
Screen and Hampton Screen1 and screens derived from conditions in which 10-subunit Pol II 
was crystallized. After crystals were grown, promising conditions were refined by variation of 
salts, pH and PEG in the reservoir. Table 5 shows the conditions in which 12-subunits Pol II 
crystals were obtained. Conditions which yielded crystals diffracting to 4.2 Å and 3.8 Å are 
marked red in Table 5.  
Table 5. Crystallization conditions for 10- and 12-subunit Pol II 
Conditions Cryoprotocol Comments Max. Reso. 
10-subunit Pol II crystallization condition 
PEG/PO4 
390 mM NH4NaPO4, pH 6.0 
15-18 % PEG 6k 
50 mM dioxane 
5 mM DTT 
shrinkage protocol 
(Cramer et al., 2001) 
16 % PEG6K, 100 mM MES pH 6.3, 
50 mM dioxane, 350 mM NaCl, 17 % 
PEG400 in 7 steps ; 4°C over 24 h 
conditions for high-
resolution 10 subunit Pol 
II 
2.8 Å  
12-subunit Pol II crystallization conditions 
PEG20K/PO4 
320 – 360 mM NH4NaHPO4, 
pH 6.0 
8-12 % PEG20k  
25 mM NaCl 
5 mM DTT 
mother solution + 0-(16-22) % 
glycerol in 5 steps; 8 °C over night 
original 12 subunit  
Pol II conditions 
ca.  
4.5 Å 
Natrix #38 
200 mM ammonium acetate 
150 mM magnesium acetate 
50 mM Hepes pH 7.0 
5 % PEG4k or 6k 
5 mM DTT or TCEP 
mother solution + 0-20 % glycerol in 5 
steps; 8 °C over night 
 3.6 Å 
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Figure 14. Crystals of 12-subunit Pol II. Left: initial; Middle: primary refinement; 
Right: refined conditions (listed in Table3) 
Conditions Cryoprotocol Comments Max. Reso. 
Tartrate/Hepes 
750 – 950 mM NH4NaTartrate 
100 mM Hepes-Na  
pH 7.5 
5 mM DTT or TCEP 
mother solution + 0-22 % glycerol in 5 
steps; 8 °C over night 
modified Hampton screen 
1 #29 
3.8 Å 
Tartrate/PEG/ 
KSCN 
12-13 % PEG-6000  
300 mM ammonium-sodium 
tartrate 
100 mM Hepes pH 7.5 
100 mM KSCN 
5 mM DTT or TCEP 
mother solution + 0-16 % glycerol in 5 
steps; 8 °C over night 
good and reproducible for 
bubble complexes  
3.8 Å  
 
Figure 14 shows 12-subunit crystals from initial to refined conditions 
 
 
Best crystals were carefully frozen with the use of different cryoprotectants and freezing 
protocols, and checked on the synchrotron to find out the best condition and harvesting 
protocol. Crystals were grown at 20° C with the hanging drop method, using a reservoir 
solution of 8 % PEG 20k, 360 mM NaH2PO4/(NH4)2HPO4 pH 6.0, 50 mM dioxane, 5 mM 
DTT. Crystals grew to a maximum size of 0.4 x 0.2 x 0.1 mm. Crystals were transferred 
stepwise to reservoir solutions with 5, 10, 18, 22 % ethylene glycol or glycerol, were 
incubated at 4° C overnight, mounted in cryo loops, and dispersed and stored in liquid 
nitrogen.  Diffraction was observed beyond 4 Å resolution (Figure 15), but radiation damage 
and anisotropy limited complete data with good statistics to 4.2 Å resolution. 
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Figure 15. Diffraction pattern of 12-subunit RNA Pol II crystal. 
Measured at SLS, X06SA beamline, 1s exposure time, oscillation increment 0.25°.
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X-ray structure determination of 12-subunit Pol II 
With the use of cryo-cooling and synchrotron radiation, complete diffraction data to 4.2 Å 
resolution were obtained (Table 6), which allowed for structure solution by molecular 
replacement. The highest peak in molecular replacement with AMORE (Navaza, 1994)) was 
obtained using as search model the core elongation complex structure, with nucleic acids 
removed (correlation coefficient=45.1/18.4 for first/second peak, 10–6.5 Å). This structure 
was used, as a model for the core. Eight additional residues of the Rpb1 linker were included. 
The archeael Rpb4/7 structure was manually fitted to 2Fobs-Fcalc and Fobs-Fcalc electron density 
maps phased with the core model ((Todone et al., 2001), Figure 16A). The orientation of 
Rpb4/7 was additionally confirmed by labeling Rpb4/7 with selenomethionine (Figure 16B). 
Manual rigid body adjustments accounted for slight changes in the relative position of three 
domains (Rpb4; yeast Rpb7 residues 1-80; yeast Rpb7 residues 81-169). Archaeal residues 
117 and 174-187 were deleted, and yeast residues 52, 53, 155, 156 were inserted. An insertion 
between α-helices H1 and H2 in yeast Rpb4 could not be modeled. Although an additional 
helical density was observed, the connectivity was uncertain. No continuous density was 
observed for an N-terminal extension of yeast Rpb4. At the resolution of the data, no 
refinement was carried out and the fitted structures were reduced to Cα backbones. Ordering 
of the switches was confirmed with a simulated annealing omit map (Figure 20), calculated 
with a model lacking switches 1-3, with the program CNS (Brunger et al., 1998). The Cα 
backbone model has been deposited with the PDB (accession code 1NT9). 
 
Table 6. X-ray diffraction data 
Dataset1 Native Rpb4/7 SeMet 
Unit cell axis2 [Å] 220.4, 391.4, 282.2 223.0, 394.5, 284.4  
Wavelength [Å] 0.9185 0.9795 (Se peak) 
Resolution [Å] (highest shell) 50-4.2 (4.35-4.2) 50-6.5 (6.7-6.5) 
Unique reflections (highest shell) 83,431 (7,893) 25,009 (2,452) 
Completeness [%] (highest shell) 93.8 (89.5) 99.9 (100.0) 
Redundancy  2.9 13.4 
I/σI 6.5 9.4 
Rsym [%] (highest shell) 9.3 (36.3) 7.5 (25.8) 
No. of sites - 13 (5 Se, 8 Zn) 
 
1Diffraction data collected at the Swiss Light Source.  2Space group C2221. 
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Figure 16. Structural analysis of the 12-subunit Pol II. (A) Fit of the Rpb4/7 counterpart structure (Todone et 
al., 2001) to the initial 4.2 Å difference Fourier map (green).  The map was phased with the Pol II core structure, 
and is contoured at 2σ Cα backbones for Rpb4 and Rpb7 are in pink and blue, respectively.  Minor adjustments 
were made to the structure, to account for yeast-specific sequence features.  The view corresponds to the “front” 
view of Pol II (Cramer et al., 2000). (B) Selenomethionine anomalous difference Fourier (yellow).  The Fourier 
was calculated with anomalous data from a crystal with selenomethionine-labeled Rpb4/7 (Table 1), and phases 
from the core model, and is contoured at 6σ  Selenomethionine was incorporated as described (Budisa et al., 
1995).  Five selenium peaks with heights between 20.5σ and 10.6σ coincide with the location of methionine side 
chains.  Indicated as yellow spheres are sulfur atoms in methionine side chains, after the corresponding 
archaeal residues were replaced. No peaks were observed for Rpb4 methionines 1 and 114, which are in flexible 
regions.  Figure prepared with O (Jones et al., 1991). 
Overall structure 
The model shows a single Rpb4/7 complex on the outside of the core, protruding from the 
base of the clamp (Figure 17A). The location of Rpb4/7 agrees with that in cryo-electron 
microscopic reconstructions of Pol II (Craighead et al., 2002) and Pol I, which reveals the 
Rpb4/7 counterpart (Peyroche et al., 2002; Bischler et al., 2002). Most of the Rpb4/7 surface 
is exposed and accessible for interactions with proteins or nucleic acids. Such interactions 
may influence the Rpb4/7 orientation that is fixed here by crystal packing. Exiting RNA may 
interact with a potential nucleic acid-binding surface of Rpb7 (Todone et al., 2001; Orlicky et 
al., 2001) that faces the Pol II “saddle,” from which RNA emerges (Figure 17B).  
Rpb4/7 binds to core with the N-terminal ribonucleoprotein-like domain of Rpb7 (Todone et 
al., 2001), termed here the “tip” (Figure.17A).  The remainder of Rpb4/7 extends far from the 
core surface, explaining why mutations in this region do not impair core binding (Orlicky et 
al., 2001). Consistent with the core-Rpb7 interaction, Rpb7 alone can bind to core (Sheffer et 
al., 1999), and Rpb7 is essential for yeast growth (McKune et al., 1993), whereas Rpb4 is not 
(Woychik and Young, 1989). Deletion of the rpb4 gene in yeast facilitates dissociation of 
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Rpb7 from core (Edwards et al., 1991). Our model suggests that loss of the Rpb4-Rpb7 
interface upon Rpb4 deletion destabilizes Rpb7 and facilitates Rpb7 dissociation. Indeed, the 
Rpb4-Rpb7 interface underlies Rpb4/7 integrity, and is conserved (Todone et al., 2001), such 
that stable chimeric heterodimers with Rpb4 and Rpb7 from various species can be formed 
(Werner et al., 2000; Sakurai et al., 1999; Larkin and Guilfoyle, 1998). Consistent with our 
model, Rpb7 overexpression can suppress Rpb4 deletion defects (Sheffer et al., 1999; Tan et 
al., 2000).  In contrast to our findings, Rpb7 dissociation upon Rpb4 deletion was explained 
earlier by core interaction primarily through Rpb4 (Edwards et al., 1991; Craighead et al., 
2002; Khazak et al., 1998). 
 
 
 
 
 
Figure 17. Architecture of the 12-subunit Pol II, coupling of Rpb4/7 binding and clamp closure, and 
upstream interaction face. (A) Ribbon model of Pol II. The view is as in Figure 16. Cyan spheres and a pink 
sphere depict eight zinc ions and an active site magnesium ion, respectively. A black line encircles the clamp. 
The linker to the C-terminal repeat domain (CTD) is indicated as a dashed line.  In the lower right corner, a 
schematic cut-away view is shown. A dashed line indicates the open clamp position observed in form 2 of the 
Pol II core structure (Cramer et al., 2001).  (B) Pol II upstream interaction face. View of the model in (A) 
from the “top” (Cramer et al., 2000). The dashed circle segment is centered at the active site and has a radius 
that corresponds to the minimal distance between the TATA box and the transcription start site (85 Å, about 
25 base pairs).  The saddle between the wall and the clamp, and the assumed direction of RNA exit are 
indicated.  A blue asterisk indicates a potential RNA binding face of Rpb7 (Todone et al., 2001; Orlicky et al., 
2001).  A key to subunit color is shown in the upper right corner.  Figures 17, 18 prepared with RIBBONS 
(Carson, 1997). 
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Rpb7 forms a conserved wedge that restrains the clamp 
The Rpb7 tip forms a wedge between the clamp, the linker, and the core subunit Rpb6 (Figure 
17A). The tip partially fills a surface “pocket,” which corresponds to the end of the previously 
identified potential RNA exit groove 1 (Cramer et al., 2000). The pocket is lined by five 
protein regions, three in Rpb1 and one each in Rpb2 and Rpb6 (Figure 18). Rpb4/7 binding to 
the pocket thus holds together three subunits, and may stabilize the Pol II subunit assembly. 
The pocket-Rpb7 interface is partially hydrophobic, and conserved among eukaryotes (Figure 
18), explaining why human Rpb4/7 can functionally replace its yeast counterpart (Khazak et 
al., 1995). A corresponding pocket-tip interaction apparently exists in eukaryotic Pol I and Pol 
III, and in the archaeal RNA polymerase.  The tip domain is conserved in the Rpb7 homologs 
of Pol I (Shpakovski and Shematorova, 1999; Peyroche et al., 2002), Pol III (Sadhale and 
Woychik, 1994; Siaut et al., 2003) and archaeal polymerase (Todone et al., 2001). Like Rpb7, 
the Rpb7 homolog of Pol I binds the common subunit Rpb6 (Peyroche et al., 2002), and can 
dissociate from core in a Pol I mutant (Smid et al., 1995). The Rpb7 homolog of Pol III is also 
dissociable, and disruption of its tip domain is lethal (Sadhale and Woychik, 1994). Since core 
subunits are either shared or homologous in all three eukaryotic enzymes (Sentenac et al., 
1992), the Rpb4/7 counterparts’ most likely bind similarly to the cores.  Thus the yeast 12-
subunit Pol II is a good model for Pol I and Pol III, and for the enzymes in higher eukaryotes, 
as Pol II subunits are highly conserved in sequence and function (Woychik, 1998). 
In the 12-subunit Pol II, the clamp adopts the closed conformation observed in the core 
elongation complex structure (Gnatt et al., 2001), consistent with electron microscopy in 
solution (Craighead et al., 2002). Except for the clamp closure, there are no gross changes in 
core structure upon Rpb4/7 binding.  Modeling the clamp in the open states observed in the 
free Pol II core structures (Cramer et al., 2001) results in a clash with the Rpb7 tip (Figure 
17A). Thus, Rpb4/7 can only bind when the clamp is closed, and the clamp can only open 
after Rpb4/7 has dissociated from the Pol II core. Residual space between the closed clamp 
and Rpb4/7 only allows for slight changes in the clamp position. 
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Implications for transcription initiation  
Coupling between Rpb4/7 binding and clamp closure is relevant for transcription initiation, 
when promoter DNA is loaded onto polymerase. Given that the DNA duplex would be loaded 
deeply into the cleft, between the clamp and the wall as suggested (Cramer et al., 2001), 
Rpb4/7 must dissociate from the Pol II core for sufficient clamp opening. However, Rpb4/7 
could rebind after DNA melting and clamp closure. Although Rpb4/7 can dissociate from the 
Pol II core in vitro (Edwards et al., 1991), it is unclear if it dissociates in vivo.  Our model 
reveals a small core-Rpb7 interface, consistent with a transient interaction, but the core-
Rpb4/7 complex is more stable in other species (Sakurai et al., 1999; Larkin and Guilfoyle, 
1998; Khazak et al., 1998). 
In an alternative scenario for inititaion, Rpb4/7 persistently bound to core would prevent 
promoter entry to the cleft, and DNA could only bind far above the active center. Upon DNA 
melting, the template strand could however pass the clamp, slip into the cleft, and bind to the 
site formed by switch regions 1–3, as observed in the core elongation complex (Gnatt et al., 
2001). Except a central part in switch 3, around Rpb2 residues 1120-1127, switches 1-3 adopt 
a similar conformation in the 12-subunit Pol II, and are no longer flexible, as in the free core 
structures ((Cramer et al., 2001) (Figure 19 and Figure 20). Thus, interaction of Rpb4/7 with 
the Pol II core induces partial formation of the binding site for the DNA template strand. The 
flexible part of switch 3 may only get ordered upon template strand binding or upon formation 
Figure 18. Pocket-tip interaction. (A) Ribbon model of the Rpb7 tip binding with its two outermost loops (Todone et al., 2001) 
to the five protein regions (Cramer et al., 2001) that line the pocket.  The view is from the“back,” roughly the inverse of that in 
Figures 16 and 17A.  Colors are as in Figure 17, except that switch region 5 is in green. (B) Sequence alignments of protein 
regions in (A) (Hs, Homo sapiens; Dm, Drosophila melanogaster; Sp, Schizosacharomyces pombe; Sc, Saccharomyces 
cerevisiae; Mj, Methanococcus jannaschii; Ss, Sulfolobus sulfataricus). Conserved residues are highlighted.  Stars below the 
alignments indicate invariant residues. 
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of an early DNA-RNA hybrid. Induced folding of the central part of switch 3 by the growing 
hybrid could underlie a transition that stabilizes the early elongation complex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is likely that promoter loading is topologically similar during bacterial transcription 
initiation, which requires only the σ factor and the core polymerase. The structural 
conservation of bacterial and eukaryotic core RNA polymerases (Darst, 2001; Cramer, 2002) 
enables a comparison of our model with recent structures of bacterial RNA polymerase bound 
Figure 19.  Changes in the switch regions and binding of the DNA template strand. (A) 
Schematic cut-away view of the Pol II core elongation complex (Gnatt et al., 2001). The view is 
related to that of Figure 17A by a 90° rotation around a vertical axis. Switches 1-3 face the 
cleft, are ordered, and interact with the DNA template strand. (B) In the free Pol II core 
structures, switches 1 and 3 are flexible, and switch 2 is in an extended conformation, allowing 
for clamp opening (7). (C) In the 12-subunit Pol II, switches 1-3 are ordered and in the same 
conformation as in (A), except a central region of switch 3 that remains flexible (Rpb2 residues 
1120-1127). Ordering of the switches was confirmed with a simulated annealing omit map 
(CNS, Brunger et al., 1998) calculated from a model lacking switches 1-3 (Figure 20). 
Figure 20. Simulated annealing omit 
map. Ordering of switches 1-3 in 12-
subunit Pol II, except of a central 
region of switch 3 that remains flexible 
(Rpb2 residues 1120-1127). Ordering 
of the switches was confirmed with a 
simulated annealing omit map (CNS, 
Brunger et al., 1998)), calculated from 
a model lacking switches 1-3.  
. 
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to σ (Murakami et al., 2002; Vassylyev et al., 2002), and bound to σ and upstream promoter 
DNA (Murakami et al., 2002).  In these structures, the σ factor interacts with regions 
corresponding to the Pol II upstream face, where TFIIB, TFIIF and TBP are proposed to 
assemble. Although the σ factor shows sequence similarity to Rpb4 (Woychik and Young, 
1989), it is not a functional counterpart of Rpb4/7, since Rpb4/7 and σ bind to different sites 
on the polymerase surfaces. The structure of bacterial polymerase with bound promoter shows 
a closed clamp and ordered switches, as observed in our model of the initiation-competent Pol 
II.  Additionally, the bacterial complex shows promoter DNA outside the cleft, consistent with 
the ladder model suggested above. 
The specific occurrence of Rpb4/7 in higher cells is reflected in its functions during 
transitions within the transcription cycle. During initiation, the Pol II CTD gets 
phosphorylated, and remains phosphorylated during RNA elongation. Dephosphorylation of 
the CTD is however required for Pol II recycling after termination, since only 
unphosphorylated Pol II can rejoin an initiation complex. CTD dephosphorylation is carried 
out by the phosphatase Fcp1 (Lin et al., 2002). Fcp1 is apparently recruited to the 
phosphorylated CTD by Rpb4/7, since Rpb4 binds Fcp1 (Kimura et al., 2002), and Rpb7 
binds the linker to the CTD, which is disordered in our crystals (Figures 17, 18).  Fcp1 
inhibits initiation complex assembly (Chambers et al., 1995), maybe because Fcp1 and a 
general factor bind to the upstream face in a mutually exclusive manner, ensuring complete 
CTD dephosphorylation before transcription reinitiation. 
Crystal packing in 12-subunit RNA Pol II facilitates obtaining of higher order complexes 
12-subunit RNA Pol II crystals show different packing in comparison to 10-subunit core. 
Looser packing results in unusually high solvent content of 80 % in comparison to core Pol II 
crystals where molecules are more tightly packed and therefore have around 50 % of solvent 
(Cramer et al., 2000). This packing in 12-subunit Pol II crystals results in stronger 
resolution/crystal size dependence due to substantially reduced number of scattering 
molecules per volume of the crystal. On the one hand, this dependency raised some technical 
problems, on the other it opened new possibilities for obtaining new, exciting, higher-order 
complexes of Pol II with additional factors. The structure of RNA polymerase II in complex 
with TFIIS (Kettenberger et al., 2003) was solved after 12-subunit Pol II crystals were 
incubated with recombinant, overexpressed in E.coli TFIIS. The very large solvent channels 
of the crystals allowed TFIIS entry and binding to its specific site on Pol II, which was not 
obstructed by crystal contacts (Figure 21). Although TFIIS binding induced large 
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conformational changes in crystal lattice the crystals still diffracted synchrotron radiation to 
3.8 Å.  
 
Conclusion 
The 12-subunit Pol II model explains and suggests functional roles of the Rpb4/7 complex, 
and extends our understanding of eukaryotic transcription towards the mechanism of 
initiation.  Our work further shows that the architecture of a dissociable multiprotein complex 
can be determined by X-ray analysis even at moderate resolution.  The methods used and 
developed here can be applied to complexes of Pol II with proteins and nucleic acids, to 
address mechanistic questions raised by the complete Pol II model. 
Figure 21. 
Crystal lattice of 
12-subunit (left) 
and 12-subunit 
with TFIIS (right). 
Yellow: core Pol II 
Blue: Rpb7, 
Red: Rpb4,  
Green: TFIIS  
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Abstract 
 
 
I determined the x-ray structure of the RNA polymerase II (Pol II) subcomplex 
Rpb4/7 at 2.3 Å resolution, combined it with a previous structure of the ten-
subunit polymerase core, and refined an atomic model of the complete 12-
subunit Pol II at 3.8 Å resolution. Comparison of the complete Pol II structure 
with structures of the Pol II core and free Rpb4/7 shows that the core-Rpb4/7 
interaction goes along with formation of an α-helix in the linker region of the 
largest Pol II subunit, and with folding of the conserved Rpb7 tip loop. Details 
of the core-Rpb4/7 interface explain facilitated Rpb4/7 dissociation in a 
temperature-sensitive Pol II mutant, and specific assembly of Pol I with its 
Rpb4/7 counterpart A43/14. The refined atomic model of Pol II serves as the 
new reference structure for analysis of the transcription mechanism, and enables 
structure solution of complexes of the complete enzyme with additional factors 
and nucleic acids by molecular replacement. 
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Introduction 
Synthesis of mRNA in eukaryotic nuclei is carried out by RNA polymerase II (Pol II). The 
mechanism of Pol II transcription has been investigated in many biochemical and detailed 
structural studies (for recent reviews see Cramer, 2004; Hahn, 2004; Asturias, 2004; Woychik 
and Hampsey, 2002). Pol II consists of a ten-polypeptide catalytic core and the heterodimeric 
Rpb4/7 complex, which can dissociate from the yeast enzyme (Edwards et al., 1991). Refined 
structures were reported for the Pol II core in free form (Cramer et al., 2000; Cramer et al., 
2001), in form of a minimal elongation complex (Gnatt et al., 2001), and in complex with the 
toxin α-amanitin (Bushnell et al., 2002). Crystallographic models of the Pol II core bound to 
the initiation factor TFIIB, and bound to a synthetic DNA-RNA hybrid were published 
recently (Westover et al., 2004; Bushnell et al., 2004). 
For the complete 12-subunit Pol II, backbone models were reported for the free enzyme 
(Armache et al., 2003; Bushnell et al., 2003), and for a complex with the elongation factor 
TFIIS (Kettenberger et al., 2003). Our previous Pol II model was derived by fitting structures 
of the core polymerase and a distantly related archaeal Rpb4/7 counterpart (Todone et al., 
2001) to a 4.2 Å crystallographic electron density map, guided by selenomethionine markers 
(Armache et al., 2003). The model showed the overall architecture of the enzyme, but did not 
reveal details of the Rpb4/7 structure or its interaction with the Pol II core. Rpb4/7 was seen 
protruding from the polymerase upstream face, where initiation factors assemble for promoter 
loading. Rpb7 formed a wedge underneath the mobile Pol II clamp, apparently restricting the 
clamp to a closed position, and preventing entry of a DNA duplex into the active center cleft. 
I present here the refined atomic model of the complete Pol II at 3.8 Å resolution. To derive 
this model I determined the crystal structure of the free Rpb4/7 subcomplex at 2.3 Å 
resolution. Comparison of the complete Pol II structure with the structures of the core enzyme 
and the Rpb4/7 subcomplex reveals folding events that accompany formation of Pol II. The 
refined complete Pol II structure provides the new reference for functional analysis of the 
eukaryotic transcription machinery. The structure also enables further structural studies of 
scarce complexes of the complete Pol II, such as a recently described complex with DNA, 
RNA, and the elongation factor TFIIS (Kettenberger et al., 2004). 
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Materials and methods 
Design of Rpb4/7 variants 
Crystallization of full length Rpb4/7 did not yield any crystals, so we designed seven deletion 
variants that varied in either the length of the N-terminus or in the length of deleted loop 
region in Rpb4. Rpb7 containing C-terminal His-tag was not mutated and remained the 
original sequence. This strategy is often done in protein crystallography when full length 
proteins contain unstructured regions which are usually flexible and can hinder crystallization.  
Design of deletion variants was based on results from a proteolytic digest with trypsin and 
chymotrypsin, on prediction of low complexity regions, on sequence alignments of yeast 
Rpb4/7 complex and archaeal E/F homologue, on secondary structure predictions, and finally 
and maybe most importantly on inspection of the electron density maps of backbone model of 
12-subunit RNA polymerase II.  
Limited proteolysis 
Full length Rpb4/7 was used as a template protein for limited proteolysis with trypsin and 
chymotrypsin. 150 µl of 4 mg/ml of protein was supplemented with 1mM CaCl2 and 0.5 µl of 
1 mg/ml particular protease was added. The reaction took place at 37°C and was monitored in 
a time course manner. Samples of 20 µl were taken after 1, 3, 5, 10, 30, 60 and 90 minutes 
and immediately denatured at 92°C with SDS to stop reaction, put on 15 % SDS-PAGE gel 
and the fragments were analyzed with Edmann sequencing. 
Cloning of Rpb4/7 variants 
N-terminal truncation constructs were amplified by PCR from full length Rpb4/7 (names of 
variants and primers contain the prefix ‘Sc4’ or ‘Sc7’ standing for Rpb4 or Rpb7 from S. 
cerevisiae (Table 1 lists primers used). Loop deletion constructs were amplified by PCR from 
construct Sc4/34 using 2-step PCR strategy (Table 2 lists primers used). For the ligation of 
each construct into the vector pET-21d all primers carried either NcoI (forward) or NotI 
(reverse) restriction sites and were inserted into pET21d using these restriction sites. Table 3 
lists sequencing primers that were used to confirm the success of cloning. 
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Table 1. Primers used for N-terminal truncation variants of Rpb4/7 
Construct Primer Name direction 
Primer 
  Sc4/34 Sc4/34NcoI  forward 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
 Sc7/Not1  reverse 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
  Sc4/66 Sc4/66NcoI  forward 5’-TGCTAGCTCCCATGGCGCGTAGGAGAGCATTTAAAAGATCG-3’ 
 Sc7/Not1  reverse 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
  Sc4/83 Sc4/83NcoI  forward 5’-TGCTAGCTCCCATGGCGAAGCACGAAAACGCCAATGATG-3’ 
 Sc7/Not1  reverse 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
 
Table 2. Primers used for loop deletion variants of Rpb4/7 
Construct 
name 
PCR 
Primer 
Name 
Primer sequence 
Loop1 1 a l1p4 5’-CCCTAGTTTCAGAATGCATAAATTGCGATCTTTTAAATGCTC-3’ 
   Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
  b l1p2 5’-GAGCATTTAAAAGATCGCAATTTATGCATTCTGAAACTAGGG-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
 2  Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
Loop2 1 a l2p4 5’-CCCTAGTTTCAGAATGCATAAACAATGCTTCTTCTTGTGTTTTTTTTGCG-3’ 
   Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
  b l2p2 5’-CGCAAAAAAAACACAAGAAGAAGCATTTGTTTATGCATTCTGAAACTAGGG-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
 2  Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
Loop3 1 a l3p4 5’-GCGTTGACGTCATCTTCATCCAGCAAATGCTTCTTCTTGTGTTTTTTTTGCG-3’ 
   Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
  b l3p2 5’-CGCAAAAAAAACACAAGAAGAAGCATTTGCTGGATGAAGATGACGTCAACGC-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
 2  Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
Loop4 1 a l4p4 5’-GCGTTGACGTCATCTTCATCCAGTTGCGATCTTTTAAATGCTC-3’ 
   Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
  b l4p2 5’-GAGCATTTAAAAGATCGCAACTGGATGAAGATGACGTCAACGC-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
 2  Sc4/34Nco1 5’-TGCTAGCTCCCATGGCGCAGCTGAAACAGATAAATC-3’ 
   Sc7/Not1 5’-CTGCTAGCTGCGGCCGCAATAGCACCCAAATAATCTTCTTTG-3’ 
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Table 3. Primers used for sequencing of Rpb4/7 constructs 
Primer Name  Primer 
Sc4sequ402f forward 5’-GGGAGGAAATAATAAAGATTTG-3’ 
Sc4sequ499r reverse 5’-GAAGCTGTATAACTGCCCCGA-3’ 
T7r reverse 5’-GCTAGTTATTGCTCAGCGG-3’ 
 
Expression and purification of Rpb4/7 variants 
All Rpb4/7 variants were expressed and purified exactly in the same manner like full length 
Rpb4/7. Test expressions were done in 1l cultures and the cells were lysed with French Press, 
resuspended in Freezing Buffer and centrifuged at 4°C. The pellet was treated with 6 M urea, 
centrifuged and supernatant was loaded on SDS-PAGE to check if and how much protein was 
in inclusion bodies. Expression of SeMet full length Rpb4/7 and loop3 variant was done as 
described previously and purification procedure did not change for these proteins. Variant 
loop3 crystallized in the same conditions as the native protein and the crystals were of similar 
size and quality. 
Crystallization of Rpb4/7 variants Sc4/34 and Loop3 
For crystallization of Sc4/34 and Loop3 sparse matrix method of trial conditions was used, 
which is based on known crystallization conditions (Jancarik and Kim, 1991). In this way one 
can test in a short time wide ranges of pH, salts and precipitants using small amounts of 
sample. Results from these initial trials can produce crystals or solubility information. For 
crystallization of the Rpb4/7 variants the hanging drop method was used. Therefore, 1 µl of 
the purified protein (solutions contained 9, 11 and 18 mg/ml protein in case of Sc4/34 and 3 
mg/ml in case of Loop3 variant) was set with on a plastic cover slide and mixed with 1 µl of 
reservoir solution. The slide was set upside down over a well with reservoir solution and 
sealed to the reservoir edge using high vacuum grease. As the drop contains lower 
concentration of crystallization agent, water vapour will leave the drop and the concentration 
will increase until supersaturation and crystal growth is reached. Crystallization took place at 
20°C and the plates were egzamined under a microscope few days after setting the drops for 
presence of crystals. Crystals were harvested with a mother solution in which they grew and 
several different cryoprotectants were carefully screened to give an idea which one is the most 
suitable. The cyroprotectants were introduced in a stepwise fashion and quick freezing at 4°C 
and at 20°C was tried. 
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Figure 1. 15% SDS-PAGE  of chymotrypsin (left) and trypsin (right) digest of Rpb4/7. N: native, control.
Rpb4/7, 1: 1 mi., 2: 2 min., 5: 5 min., 10: 10 min., 30: 30 min., 60: 60 min., 90: 90 min., M: marker, arrows indicate 
bands representing cuts which were N-terminally sequnced (with sequences shown above the respective bands). These 
sequences are depicted with red numbers and they represent 3 distinct digestion species after proteolytic digest. 
Results and discussion 
Design of Rpb4/7 variants  
Proteolytic digest 
Limited proteolysis was done by incubation of 150 µl of 4 mg/ml solution of native Rpb4/7. 1 
mM CaCl2 and 0.5 µl of 1 mg/ml protease (trypsin or chymotrypsin) at 37°C and 10 µl 
samples were taken after 1, 3, 5, 10, 30, 60 and 90 minutes and immediately denatured to 
inactivate the protease. After all samples were collected they were loaded onto SDS-PAGE 
(Figure 1) and the bands representing the parts of the protein that seemed stable were excised 
from the gel and analyzed by Edmann sequencing. Chymotrypsin cuts after aminoacid 
number 33 and trypsin after aminoacid 82 in Rpb4 and these immediately suggested the 
variant design for Rpb4. Trypsin also cut in Rpb7 after aminoacid 60 but as we knew this part 
of Rpb7 was not supposed to be manipulated with since it interacts with RNA Pol II. 
 
 
 
The cuts detected by proteolytic digest coincided well with the low complexity regions 
detected by SEG (Figure 2) and secondary structure prediction (Figure 3) for these parts of 
Rpb4 was indicating rather flexible loop regions. 
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Figure 3. Secondary structure prediction in Rpb4. (Rost  and Sander,1993) 
Red H indicates helices, blue E: sheets, black: loops, below the secondary structure 
prediction are numbers indicating from 0-9 the reliability of prediction 
Figure 2. Prediction of low complexity regions in Rpb4. (SEG, Wootton and Federhen, 1996) 
Red crosses mark the regions which appear to be unstructured 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results from experimental proteolytic digest and bioinformatics agreed with each other. 
The 12-subunit RNA polymerase II backbone model (Armache et al., 2003) was egzamined to 
check wheather removal of these regions will not destabilize binding of Rpb4/7 variants to the 
core and wheather they are not involved in Rpb4 Rpb7 dimer formation. This information 
resulted in the strategy of variant design where different length N-terminal truncations and 
different loop deletions in Rpb4 were tried (Table 4). 
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Table 4. Rpb4/7 variants  
Variant 
name 
Description Amino acid residues 
Total number 
of amino acids 
Molecular 
weight kDa 
Sc4/34 
N-terminal deletion of 
Rpb4 before aa No. 34  
Rpb4: 34 – 221 
Rpb7: full length 
Rpb4: 188 aa 
Rpb7: 171 aa 
Rpb4: 21,5  
Rpb7: 19 
Sc4/66 
N-terminal deletion of 
Rpb4 before aa No. 66  
Rpb4: 66 – 221 
Rpb7: full lenght  
Rpb4:156 aa 
Rpb7: 171 aa 
Rpb4: 17,8 
Rpb7: 19 
Sc4/83 
N-terminal deletion of 
Rpb4 before aa No. 83  
Rpb4: 83 – 221 
Rpb7: full length 
Rpb4: 139 aa 
Rpb7: 171 aa 
Rpb4: 15,6 
Rpb7: 19 
Loop1 
Loop deletion of Rpb4 
from K75 till D112 
Rpb4: 34-74, 113-221 
Rpb7: full length 
Rpb4: 150 aa 
Rpb7: 171 aa 
Rpb4: 17,1 
Rpb7: 19 
Loop2 
Loop deletion of Rpb4 
from K83 till D112  
Rpb4: 34-82, 113-221 
Rpb7: full length 
Rpb4: 158 aa 
Rpb7: 171 aa 
Rpb4: 18,2 
Rpb7: 19 
Loop3 
Loop deletion of Rpb4 
from K83 till D100 
Rpb4: 34-82, 101-221 
Rpb7: full length 
Rpb4: 170 aa 
Rpb7: 171 aa 
Rpb4: 19,5 
Rpb7: 19 
Loop4 
Loop deletion of Rpb4 
from K75 till D100 
Rpb4: 34-74, 101-221 
Rpb7: full length 
Rpb4: 162 aa 
Rpb7: 171 aa 
Rpb4: 18,4 
Rpb7: 19 
 
The choice of N-terminal truncations and loop deletions was clear from the start, but the 
proper combination of both was discovered upon expressions and purifications of individual 
variants. 
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Figure 6. Loop deletions 
after 2nd PCR. 
1 = Loop1; 2 = Loop2 
3 = Loop3; 4 = Loop4 
 
Figure 5. Loop deletions after 1st PCR. 
1a = Loop1, PCRa; 1b = Loop1, PCR1b 
2a = Loop2, PCRa; 2b = Loop2, PCR2b 
3a = Loop3, PCRa; 3b = Loop3, PCR3b 
4a = Loop4, PCRa; 4b = Loop4, PCR4b 
Figure 8: Loop deletions after test restriction. 
Upper band = vector; 1 = Loop1; 2 = Loop2; 3 = Loop3; 4 =  Loop4 
Cloning of Rpb4/7 variants 
Figures 4-6 show 1 % agarose gels with PCR products. 
 
 
 
  
 
  
 
 
All variants were cloned into pET-21d vector and transformed to XL-1blue cells for DNA 
amplification and BL 21(DE3) for protein expression. 
The incorporation of construct into vector was checked by test restriction and sequencing 
(Figures 7 and 8) 
 
 
 
 
 
 
 
 
Variants were cloned using the same double expression strategy, which was used for full-
length Rpb4/7 construct with a T7 promoter in front of each ORF and C-terminal His-tag on 
Rpb7. 
             Figure 4. Three N-terminal  
                deletion variants after PCR. 
                1 = Sc4/34 
                2 = Sc4/66 
                3 = Sc4/83 
Figure 7. Three N-terminal deleted 
variants after test restriction. 
Upper band = vector 
1 = Sc4/34 
2 = Sc4/66 
3 = Sc4/83 
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Solubility test of Rpb4/7 variants 
Test expressions were carried out to find the Rpb4/7 variant showing optimal expression, 
solubility and stoichiometry (amount of Rpb4 and Rpb7 should be equal to ensure proper 
behaviour during crystallization). All variants were expressed in 1l LB medium and purified 
over His-tag by Ni-NTA affinity chromatography. The optimal imidazole concentration of the 
elution mixture was tested and determined by a step-gradient of 10, 20, 50 and 200 mM 
imidazole. As elution occurred mostly at 50 or 200 mM, and these 2 steps (and sometimes 
also the elution step with 20 mM) were subdivided again. Instead of using once the full 
amount of elution mixture, twice or three times the half or the third, respectively, were applied 
onto the column, so that one could determine if the protein gets eluted early or late under this 
condition. The fractions were then checked on SDS-PAGE for their concentration and purity. 
Variant Sc4/34, lacking the first 33 amino acids at the N-terminus was well expressed and 
soluble, while the other two N-terminal deletions, Sc4/66 and Sc4/83 were expressed, but 
appeared not to be stable under high concentrations of imidazole (the amount of Rpb7 seems 
to in increased, whereas Rpb4 is degraded). Figures 9-11 show SDS-PAGE gels of test 
expressions of variants Sc4/34, Sc4/66 and Sc4/83 respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. 15 % SDS-PAGE of Sc4/34 1l expression after Ni-NTA purification.  
45 µl protein solution were put on the gel; 
Cent: after centrifugation (clear lysate); Numbers indicate the concentration of imidazole 
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Figure 11. 15 % SDS-PAGE of Sc4/83 after Ni-NTA purification. 
45 µl protein solution were put on the gel; 
Numbers indicate the concentration of imidazole 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It was clear from these test expressions that variant Sc4/34 was very well expressed, the two 
subunits seemed to form a stable dimer and elute as intact stoichiometric complex. In case of 
Sc4/66 the dimer is apparently destabilized and what is seen on the SDS-PAGE, Rpb4 is 
eluted already at lower imidazole concentrations and Rpb7 is still bound to the column matrix 
and elutes at higher concentrations of imidazole. Exactly the same behaviour which is 
disfavoured for future experiments was seen for variant Sc4/83. Conclusively, from the N-
terminal deletion variants, Sc4/34 was chosen for further experiments and all the loop deletion 
variants were based on it, so that every loop variant was shortened both at the N-terminus and 
at the loop. 
Figure 10. 15 % SDS-PAGE of Sc4/66 1l expression after Ni-NTA purification.  
45 µl protein solution were put on the gel; 
Cent: after centrifugation (clear lysate); Numbers indicate the concentration of imidazole 
 
CHAPTER III: STRUCTURES OF COMPLETE RNA POLYMERASE II AND ITS SUBCOMPLEX RPB4/7 
 
 
70 
Figure 12.  
15 % SDS-PAGE of 
Loop deletions 1l 
expression after  Ni-
NTA.  
45 µl were put on the 
gel;  
c:= after 
centrifugation (clear 
lysate);  
p:= pellet;  
f:= flow through;  
w:= wash; 
 
Numbers indicate the 
concentration of 
imidazole; 
1 = Loop1 
2 = Loop2 
3 = Loop3 
4 = Loop4 
Figure 13. 15 % SDS-PAGE of elution 
fractions of Rpb4/7 loop deletions 
from 1l expression containing the 
highest amount of protein. 
 
5 µl of the protein solution were put on 
the gel; 
 
Loop1: fraction 50/2;  
Loop2: fraction 200/1 
Loop3: fraction 50/2;  
Loop4: fraction 50/2 
Test expression and Ni-NTA affinity chromatography were performed in exactly the same 
manner for loop variants as for N-terminal truncation mutants and the fractions loaded on 
SDS-PAGE to check for solubility and behaviour of individual variant (Figures 12 and 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Following observation could be made after the analysis of test expressions and affinity 
chromatography purification. Loop1, containing the longest deleted loop had the lowest 
expression levels in comparison with the other loop deletions. Loop2 was well expressed, but 
showed strange shifted bands, which can be accounted for destabilization and degradation of 
Rpb4. Loop3 containing the shortest deleted loop, was expressed in extremely high amounts 
and was also soluble, and dimer showed proper stoichiometry and appeared to be stable. 
Loop4 was also expressed in extremely high amounts, but the dimerization of Rpb4 and Rpb7 
seemed to be destabilized in this variant what can be seen on the SDS-PAGE gel where it 
appears that the band from Rpb7 seemed to be much stronger than the one from Rpb4 (Table 
1 2
3 4
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5). Consequently, from the loop deletion variants, variant Loop3 was taken for further 
expression and crystallization. 
Table 5. Summary of all the information about different variants of Rpb4/7 that were created 
during this work. 
Variant name Expression  features 
Sc4/34 ++ Soluble, stable 
Sc4/66 + Not stable, higher amount of Rpb7 
Sc4/83 + Not stable, higher amount of Rpb7 
Loop1 + Soluble, stable 
Loop2 ++ Bands are shifted 
Loop3 +++ Soluble, stable 
Loop4 +++ Soluble, higher amount of Rpb7 
+  indicates expression 
++  indicates high expression 
+++  indicates excellent expression 
Expression, purification, and crystallization of Rpb4/7 variants 
After a successful 1l test expression, Sc4/34 was expressed in 8l LB medium to get reasonable 
amounts for crystallization and purified by Ni-NTA gravity flow affinity chromatography. 
The optimal imidazole concentration of the elution solution was tested and determined by a 
step gradient of 10, 20, 50 and 200 mM of imidazole, and the profile was very similar to the 
one for full-lengh Rpb4/7 complex. The elution occurred mostly at the concentration of 
imidazole between 20–200 mM. The concentration of protein in these fractions was estimated 
with Bradford reagent and the purity was checked on SDS-PAGE where samples from these 
fractions were loaded (Figure 16). The 50 and 200 mM imidazole peak fractions were pooled 
together diluted and applied on the anion exchange chromatography ResourceQ column 
(Figure 14 and 16). The last and final step of purification was Superose 12 gel filtration and at 
this step Pol II buffer was used (Figure 15 and 16). 
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Figure 14. ResourceQ anion exchange chromatography of Sc4/34  
Blue: absorption at 280 nm, red absorption at 260 nm, green: salt gradient, 
 
Figure 15. Superose 12 gel filtration chromatography of Sc4/34.  
blue: absorption at 280 nm 
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Figure 16. 15 % SDS-PAGE of Sc4/34 after Ni-NTA, anion exchange chromatography  
and gel filtration. 
Numbers indicate the concentration of imidazole 
ResourceQ:= peak fractions from ResourceQ column (anion exchanger); 
Superose 12:= peak fractions from Superpose 12 (gel filtration) 
 
 
 
 
 
 
 
 
 
 
 
 
Crystallization with variant Sc4/34 were carried out with the hanging drop vapour diffusion 
method. Establishment of crystallization conditions was done by sparse matrix sampling using 
commercially available screens from Hampton. After crystals were grown, promising 
conditions were refined by variation of salts, pH, PEG and additives in the reservoir. 
Unfortunately the crystals were destroyed during freezing and refinement screens did not 
come up with satisfying results. Since I could obtain crystals by deletion of the flexible N-
terminus, thus the possibility for getting crystals seemed to be even better, when a variant 
with additional deletion of the flexible loop would be introduced. Hence, crystallization 
experiments with variant Loop3 were carried out as the most promising strategy towards 
solving a structure of Rpb4/7. 
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Figure 17. 15 % SDS-PAGE of Loop3 
Rpb4/7 variant after Ni-NTA 
purification. 
20 µl protein solution were put on the gel; 
Numbers indicate the concentration of 
imidazole 
M: protein marker 
 
 
Expression and purification of Rpb4/7 variant Loop3 
Rpb4/7 variant Loop3 was expressed in 8l LB medium to get reasonable amounts for 
crystallization and purified by Ni-NTA gravity flow affinity chromatography. The protein is 
not stable in pH 7.5 in which it precipitates in few minutes after elution from Ni-NTA. The 
optimal pH = 8.0 and in all the subsequent purifications, the buffers were adjusted to this 
value. The elution occurred mostly at the concentration of imidazole between 20–200 mM. 
The concentration of protein in these fractions was estimated with Bradford reagent and the 
purity was checked on SDS-PAGE (Figure 17). 
 
 
 
 
 
 
 
 
Main fractions were pooled together, diluted 3 times with buffer C to reach the salt 
concentration below 100 mM NaCl (ResourceQ buffer A), and applied to the anion exchange 
chromatography ResourceQ column (Figure 18). The final step of purification was Superose 
12 gel filtration in Pol II buffer (Figure 19). The quality of the protein after this purification is 
very high as can be seen on the gel above (Figure 20). The protein behaves well and is easy to 
handle, although all the buffers need to have a proper pH, since small changes can affect 
Loop3 stability causing protein precipitatation. Protein could be frozen in Pol II buffer in 
liquid nitrogen and stored at -80°C for the crystallization experiments. 
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Figure 18. ResourceQ anion exchange chromatography of Loop3 Rpb4/7 variant. 
blue:absorption at 280 nm, red absorption at 260 nm, green: salt gradient 
 
Figure 19.  Superose 12 gel filtration chromatography of Loop3.  
Blue: absorption at 280 nm 
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Figure 20.  
15 % SDS-PAGE of 
Loop3 variant after 
ResourceQ (lane 1 and 
2); and Superose 12 
(lane 3). M: marker 
 
 
 
 
 
 
 
 
 
 
 
 
Crystallization of Loop3 variant 
Peak protein fractions from Superose 12 could be concentrated only to 3 mg/ml. Higher 
protein concentration was not possible to obtain due to protein precipitation which is probably 
the result of instability of this variant at higher concentrations. Crystallization trials with the 
variant Loop3 were carried out with the hanging drop vapour diffusion method. Establishment 
of crystallization conditions was done by sparse matrix sampling using commercially 
available screens from Hampton. After crystals were grown, promising conditions were 
refined by variation of salts, pH, PEG and additives in the reservoir (Table 6). 
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Table 6. Conditions from Hampton Screens which resulted in crystals. 
Screen Reage
nt 
Salt Precipitant Buffer Cryo Crystals 
5 0.2 M magnesium 
chloride 
hexahydrate 
20 % w/v 
polyethylene 
glycol 3350 
- - intergrown, 
3D,  
13 0.2 M  
sodium 
thiocyanate 
20 % w/v 
polyethylene 
glycol 3350 
- - stacks of thin 
needles 
14 0.2 M 
potassium 
thiocyanate 
20 % w/v 
polyethylene 
glycol 3350 
- - stacks of thin 
needles 
15 0.2 M  
lithium nitrate 
20 % w/v 
polyethylene 
glycol 3350 
- - stacks of thin 
needles 
20 0.2 M magnesium 
formate 
20 % w/v 
polyethylene 
glycol 3350 
- - single, 3D, 
grow from  
precipitate 
25 0.2 M magnesium 
acetate 
tetrahydrate 
20 % w/v 
polyethylene 
glycol 3350 
- - single, 3D,  
fairly big, sharp 
edges 
33 0.2 M  
sodium sulfate 
decahydrate 
20 % w/v 
polyethylene 
glycol 3350 
- - single, 3D,  
high  
birefringence 
34 0.2 M 
 potassium sulfate 
20 % w/v 
polyethylene 
glycol 3350 
- - single, 3D,  
high  
birefringence 
36 0.2 M 
 di-sodium tartate 
dihydrate 
20 % w/v 
polyethylene 
glycol 3350 
- - single, 3D,  
fairly big, sharp 
edges  
37 0.2 M  
potassium sodium 
tartrate 
tetrahydrate 
20 % w/v 
polyethylene 
glycol 3350 
- - microcrystals 
PEG/Ion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PEG/Ion 
38 0.2 M 
di-ammonium 
tartrate 
20 % w/v 
polyethylene 
glycol 3350 
- - single, 
long thin  
needles, 
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 44 0.2 M  
di-ammonium 
hydrogen 
phosphate 
20 % w/v 
polyethylene 
glycol 3350 
- - intergrown, 3D, 
high  
birefringence 
6 0.2 M 
magnesium 
chloride 
hexahydrate 
24 % w/v 
polyethylene 
glycol 4000 
0.08 M 
tris  
hydrochloride
pH8.5 
20 % v/v 
glycerol  
anhydrous 
single, 3D, 
sharp edges 
9 0.17 M 
ammonium 
acetate 
25.5 % w/v 
polyethylene 
glycol 4000 
0.085 M 
tri-sodium 
citrate 
dehydrate 
pH5.6 
15 % v/v 
glycerol  
anhydrous 
single, 
needles 
22 0.17 M 
sodium acetate 
trihydrate 
25.5 % w/v 
polyethylene 
glycol 4000 
0.085 M 
tris  
hydrochloride
pH8.5 
15 v/v 
glycerol  
anhydrous 
single, 3D  
 
 
 
 
 
 
 
Cryo 
40 - 19 % w/v 
iso-propanol 
19 %w/v 
polyethylene 
glycol 4000 
0.095 M 
tri-sodium  
citrate  
dehydrate 
pH5.6 
15 v/v 
glycerol  
anhydrous 
single, 
needles 
12 0.2 M 
magnesium 
chloride 
hexahydrate 
30 % 
iso-propanol 
0.1 M 
Sodium 
HEPES 
pH7.5 
- single, 3D, 
high 
birefringence 
 
 
 
Crystal 
Screen 33 - 4 M 
sodium formate 
- - microcrystals 
 
Several conditions were chosen for further refinement and they are marked red in the Table 6. 
Figure 21 shows a few examples of crystals obtained from initial screens (before refinement). 
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Figure 22. Pictures of crystals of Rpb4/7 Loop3 variant from refinement screens. 
 
Figure 23. Diffraction pattern of Rpb4/7 variant 
Loop3 crystal. Measured at SLS, X06SA beamline, 
1s exposure time, oscillation increment 0.5°. 
 
 
Figure 21. Pictures of crystals of Rpb4/7 Loop3 variant from initial screens. 
The refinement screens varied the pH, the salt and the precipitant concentrations and resulted 
in several conditions which gave rise to crystals diffracting better than 3 Å. Figure 22 shows 
crystals obtained from refinement screens. 
 
 
Best crystals were carefully frozen with the use of different cryoprotectants and freezing 
protocols and measured on the rotating anode home source to find out the best condition and 
harvesting protocol. The refined condition 44 from PEG/ION (0.2 M di-ammonium hydrogen 
phosphate pH 7.9, 20-22 % polyethylene glycol 3350, 5 mM DTT) gave rise to crystals which 
grew to a maximum size of 0.3 x 0.2 x 0.1 mm. Crystals were transferred stepwise to reservoir 
solutions containing additionally 5, 10, 18, and 22 % glycerol, and were plunged in liquid 
nitrogen. These crystals diffracted to around 2 Å (Figure 23) and allowed for structure 
determination of subcomplex of Rpb4/7. 
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Structure determinations 
We could extend the resolution of the crystals of 12-subunit Pol II from 4.2 to 3.8 Å (Table 
7), but not any further, likely because of the high solvent content of around 80 %. Complete 
diffraction data were collected in 0.5° increments at the Swiss Light Source (Table 7). 
Molecular replacement with AMORE and the ten-subunit Pol II (PDB code 1I6H with nucleic 
acids removed) as search model resulted in a unique solution (correlation coefficient = 52.4, 
second best solution = 30.5). An initial electron density map was improved by solvent 
flipping. The high quality of the map allowed us to adjust the structure of the polymerase core 
(Cramer et al., 2001; Gnatt et al., 2001) with program O (Jones et al., 1991) and to build parts 
of the Rpb4/7 as an atomic model.  
To complete the model, I however had to solve the crystal structure of free Rpb4/7 at high 
resolution. Full-length recombinant Rpb4/7 failed to crystallize, but crystals were obtained 
after 34 residues were removed from the proteolytically sensitive N-terminal tail of Rpb4 
(Figure 24). Additional deletion of a proteolytically sensitive loop in Rpb4 resulted in larger 
crystals that diffracted synchrotron radiation to 2 Å resolution. A MAD experiment was 
performed with selenomethionine-containing crystals at the Swiss Light Source (Table 7). 
Data were processed with DENZO and SCALEPACK (Otwinowski and Minor, 1996). The 
program SOLVE (Terwilliger, 2002) detected 14 selenium sites and was used for MAD 
phasing (Z-score=42.8, figure of merit=0.37). A subsequent anomalous difference Fourier 
identified four additional peaks. After phasing with SHARP (La Fortelle and Bricogne, 1997), 
six additional selenium peaks were detected, giving a total of 24 selenium peaks. The peaks 
stemmed from four copies of the Rpb4/7 complex in the asymmetric unit and could be 
assigned to methionines M1, M22, M106, and M115 in Rpb7, and M145 in Rpb4 (double 
peak). Phasing with all selenium peaks resulted in a figure of merit of 0.40 and in an electron 
density map that enabled building of an initial model with program O (Jones et al., 1991) that 
was partially refined with CNS (Brunger et al., 1998). The native crystal belonged to the same 
space group as the selenomethionine crystals (P21212), but the crystallographic c-axis is half 
the length (Table 7), resulting in two Rpb4/7 complexes per asymmetric unit instead of four 
complexes. Thus a dimer of two Rpb4/7 complexes was used as a search model in AMORE 
(Navaza, 1994) to solve the native structure by molecular replacement (Table 7, correlation 
coefficient=42.7, next highest peak=36.9). The atomic Rpb4/7 structure was refined to a free 
R-factor of 27.4 % at 2.3 Å resolution (Table 7, Figures 24, 27). Due to the high resolution, a 
total of 154 water molecules could be added to the refined model. An atomic model is of very 
high stereochemical quality and shows 99 % of the residues in allowed and additionally 
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allowed regions of the Ramachandran plot, and none of the residues in disallowed regions 
(Table 7). 
The refined Rpb4/7 structure served as a guide for completion of the Rpb4/7 model within Pol 
II. After removal of the water molecules, restricted refinement of atomic positions and B-
factors, minor adjustments of the complete Pol II model led to a structure with high 
stereochemical quality with 98.5 % of the residues in allowed and additionally allowed 
regions of the Ramachandran plot (Table 7, Figure 28). Two factors apparently enabled 
refinement of an atomic Pol II model with data to 3.8 Å resoluion. First, combination of two 
refined structures, the core Pol II structure and the Rpb4/7 structure, resulted in a very good 
starting model. Second, the high solvent content allowed for powerful electron density 
modification, and resulted in a favorable ratio of observed reflections to refinement 
parameters. The 3.8 Å electron density map has high quality, and side chains are generally 
visible (Figure 27).  
Table 7. X-ray diffraction data 
Crystal Rpb4/7 SeMet Rpb4/7 Native Complete Pol II 
Data collection1  
Space group P21212 P21212 C2221 
Wavelength [Å] 0.97946 peak 0.93930 
remote 
0.97973 inflection 0.93200 0.97924 
Unit cell axis [Å] 103.39, 114.69, 161.42 103.65,114.81, 
80.48 
222.7, 395.1, 284.3 
Resolution [Å] 20-2.6 
(2.69-2.60) 
20-2.6 
(2.69-2.60) 
20-2.6 (2.69-2.60) 50-2.3 (2.4-2.3) 50-3.8 (3.95-3.8) 
Completeness [%] 99.6 (99.5) 99.7 (99.6) 99.7 (99.6) 95.2 (92.0) 99.3 (97.0) 
Unique reflections 59,077 
(5,811) 
59,144 
(5,816) 
59,129 (5,815) 41,315 (4,872) 121,866 (13,089) 
Redundancy 4.5 4.5 4.3 3.2 3.2 
Rsym [%] 7.9 (21.6) 7.4 (29.4) 8.3 (40.3) 4.9 (31.0) 7.3 (35.3) 
<I/σI> 15.0 13.3 11.7 16.0 11.5 
f´ -7.8 -2.28 -9.6   
f´´ 5.0 3.53 2.5   
Refinement      
Residues    583 3902 
Zn2+/Mg2+    -/- 8/1 
Waters molecules    154 - 
RMSD bonds [Å]    0.007 0.009 
RMSD angles [°]    1.36 1.53 
Rcryst [%]    22.8 25.7 
Rfree [%]    27.4 28.5 
1All data were collected at beamline X06SA at the Swiss Light Source, Villigen, Switzerland. 
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Rpb4/7 structure 
The overall structure of the Rpb4/7 complex is similar to its archaeal counterpart (Todone et 
al., 2002). Rpb4 binds between two Rpb7 domains, the N-terminal “tip” domain and a C-
terminal domain (Figure 24B). Compared with the archaeal protein, Rpb7 lacks the C-
terminal helix K4, and has an additional helix inserted into strand A3 (K*, Figure 24). About 
half of the Rpb4 residues (48-57, 138-221) fold as in the archaeal counterpart (Figure 25). 
Rpb4 additionally contains a non-conserved N-terminal extension (residues 1-46), a longer 
helix H1, and an insertion between helices H1 and H2 (H1-H2 insertion), which comprises a 
long disordered loop and an additional helix (H*, Figure 24). The Rpb4 N-terminal extension 
is flexible in free Rpb4/7, but forms a partially ordered loop in the Pol II structure. This Rpb4 
N-terminal extension is apparently associated weakly with Rpb2 in the complete Pol II 
structure (Figures 28 and 29). Residues involved in Rpb2-Rpb4 contacts are however not 
conserved, and the 34 N-terminal residues of Rpb4 are not required for binding to the Pol II 
core in vitro (not shown). Three N-terminal residues of Rpb4 associate with the sheet of the 
Rpb7 tip, similar to the N-terminal half of strand A1 in the archaeal counterpart (Figures 24B, 
28). Charge distribution on both archaeal and yeast Rpb4/7 is consistent with putative role of 
dimer in binding of exiting, transcribed RNA (Figure 26). 
Folding transitions upon Pol II core-Rpb4/7 interaction 
In addition to the Rpb4 N-terminal extension, other protein elements fold upon Rpb4/7-core 
interaction. The Rpb7 tip domain binds to the Pol II core with the helical turn K1, and with 
the highly conserved “tip loop,” which is disordered in the free Rpb4/7 structure, but folds 
upon core binding (Figure 29). There are no obvious changes in the conformation of the H1-
H2 insertion upon core binding. Rpb4/7 binding however induces formation of an α-helix in 
the previously disordered residues 1445-1455 in the linker region of the largest Pol II subunit 
(Rpb1 helix α50, Figure 29). Folding transitions upon interaction with Pol II are also observed 
in the elongation factor TFIIS (Kettenberger et al., 2003) and the initiation factor TFIIB 
(Bushnell et al., 2004), and appear to be a common theme in interactions of the Pol II core 
with accessory factors. 
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Figure 24. Structure of the Rpb4/7 complex. 
(A) Primary and secondary structure. Structure-based alignments of amino acid sequences of S. cerevisiae 
Rpb7 with M. jannaschii RpoE (top) and of S. cerevisiae Rpb4 with M. jannaschii RpoF (bottom). Secondary 
structure elements are shown above and beneath the respective sequences (cylinders, α-helices; arrows, β-
strands; lines, loops; dashed lines, disordered; grey shading, absent from the crystallized variant), and are 
labeled according to (Todone et al., 2001). Conserved residues are highlighted according to decreasing 
conservation from dark green, through light green and orange, to yellow. Cleavage sites revealed by limited 
proteolysis are indicated with arrows. Residues that are within 4 Å from residues of the Pol II core in the 
complete polymerase structure are indicated with a blue dot. Figure prepared with ALSCRIPT (Barton, 1993). 
(B) Comparison of the structures of yeast Rpb4/7 (this study, left) and archaeal RpoF/E (15). Rpb7/RpoE are 
in blue and Rpb4/RpoF are in red. Disordered in the Rpb4/7 structure are the Rpb7 tip loop (residues 57-68), 
and Rpb4 residues 35-46, 77-81, and 101-118. Rpb4 residues 1-34 and 82-100 were not present in the 
crystallized variant. Figures were prepared with MOLSCRIPT (Kraulis, 1991) and PYMOL (DeLano 
Scientific).  
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Figure 27. Electron density maps. 
2Fo-Fc Electron density maps around the final 
model of Rpb4 residues 176-196 are shown for 
free Rpb4/7 at 2.3 Å resolution (left) and for 
the complete Pol II at 3.8 Å resolution (right). 
The maps are contoured at 1σ. The figure was 
prepared with BOBSCRIPT (Esnouf, 1997). 
Figure 25. Superposition of Rpb4/7 and E/F. 
RMSD for 45 C-alpha atoms is around 3.2Å; 
Rpb4/7 in red and blue respectively and E/F in 
grey 
Figure 26. Electrostatic potential of Rpb4/7. 
This view corresponds to the classical view 
rotated by 180° around y-axis and tilted 
towards us about 20° around x-axis. Potential 
was calculated with Pymol. Blue positive, red: 
negative  
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Figure 28. Complete RNA polymerase II structure. 
Ribbon diagram. Two standard views “front” and “top” are shown (Cramer et al., 2000 and 2001). The 12 
subunits Rpb1-Rpb12 are colored according to the key below the views. Dashed lines represent disordered 
loops. Eight zinc ions and the active site magnesium ion are depicted as cyan spheres and a pink sphere, 
respectively. Secondary structure assignments for the Pol II core taken from (Cramer et al., 2001).  
 
Figure 29. Folding transitions upon Rpb4/7 binding to the Pol II core. 
The complete Pol II structure (left) and free Rpb4/7 structure (right) are represented as grey coils. Elements 
that fold upon the interaction are colored in blue (Rpb7 tip loop), red (Rpb4 N-terminal extension), and 
orange (additional helix α50 in the Rpb1 linker to the carboxyl-terminal domain).  
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Specificity of the Pol II core-Rpb4/7 interaction 
The complete Pol II structure reveals details of the Pol II core-Rpb4/7 interaction, which 
refine our previous description of the involved protein elements (Armache et al., 2003). For 
example, the structure reveals a hydrogen bond between residue G66 of Rpb7 and residue 
Q100 of Rpb6 in the Pol II core. This hydrogen bond explains why mutation of residue Q100 
in Rpb6 leads to facilitated Rpb4/7 dissociation and to reduced Pol II activity upon a shift to 
non-permissive temperatures (Tan et al., 2003). The detailed information on the core-Rpb4/7 
interaction also helps to rationalize why another nuclear RNA polymerase, Pol I, binds 
specifically to A43/14, the Rpb4/7 counterpart. Specificity of A43/14 for the Pol I core may 
result from an ionic contact between a lysine that replaces the Rpb7 residue P63 in A43 and a 
patch of three glutamates that replace the Rpb1 residues T13, M1433, and G1439 in the 
largest Pol I subunit. I could however not find a straightforward explanation for specific 
interaction of the core of the third nuclear RNA polymerase, Pol III, with its Rpb4/7 
counterpart C25/17. It is possible that additional, Pol III-specific subunits are involved in 
defining the specificity in subunit assembly. 
Importance of the refined 12-subunit Pol II in phasing new structures 
The most important factor in a successful molecular replacement is a good search model. The 
refined, atomic model of 12-subunit RNA polymerase II at 3.8 Å is crucial for phasing new 
structures of the complete Pol II in complex with additional factors (Kettenberger et al., 
2004). The complex of 12-subunit Pol II with nucleic acids was initially phased with 10-
subunit core Pol II model and with 12-subunit 4.2 Å model but the density for nucleic acids 
became clear enough to build them after the refined 12-subunit 3.8 Å model was used for 
phasing (Kettenberger et al., 2004; Figure 30). 
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Figure 30. 2Fo-Fc of nucleic acids bound to Pol II calculated using different Pol II models for 
phasing. (Kettenberger et al., 2004); (A) 10-subunit Pol II (Cramer et al., 2001) was used for phasing; 
(B) 12-subunit 4.2Å model (Armache et al., 2003) was used for phasing; (C) 3.8Å refined atomic model 
of 12-subunit Pol II (Armache et al., 2004) was used for phasing; R free after rigid body refinement 
(CNS)
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Abstract 
 
 
The refined atomic model of the complete 12-subunit RNA polymerase II at 
3.8 Å resolution enabled homology modeling of the two other nuclear RNA 
polymerases. In Pol I and Pol III, 65 % and 77 % of the Pol II fold are 
conserved, respectively, much more than anticipated from canonical alignments. 
Conservation of the nucleic acid-binding cleft predicts that the mechanism of 
RNA elongation is essentially the same in these enzymes. Structural differences 
occur on the upstream surfaces, which bind different initiation factors, 
accounting for promoter specificity. Differential assembly of the three 
polymerases relies on four major specific interfaces between homologous 
subunits. The homologous subunits also contribute invariant residues to 
interfaces with the five subunits that are common to all three polymerases, and 
that form molecular staples at equivalent surface positions. 
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Introduction 
The refined structure of the complete Pol II (Armache et al., 2004) enabled homology 
modeling of Pol I and Pol III, which helps to understand the specific assembly of the three 
eukaryotic, nuclear RNA polymerases. Additionally analysis of these models showed that 
surface regions involved in RNA elongation are conserved, whereas regions involved in 
initiation factor binding are divergent. Since the five common subunits are identical in all 
three polymerases, they cannot contribute to specific enzyme assembly. Instead, they appear 
to stabilize the homologous subunits and their specific interactions and serve as “molecular 
staples”. The Pol I and Pol III models show that the common subunits can bind at equivalent 
locations in these enzymes, despite the divergent interfaces, by forming a limited set of key 
contacts with invariant residues of the homologous subunits (“hot spots”). The refined 
complete Pol II structure, together with the models of Pol I and Pol III, provide a reference for 
functional analysis of the eukaryotic transcription machineries. 
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Results and Discussion 
Modeling of RNA polymerases I and III 
The complete Pol II structure enabled homology modeling of Pol I and Pol III, which provides 
insights into similarities and differences in the structure and function of the three nuclear 
RNA polymerases in eukaryotes. Subunits Rpb5, 6, 8, 10, and 12 are common to all three 
polymerases and were included in the models (Table 1). The Pol II subunit Rpb9 was 
excluded from modeling because its putative counterparts A12.2 and C11 also show 
homology to the elongation factor TFIIS in their C-terminal domains, resulting in an 
ambiguity. The Rpb4/7 complex has counterparts in Pol I and Pol III (Hu et al., 2002; 
Peyroche et al., 2002; Sadhale and Woychik, 1994; Shpakovski and Shematorova, 1999). 
Rpb7 shows clear homology, but Rpb4 shows very weak sequence conservation, and thus was 
excluded from the models. The two large subunits, Rpb1 and Rpb2, and subunits Rpb3 and 
Rpb11, have homologues in Pol I and Pol III (Table 1).  
Table 1. Subunits in Pol II structure and Pol I/III models 
Pol II    Pol I   Pol III   
Subunit Type Residues 
in 
sequence 
Residues 
in 
refined 
structure 
Subunit Sequence 
identity 
[%] 
Conserve
d fold [%] 
Subunit Sequence 
identity 
[%] 
Conserved 
fold [%] 
Rpb1 homolog 1733 1416 A190 22.1 63.6 C160 28.4 83.2 
Rpb2 homolog 1224 1097 A135 25.4 71.0 C129 35.8 87.2 
Rpb3 homolog 318 266 AC40 25.8 60.2 AC40 25.8 60.2 
Rpb4 homolog 221 177 A14 excluded excluded C17 Excluded excluded 
Rpb5 common 215 214 Rpb5 100 100 Rpb5 100 100 
Rpb6 common 155 84 Rpb6 100 100 Rpb6 100 100 
Rpb7 homolog 171 171 A43 21.6 46.8 C25 24.6 46.8 
Rpb8 common 146 133 Rpb8 100 100 Rpb8 100 100 
Rpb9 unclear 122 119 A12.2 excluded excluded C11 Excluded excluded 
Rpb10 common 70 65 Rpb10 100 100 Rpb10 100 100 
Rpb11 homolog 120 114 AC19 20.8 81.6 AC19 20.8 81.6 
Rpb12 common 70 46 Rpb12 100 100 Rpb12 100 100 
Specific subunits 
-  - - Pol I 
specific:
A49, 
A34.5 
- - Pol III 
specific:
C82/C34
/C31, 
C53, 
C37 
- - 
Overall  4562 3902  33.6 65.4  38.8 77.1 
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Initial sequence alignments of the Pol II subunits Rpb1, 2, 3, 7, and 11 with their counterparts 
in Pol I and Pol III (Clustal W, Thompson et al., 1994) contained many obvious errors, which 
resulted from locally weak or absent conservation, and from misplaced gaps. We corrected the 
alignments in an iterative procedure based on the Pol II structure (Figure 2). Residues that 
lacked counterparts in Pol I or Pol III were removed from the structure, identical residues 
were kept, and conserved residues were replaced by their counterparts. Inspection of the 
resulting models for the chemical environment of each residue revealed reasonable packing in 
many regions. Key conserved residues often formed hydrophobic cores or salt bridges with 
residues that are distant in sequence, confirming the alignment in regions with weak sequence 
similarity. Steric clashes or disallowed contacts identified sequence stretches that were 
incorrectly aligned. These stretches were realigned manually, resulting in improved homology 
models that were inspected again. Iteration of this procedure converged on reliable models for 
large portions of Pol I and Pol III (Figure 3). Insertions and deletions in the two large subunits 
of Pol I and Pol III locate to the enzyme surfaces, and do not disturb the core folds (Figure 3). 
Since doubtful parts were excluded from the models, further regions of conserved fold may 
exist.  
Similarity of RNA polymerases and elongation mechanism 
The modeling showed that at least 65 % and 77 % of the Pol II fold is conserved in Pol I and 
Pol III, respectively (Table 2). In the two dominating large subunits of Pol III, even 83 % and 
87 % of the Pol II fold are conserved. This is surprising given that the sequence identity in the 
two large subunits in Pol I and Pol III ranges from 22 % to 36 % only (Table 2). The 
structurally and functionally essential core of Pol II is thus fully conserved in the two other 
polymerases (Figure 2). Of the two large subunits, only the folds of the Rpb1 jaw domain and 
the Rpb2 external domain 1 are not conserved (Figure 2). In Pol I, the foot domain in the 
largest subunit is also likely to have a different fold, or it could be highly diverged in 
sequence. Rpb4/7 is structurally different from its counterparts, except for the Rpb7 tip 
domain that binds the polymerase core. 
Conserved surfaces on homologous subunits of the three polymerases are found around the 
incoming DNA, in the active site and the binding-site for the DNA-RNA hybrid, and at the 
RNA exit tunnel. This suggests that the basic mechanism of RNA elongation is the same in all 
three polymerases. Also conserved is the overall surface charge distribution of the enzymes, 
with a positively charged active center cleft (not shown). Surfaces outside the cleft are not 
conserved (Figure 3), except for a few small patches, reflecting differential interactions with 
transcription factors and polymerase-specific subunits. In addition to the 12 subunits that are 
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either identical or homologous to the Pol II subunits, Pol I contains the specific subunits 
A34.5 and A49, and Pol III contains the specific subcomplex C82/C34/C31, and the specific 
subunits C53 and C37. 
Initiation factor binding and promoter specificity 
During initiation, the polymerases contact promoter DNA indirectly, via specific initiation 
factors (Figure 1). Initiation factors bind to the enzyme upstream face, which is mainly 
formed by the clamp, wall, dock domain, and the Rpb4/7 complex (Figure 3, (Armache et al., 
2003)). The upstream faces of the three polymerases are diverse, due to insertions and 
deletions on the surfaces of the clamp, wall and dock domains, due to structural differences 
between Rpb4/7 and its counterparts, and due to specific Pol I and Pol III subunits bound in 
this region. Structural differences in the upstream face of the three polymerases can account 
for specific initiation factor binding, explaining recognition of different promoter classes.  
The Pol II dock domain binds TFIIB (Bushnell et al., 2004; Chen and Hahn, 2003). A similar 
dock domain in Pol III could bind the TFIIB-related factor Brf1 (Figure 3), and a 14-residue 
insertion on the dock domain surface in Pol I reflects the absence of a TFIIB-like factor in this 
system (Figure 3, Bushnell et al., 2004; Chen and Hahn, 2003). The Rpb4/7 complex binds 
TFIIF (Chung et al., 2003), whereas its structurally different counterparts A43/14 and C25/17 
bind Rrn3 (Peyroche et al., 2000; Yuan et al., 2002), and Brf1 (Ferri et al., 2000), 
respectively. C25/17 also binds the Pol III-specific subunit C31, which resides in a 
subcomplex C82/C34/C31 that also binds to the initiation factors TBP and TFIIIC (Flores et 
al., 1999; Geiduschek and Kassavetis, 2001; Schramm and Hernandez, 2002; Wang and 
Roeder, 1997; and references therein), and to the outside of the clamp near zinc site Zn8 
(Figure 3). The second largest Pol III subunit C129 contains a seven-residue deletion near the 
adjacent zinc site Zn7 (Figures 2 and 3). The outside of the clamp in Pol I is also structurally 
different, since it shows insertions of five and 36 residues near zinc site Zn7 (Figure 3). The 
flap loop on top of the wall of Pol I is seven residues shorter than in Pol II. The coiled-coil at 
the inner side of the clamp is seven residues longer (Figure 3), and apparently binds subunit 
A49 (Bischler et al., 2002). A corresponding region interacts with the σ factor in bacterial 
RNA polymerase (Vassylyev et al., 2002; Murakami et al., 2002), and is near TFIIF in the 
Pol II system (Chung et al., 2003). Below the dock domain is the Rpb3/11 heterodimer that 
binds the Mediator complex that is required for regulated Pol II transcription (Davis et al., 
2002). An exposed zinc-binding loop in Rpb3 is not present in AC40, and may contribute to 
specific association of Mediator with Pol II.  
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Figure 1. Initiation of transcription by 3 eucaryotic, nuclear RNA polymerases.  
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Figure 2. Modeling of RNA polymerases I and III. Pol II structure-guided sequence alignments of 
subunits homologous in nuclear RNA polymerases. The domain organization of Pol II subunits Rpb1, 2, 
3, 7 and 11 is shown as diagrams (Cramer et al., 2001). Above and below the diagrams, regions 
conserved in fold in the homologous subunits of Pol I and Pol III are indicated with orange bars. 
Regions that apparently adopt a different structure are indicated with black brackets. The number of 
residues apparently inserted or deleted in the Pol I/III subunits as compared to the Pol II subunits are 
indicated. Yellow and red spheres represent insertions and deletions of more than three residues, 
respectively, in the Pol I/III sequences 
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Figure 3. Modeling of RNA polymerases I and III. (A) Exact positions of apparent insertions and 
deletions in the homologous subunits. The numbers correspond to the last aligned Pol II residue before 
the insertion/deletion in Pol I and Pol III. (B) Backbone coil representation of Pol II colored according 
to Fig. 2A (top). Elements on the upstream face are encircled (clamp, clamp coiled-coil, dock domain, 
wall). (C) Conservation of the Pol II fold in Pol I (left) and Pol III (right). The Pol II representation in 
(B) has been colored as follows. Regions in homologous subunits that are conserved in fold are in 
orange (C). Deletions and insertions in the Pol I and Pol III amino acid sequences as compared with 
Pol II are shown as red and yellow spheres, respectively, if they exceed three amino acid residues in 
length (numbers defined in (A)). Additional subunits and initiation factors are indicated as black circles 
and their physical interactions with black lines (compare text). 
CHAPTER IV: MODELING OF POL I AND III BASED ON THE REFINED STRUCTURE OF 12-SUBUNIT POL II 
 
 
97 
Specific assembly of Pol I, II, and III 
The Pol II structure and the models for Pol I and Pol III suggest that differential assembly of 
the three enzymes from sets of common, homologous, and specific subunits can be achieved 
in five major specific steps (Figure 4). First, stable heterodimers are formed by the Pol II 
subunits Rpb3 and Rpb11, or the corresponding subunits AC40 and AC19 in both Pol I and 
Pol III. Second, the Rpb3/11 heterodimer binds Rpb2, and the AC40/19 heterodimer binds 
either A135 or C129, the second largest subunits of Pol I and Pol III, respectively. The 
common subunits Rpb10 and Rpb12 bridge between the heterodimer and the second largest 
subunit, stabilizing the interaction. Third, the second largest subunit specifically binds its 
cognate largest subunit, which is stabilized by the common subunits Rpb5, 6, and 8. Forth, the 
two large subunits specifically bind the Rpb4/7 complex or its counterparts. Finally, 
additional specific subunits associate with the surface of Pol I and Pol III. Biochemical data 
generally support this assembly model (Werner and Weinzierl, 2002), but the order of the 
assembly steps remains unclear. 
Detailed analysis of the subunit-subunit interfaces in the three polymerases suggests the 
structural basis for specific enzyme assembly. Several hydrophobic residues in the 
heterodimeric interfaces of Rpb3/11 and AC40/19 differ in size, resulting in specifc 
heterodimerization (step 1 in Figure 4). For example, residues Rpb3 L33 and Rpb11 A48 are 
replaced by phenylalanine and tyrosine, respectively, in the AC40/19 heterodimer. Either 
A135 or C129 can interact with AC40/19, because they contribute three invariant residues to 
the interface (Rpb2 residues Y833, F1001, and Y1073, step 2 in Figure 4). Association of 
AC40/19 with either A135 or C129 may lead to formation of a new salt bridge between a 
glutamate that replaces Rpb2 residue K1079 in both A135 and C129, and an arginine that 
replaces the Rpb3 residue A225 in AC40. Rpb2 association with AC40/19 is therefore 
disfavored because two positively charged residues would approach each other in the 
interface. The two large subunits form a very extended contact surface that is strongly 
conserved, and specificity in the interaction between cognate large subunits can thus not be 
attributed to a defined region (step 3 in Figure 4). Specific binding of Rpb4/7 and its 
counterparts to the cores of the three polymerases can partially be rationalized (step 4 in 
Figure 4). Specificity of the Rpb4/7 counterpart A43/14 for the Pol I core may result from an 
ionic contact between a lysine that replaces the Rpb7 residue P63, and a patch of three 
glutamates that replace the Rpb1 residues T13, M1433, and G1439. 
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Common subunits as molecular staples 
Since the five common subunits are identical in all three polymerases, they cannot contribute 
to specific enzyme assembly. Instead they appear to stabilize the homologous subunits and 
their specific interactions. Rpb5 binds to a region in Rpb1 that is predicted to be disordered in 
free Rpb1 (FOLDINDEX, Uversky et al., 2000), Rpb6 has been shown to stabilize Rpb1 
(Nouraini et al., 1996), Rpb10 and Rpb12 bridge between Rpb2 and Rpb3, and Rpb12 
additionally bridges Rpb2 regions that are distant in sequence. The Pol I and Pol III models 
show that the common subunits can bind at equivalent locations in these enzymes, despite the 
divergent interfaces, by forming a limited set of key contacts with invariant residues of the 
homologous subunits (“hot spots,” Table 3). For example, the invariant phenylalanine F866 in 
Rpb1 inserts into a hydrophobic pocket of Rpb5, whereas the rest of the interface between 
Rpb5 and the largest polymerase subunits is strongly divergent (Figure 5). The two acidic 
Rpb2 residues E116 and D896 form salt bridges with two basic residues in Rpb12, and are 
invariant in Pol I and Pol III (Table 3). 
Architectural principles 
Comparison of the structures of Pol II and the ribosome (Ban et al., 2000; Ramakrishnan, 
2002; Schluenzen et al., 2000; Wimberly et al., 2000) reveals principles underlying the 
architecture of these multi-macromolecular machines. In Pol II, two large subunits and an 
additional heterodimer form the central mass of the enzyme and the active center, whereas 
five small surface subunits stabilize the complex. In the ribosome, large RNA chains form the 
central mass and the active site of the ribozyme, whereas small protein subunits on the surface 
seem to stabilize the complex like molecular staples. The number of these stabilizing protein 
subunits increased during evolution. Eukaryotic ribosomes contain more small protein 
subunits than bacterial ribosomes, and eukaryotic RNA polymerases contain five stabilizing 
common subunits, of which only one has a homologue in the bacterial enzyme (Rpb6, 
(Minakhin et al., 2001; Mukherjee and Chatterji, 1997). 
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Figure 4. Specific assembly of eukaryotic nuclear RNA polymerases. Model for assembly of Pol II, Pol 
I, and Pol III (from left to right). Subunit colors and the view (top) are as in Fig. 2A. Five specific subunit-
subunit interactions may direct differential assembly of the three enzymes (numbers in red squares). 
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Figure 5. Example of a prominent contact residue (“hot spot”). Invariant phenylalanine F866 (yellow) 
in Rpb1 (grey) interacts with a hydrophobic pocket of Rpb5 (magenta), whereas the rest of the interface 
between Rpb5 and the largest polymerase subunit is strongly divergent. 
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Table 2. Invariant contacts between common and homologous subunits 
Common 
subunit 
Residues Contacted homologous subunit in Pol 
I, II, III  
Invariant “hot spot” 
residues 
Rpb5 Y168 
Y168, Y211 
Rpb1, A190 C160 R857 
F866 
Y88, A91 
E89, T81, R136 
G95, 
N104, 
I120 
Rpb1, A190, C160 L504 
Y852 
A499 
T381 
Y383 
Rpb6 
Q100 Rpb7, A43, C25 G66 
Rpb8 Y20, N21, K22, V23 
N43 
L46 
N43, L46, D94, Y95, 
V96 
W79 
W79 
D94 
V96 
Rpb1, A190, C160 D538 
F540 
L571 
K567 
P563 
W572 
P568 
I565 
I566 
I2 
E19 
D55, E58, I57 
F60, L61 
L61, R62, Y63, N64 
Rpb3, AC40 L143 
Y114 
K146 
V57 
R148 
Rpb10 
Y44 
R48 
Rpb2, A135, C129 I1006 
D1009 
R54 
K58 
Rpb2, A135, C129 E116 
D896 
Rpb12 
R60, F67 Rpb3, AC40 D60 
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Sequence alignments of homologous subunits in Pol I, Pol II and Pol III 
Underlined-conserved in fold 
Star- invariant 
Rpa1-Rpb1 
 
sp|P10964|RPA1_YEAST      ---MDISKPVGSEITSVDFGILTAKEIRNLSAKQITNPTVLDNLG-HPVSGGLYDLALGA 56 
sp|P04050|RPB1_YEAST      MVGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIGGLNDPRLGS 60 
                              : *..    :..*:**:::.:*:* :*. :*  * .:*:   :.  *** *  **: 
 
sp|P10964|RPA1_YEAST      FLRNL-CSTCGLDEKFCPGHQGHIELPVPCYNPLFFNQLYIYLRASCLFCHHFRLKSVE- 114 
sp|P04050|RPB1_YEAST      IDRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHNE 120 
                          : *** *.**  . : **** ***:*. * ::  *: ::    .. *:.* :: *.     
 
sp|P10964|RPA1_YEAST      VHRYACKLRLLQYGLIDESYKLDEITLGSLNSSMYTDDEAIEDNEDEMDGEGSKQSKDISS 175 
sp|P04050|RPB1_YEAST      LMRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDP----------------------- 
                                                                
 
sp|P10964|RPA1_YEAST      TLLNELKSKRSEYVDMAIAKALSDGRTTERGSFTATVNDERKKLVHEFHKKLLSRGKCDN 235 
sp|P04050|RPB1_YEAST      ----------------------------------------------------TQLVSRGG 166 
                                                                            
 
sp|P10964|RPA1_YEAST      CGMFSPKFRKDGFTKIFETALNEKQITNNRVKGFIRQDMIKKQKQAKKLDGSNEASANDE 295 
sp|P04050|RPB1_YEAST      CGNTQPTIRKDGLKLVGS---------------------WKKDRATGDADEPELRVLSTE 205 
                          **  .*.:****:. : .                      **:: : . * .:    . * 
 
sp|P10964|RPA1_YEAST      ESFDVGRNPTTRPKTGSTYILSTEVKNILDTVFRKEQCVLQYVFHSRPNLSRKLVKADSF 355 
sp|P04050|RPB1_YEAST      EILNIFKHISVKDFTS-------------------------------LGFNEVFSRPEWM 234 
                          * ::: :: :.:  *.                                .:.. : :.: : 
 
sp|P10964|RPA1_YEAST      FMDVLVVPPTRFRLPSKLGEEVHENSQNQLLSKVLTTSLLIRDLNDDLSKLQKDKVSLED 415 
sp|P04050|RPB1_YEAST      ILTCLPVPPPPVRPSISFNESQRG---EDDLTFKLADILKANISLETLEHNGAP------ 291 
                          ::  * ***. .* . .:.*. : :.:   *:  *:  *  .   : *.:    : ::*: 
 
sp|P10964|RPA1_YEAST      RRVIFSRLMNAFVTIQNDVNAFIDSTKAQG-RTSGKVPIPGVKQALEKKEGLFRKHMMGKR 475 
sp|P04050|RPB1_YEAST      --HHAIEEAESLLQFHVATYMDNDIAGQPQALQKSGRPVKSIRARLKGKEGRIRGNLMGKR 344 
 
 
sp|P10964|RPA1_YEAST      VNYAARSVISPDPNIETNEIGVPPVFAVKLTYPEPVTAYNIAELRQAVINGPDKWPGATQ 535 
sp|P04050|RPB1_YEAST      VDFSARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLTQLVRNGPNEHPGAKY 404 
                          *:::**:*** ***:* :::***  :* .***** **.*** .* * * ***:: ***.  
 
sp|P10964|RPA1_YEAST      IQNEDGSLVSLIGMSVEQRKALANQLLTPSSNVSTHTLNKKVYRHIKNRDVVLMNRQPTL 595 
sp|P04050|RPB1_YEAST      VIRDSGDRIDLR--------------YSKRAGDIQLQYGWKVERHIMDNDPVLFNRQPSL 450 
                          : .:.*. :.*                :  :.      . ** *** :.* **:****:* 
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sp|P10964|RPA1_YEAST      HKASMMGHKVRVLPNEKTLRLHYANTGAYNADFDGDEMNMHFPQNENARAEALNLANTDS 655 
sp|P04050|RPB1_YEAST      HKMSMMAHRVKVIPYS-TFRLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAVPL 509 
                          ** ***.*:*:*:* . *:**: : *..***********:*.**.*::***  :*. .   
 
sp|P10964|RPA1_YEAST      QYLTPTSGSPVRGLIQDHISAGVWLTSKDSFFTREQYQQYIYGCIRPEDGHTTRSKIVTL 715 
sp|P04050|RPB1_YEAST      QIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNMLYWVPDWDG--------VIP 561 
                          * ::* *..*  *::** :..   ** :*:*:  :*  : :*     :.        *   
 
sp|P10964|RPA1_YEAST      PPTIFKPYPLWTGKQIITTVLLNVTPPDMPGINLISKNKIKNEYWGKGSLENEVLFKDGA 775 
sp|P04050|RPB1_YEAST      TPAIIKPKPLWSGKQILSVAIP----------NGIHLQRFDEGTTLLSPKDNGMLIIDGQ 611 
                          .*:*:** ***:****::..:           * *  :::.:     .. :* :*: **  
 
sp|P10964|RPA1_YEAST      LLCGILDKSQYGASKYGIVHSLHEVYGPEVAAKVLSVLGRLFTNYITATAFTCGMDDLRL 835 
sp|P04050|RPB1_YEAST      IIFGVVEKKTVGSSNGGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNGFSTGI----- 671 
                          :: *:::*.  *:*: *::* : .  **:*.**::. : ::.. ::  ..*: *:.*    
 
sp|P10964|RPA1_YEAST      TAEGNKWRTDILKTSVDTGREAAAEVTNLDKDTPADDPELLKRLQEILRDNNKSGILDAV 895 
sp|P04050|RPB1_YEAST      --GDTIADGPTMREITETIAEAKKKVLDVTKEAQAN-----------LLTAKHGMTLRES 713 
                           .         ::  .:*  **  :* :: *:: *:           *   ::.  *    
 
sp|P10964|RPA1_YEAST      TSSKVNAITSQVVSKCVPDGTMKKFPCNSMQAMALSGAKGSNVNVSQIMCLLGQQALEGR 955 
sp|P04050|RPB1_YEAST      FEDNVVRFLNEARDKAGRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGK 773 
                           ..:*  : .:. .*.   . ::    *.:: *.::*:*** :*::*: . :***::**: 
 
sp|P10964|RPA1_YEAST      RVPVMVSGKTLPSFKPYETDAMAGGYVKGRFYSGIKPQEYYFHCMAGREGLIDTAVKTSR 1015 
sp|P04050|RPB1_YEAST      RIAFGFVDRTLPHFSKDDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAE 833 
                          *:.. . .:*** *.  : .. : *:*:. :  *:.***::**.*.************:. 
 
sp|P10964|RPA1_YEAST      SGYLQRCLTKQLEGVHVSYDNSIRDADGTLVQFMYGGDAIDITKESHMTQFEFCLDNYYA 1075 
sp|P04050|RPB1_YEAST      TGYIQRRLVKALEDIMVHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQ-SLDTIGGSDAA 892 
                          :**:** *.* **.: * ***: *:: *.::**:** *.:* :: .:  .::   ..  * 
 
sp|P10964|RPA1_YEAST      LLKKY-----------------NPSALIEHLDVESALKYSKKTLKYRKKHS------KEP 1112 
sp|P04050|RPB1_YEAST      FEKRYRVDLLNTDHTLDPSLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEA 952 
                          : *:*                 . * :: .*.::  *. . * *   :*.        *. 
 
sp|P10964|RPA1_YEAST      HYKQSVKYDPVLAKYNPAKYL----------GSVSENFQDKLESFLDKN-------- 1151 
sp|P04050|RPB1_YEAST      NWPLPVNIRRIIQNAQQTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQR 1012 
                          ::  .*:   :: : : : ::. ..             :::*::*  : .**         
 
sp|P10964|RPA1_YEAST      ---------------SKLFKSSDGVNEKKFR---ALMQLKYMRSLINPGEAVGIIASQSV 1193 
sp|P04050|RPB1_YEAST      DAVTLFCCLLRSRLATRRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSI 1072 
                                         :: . ..  :.:: *  ---    :::**:::*** **::*:**: 
 
sp|P10964|RPA1_YEAST      GEPSTQMTLNTFHFAGHGAANVTLGIPRLREIVMTASAAIKTPQMTLPIWN--DVSDEQA 1251 
sp|P04050|RPB1_YEAST      GEPATQMTLNTFHFAGVASKKVTSGVPRLKEILN-VAKNMKTPSLTVYLEPGHAADQEQA 1131 
                          ***:************ .: :** *:***:**:  .:  :***.:*: :     ..:*** 
 
sp|P10964|RPA1_YEAST      DTFCKSISKVLLSEVIDKVIVTETTGTSNTAGGNAARSYVIHMRFFDNNEYSEEYDVSKE 1311 
sp|P04050|RPB1_YEAST      KLIRSAIEHTTLKSVTIASEIYYDPDPRSTVIPEDEEIIQLHFSLLDEEAEQSFDQQSPW 1191 
                          . : .:*.:. *..*     :   ... .*.  :  .   :*: ::*::  ..  : *   
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sp|P10964|RPA1_YEAST      ELQNVISNQFIHLLEAAIVKEIKKQKRTTGPDIGVAVP---------RLQTDVANSSSNS 1362 
sp|P04050|RPB1_YEAST      LLRLELDRAAMNDKDLTMGQVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVRPKSLDAE 1251 
                           *:  :..  ::  : :: :  :: *:*   *: *  .         * :.  .:* . . 
 
sp|P10964|RPA1_YEAST      KRLEEDNDEEQSHKKTKQAVSYDEPDEDEIETMREAEKSSDEEGIDSDKESDSDSEDEDV 1422 
sp|P04050|RPB1_YEAST      TEAEEDHMLKKIENTMLENITLR  
                          .. ***:  :: .:.  : ::   
 
sp|P10964|RPA1_YEAST      DMNEQINKSIVEANNNMNKVQRDRQSAIISHHRFITKYNFDDESGKWCEFKLELAADTEKLLMVN 1487 
 
 
sp|P10964|RPA1_YEAST      IVEEICRKSIIRQIPHIDRCVHPEPENGKRVLVTEGVNFQAMWDQEAFIDVDGITSNDVA -- 
sp|P04050|RPB1_YEAST      GVENIERVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPG-IDPTRIYTNSFI 1333 
                           **:* *  :::   ::   .    :: : ** *:***:. :    . **   * :*..  
 
sp|P10964|RPA1_YEAST      AVLKTYGVEAARNTIVNEINNVFSRYAISVSFRHLDLIADMMTRQGTYLAFNRQGMETS- -- 
sp|P04050|RPB1_YEAST      DIMEVLGIEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRHGFNRSN 1393 
                           :::. *:**.* :: :*: **::  .  *.:**: *:.*:** **   :..*:*:: *  
 
sp|P10964|RPA1_YEAST      TSSFMKMSYETTCQFLTKAVLDNEREQLDSPSARIVVGKLNNVGTGSFDVLAKVPNAA-- -- 
sp|P04050|RPB1_YEAST      TGALMRCSFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDEESLVKY ->CTD 
                          *.::*: *:* * ::* :*  . * ::  . * .:::*::  :***:***: .  . .   
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Rpb1-Rpc1  
 
sp|P04050|RPB1_YEAST      MVGQQYSSAPLRTVKEVQFGLFSPEEVRAISVAKIRFPETMDETQTRAKIG-GLNDPRLG 59 
sp|P04051|RPC1_YEAST      -MKEVVVSETPKRIKGLEFSALSAADIVAQSEVEVSTRDLFDLEKDRAPKANGALDPKMG 59 
                           : :   * . : :* ::*. :*. :: * * .::   : :*  : **  . *  **::* 
 
sp|P04050|RPB1_YEAST      SIDRNLKCQTCQEGMNECPGHFGHIDLAKPVFHVGFIAKIKKVCECVCMHCGKLLLDEHN 119 
sp|P04051|RPC1_YEAST      VSSSSLECATCHGNLASCHGHFGHLKLALPVFHIGYFKATIQILQGICKNCSAILLSETD 119 
                            . .*:* **: .: .* *****:.** ****:*::    :: : :* :*. :**.* : 
 
sp|P04050|RPB1_YEAST      ------ELMRQALAIKDSKKRFAAIWTLCKTKMVCETDVPSEDDPTQLVSRGGCGNTQPT 173 
sp|P04051|RPC1_YEAST      KRQFLHELRRPGVDNLRRMGILKKILDQCKKQRRCLHCGALNG--VVKKAAAGAGSAALK 177 
                                ** * .:        :  *   **.:  *    . :....   : .*.*.:  . 
 
sp|P04050|RPB1_YEAST      IRKDGLKLVG--------SWKKDRATGDADEPELR--------VLSTEEILNIFKHISVK 217 
sp|P04051|RPC1_YEAST      IIHDTFRWVGKKSAPEKDIWVGEWKEVLAHNPELERYVKRCMDDLNPLKTLNLFKQIKSA 237 
                          * :* :: **         *  :     *.:***.         *.. : **:**:*.   
 
sp|P04050|RPB1_YEAST      DFTSLGFNEVFS--RPEWMILTCLPVPPPPVRPSISFNES-QRGEDDLTFKLADILKANI 274 
sp|P04051|RPC1_YEAST      DCELLGIDATVPSGRPETYIWRYLPAPPVCIRPSVMMQDSPASNEDDLTVKLTEIVWTSS 297 
                          *   **:: ...  ***  *   **.**  :***: :::*   .*****.**::*: :.  
 
sp|P04050|RPB1_YEAST      SLETLEHNGAPHHAIEEAESLLQFHVATYMDNDIAGQPQALQKSG-----RPVKSIRARL 329 
sp|P04051|RPC1_YEAST      LIKAGLDKGISINNMMEHWDYLQLTVAMYINSDSVNPAMLPGSSNGGGKVKPIRGFCQRL 357 
                           :::  .:* . : : *  . **: ** *::.* .. .    .*.     :*::.:  ** 
 
sp|P04050|RPB1_YEAST      KGKEGRIRGNLMGKRVDFSARTVISGDPNLELDQVGVPKSIAKTLTYPEVVTPYNIDRLT 389 
sp|P04051|RPC1_YEAST      KGKQGRFRGNLSGKRVDFSGRTVISPDPNLSIDEVAVPDRVAKVLTYPEKVTRYNRHKLQ 417 
                          ***:**:**** *******.***** ****.:*:*.**. :**.***** ** ** .:*  
 
sp|P04050|RPB1_YEAST      QLVRNGPNEHPGAKYVIR-DSGDRIDLRYSKRAGDIQ-LQYGWKVERHIMDNDPVLFNRQ 447 
sp|P04051|RPC1_YEAST      ELIVNGPNVHPGANYLLKRNEDARRNLRYGDRMKLAKNLQIGDVVERHLEDGDVVLFNRQ 477 
                          :*: **** ****:*::: :.. * :***..*    : ** *  ****: *.* ****** 
 
sp|P04050|RPB1_YEAST      PSLHKMSMMAHRVKVIPYSTFRLNLSVTSPYNADFDGDEMNLHVPQSEETRAELSQLCAV 507 
sp|P04051|RPC1_YEAST      PSLHRLSILSHYAKIRPWRTFRLNECVCTPYNADFDGDEMNLHVPQTEEARAEAINLMGV 537 
                          ****::*:::* .*: *: ***** .* :*****************:**:***  :* .* 
 
sp|P04050|RPB1_YEAST      PLQIVSPQSNKPCMGIVQDTLCGIRKLTLRDTFIELDQVLNMLYWVPD--WDGVIPTPAI 565 
sp|P04051|RPC1_YEAST      KNNLLTPKSGEPIIAATQDFITGSYLISHKDSFYDRATLTQLLSMMSDGIEHFDIPPPAI 597 
                            ::::*:*.:* :. .** : *   :: :*:* :   : ::*  :.*   .  **.*** 
 
sp|P04050|RPB1_YEAST      IKPKPLWSGKQILSVAIP---NGIHLQRFDEGTTLLSP-----------KDNGMLIIDG- 610 
sp|P04051|RPC1_YEAST      MKPYYLWTGKQVFSLLIKPNHNSPVVINLDAKNKVFVPPKSKSLPNEMSQNDGFVIIRGS 657 
                          :**  **:***::*: *    *.  : .:*  ..:: *           :::*::** *  
 
sp|P04050|RPB1_YEAST      QIIFGVVEKKTVGSSN-GGLIHVVTREKGPQVCAKLFGNIQKVVNFWLLHNGFSTGIGDT 669 
sp|P04051|RPC1_YEAST      QILSGVMDKSVLGDGKKHSVFYTILRDYGPQEAANAMNRMAKLCARFLGNRGFSIGINDV 717 
                          **: **::*..:*..:  .:::.: *: *** .*: :..: *:   :* :.*** **.*. 
 
 
 
SUPPORTING MATERIAL: SEQUENCE ALIGNMENTS OF HOMOLOGOUS SUBUNITS IN POL I, POL II AND POL III 
 
 
106 
sp|P04050|RPB1_YEAST      IADGPTMREITETIAEAKKKVLDVTKEAQANLLTAKHGMTLRESFEDNVVRFLNEARDKA 729 
sp|P04051|RPC1_YEAST      TPADDLKQKKEELVEIAYHKCDELITLFNKGELETQPGCNEEQTLEAKIGGLLSKVREEV 777 
                           . .   ::  * :  * :*  :: .  : . * :: * . .:::* ::  :*.:.*::. 
 
sp|P04050|RPB1_YEAST      GRLAEVNLKDLNNVKQMVMAGSKGSFINIAQMSACVGQQSVEGKRIAFGFVDRTLPHFSK 789 
sp|P04051|RPC1_YEAST      GDVCINELDNWNAPLIMATCGSKGSTLNVSQMVAVVGQQIISGNRVPDGFQDRSLPHFPK 837 
                          * :.  :*.: *    *. .***** :*::** * **** :.*:*:. ** **:****.* 
 
sp|P04050|RPB1_YEAST      DDYSPESKGFVENSYLRGLTPQEFFFHAMGGREGLIDTAVKTAETGYIQRRLVKALEDIM 849 
sp|P04051|RPC1_YEAST      NSKTPQSKGFVRNSFFSGLSPPEFLFHAISGREGLVDTAVKTAETGYMSRRLMKSLEDLS 897 
                          :. :*:*****.**:: **:* **:***:.*****:***********:.***:*:***:  
 
sp|P04050|RPB1_YEAST      VHYDNTTRNSLGNVIQFIYGEDGMDAAHIEKQSLDTIGGSDAAFEKRYRVDLLNTDHTLD 909 
sp|P04051|RPC1_YEAST      CQYDNTVRTSANGIVQFTYGGDGLDPLEMEGNAQPVN--FNRSWDHAYNITFNNQDKGLL 955 
                           :****.*.* ..::** ** **:*. .:* ::  . .. : :::: *.: : * *: *  
 
sp|P04050|RPB1_YEAST      P-SLLESGSEILGDLKLQVLLDEEYKQLVKDRKFLREVFVDGEANWPLPVNIRRIIQNAQ 968 
sp|P04051|RPC1_YEAST      PYAIMETANEILGPLEERLVRYDNSGCLVKREDLNKAEYVD------QYDAERDFYHSLR 996 
                          * :::*:..**** *: :::  ::   *** ..: :  :**..:. . . .     ..:. 
 
 
sp|P04050|RPB1_YEAST      QTFHIDHTKPSDLTIKDIVLGVKDLQENLLVLRGKNEIIQNAQRDAVTLFCCLLRSRLAT 1028 
sp|P04051|RPC1_YEAST      EYIN----------------GKATALANLRKSRGMLGLLEPPAKELQGIDPDETVPDNVK 1053 
                          ------------------- *      **   **   ::: . ::   :      .  .. 
 
sp|P04050|RPB1_YEAST      RRVLQEYRLTKQAFDWVLSNIEAQFLRSVVHPGEMVGVLAAQSIGEPATQMTLNTFHFAG 1088 
sp|P04051|RPC1_YEAST      TSVSQLYRISEKSVRKFLEIALFKYRKARLEPGTAIGAIGAQSIGEPGTQMTLKTFHFAG 1113 
                            * * **:::::.  .*.    :: :: :.**  :*.:.*******.*****:****** 
 
sp|P04050|RPB1_YEAST      VASKKVTSGVPRLKEILNVAKNMKTPSLTVYLEPGHAADQEQAKLIRSAIEHTTLKSVTI 1148 
sp|P04051|RPC1_YEAST      VASMNVTLGVPRIKEIINASKVISTPIINAVLVN--DNDERAARVVKGRVEKTLLSDVAF 1171 
                          *** :** ****:***:*.:* :.** :.. *  .   *:. *::::. :*:* *..*:: 
 
sp|P04050|RPB1_YEAST      ASEIYYDPDPRSTVIPEDEEIIQLHFSLLDEEAEQSFDQQSPWLLRLELDRAAMNDKDLT 1208 
sp|P04051|RPC1_YEAST      YVQDVYKDN-------------------------LSFIQVRIDLGTIDKLQLELTIEDIA 1206 
                            :  *. :. ::  .....  .   :  ...:. ** *    *  ::  :  :. :*::helixPHD 
 
sp|P04050|RPB1_YEAST      MGQVGERIKQTFKNDLFVIWSEDNDEKLIIRCRVVRPKSLDAETEAEEDHMLKKIEN-TM 1267 
sp|P04051|RPC1_YEAST      VAITRASKLKIQASDVNIIGKDRIAINVFPEGYKAKSISTSAKEPSENDVFYRMQQLRRA 1266 
                          :. .     :   .*: :* .:    ::: .   .:. * .*:  :*:* : :  :     
 
sp|P04050|RPB1_YEAST      LENITLRGVENIERVVMMKYDRKVPSPTGEYVKEPEWVLETDGVNLSEVMTVPGIDPTRI 1327 
sp|P04051|RPC1_YEAST      LPDVVVKGLPDISRAVINIRD------------DGKRELLVEGYGLRDVMCTDGVIGSRT 1314 
                          * ::.::*: :*.*.*:   * . .:.:..  .: :  * .:* .* :** . *:  :*  
 
sp|P04050|RPB1_YEAST      YTNSFIDIMEVLGIEAGRAALYKEVYNVIASDGSYVNYRHMALLVDVMTTQGGLTSVTRH 1387 
sp|P04051|RPC1_YEAST      TTNHVLEVFSVLGIEAARYSIIREINYTMSNHGMSVDPRHIQLLGDVMTYKGEVLGITRF 1374 
                           ** .::::.******.* :: :*:  .::..*  *: **: ** **** :* : .:**. 
 
sp|P04050|RPB1_YEAST      GFNRSNTGALMRCSFEETVEILFEAGASAELDDCRGVSENVILGQMAPIGTGAFDVMIDE 1447 
sp|P04051|RPC1_YEAST      GLSKMRDSVLQLASFEKTTDHLFDAAFYMKKDAVEGVSECIILGQTMSIGTGSFKVVKG- 1433 
                          *:.: . ..*  .***:*.: **:*.   : *  .**** :****  .****:*.*: .. 
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sp|P04050|RPB1_YEAST      ESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGG 1507 
sp|P04051|RPC1_YEAST      ----------------------------------TNISEKDLVPKRCLFESLSNEAALKA 1459 
                          .:  .  .... :. ....... :. :..:.  .:::. ** :    *.:* **:*   . 
 
sp|P04050|RPB1_YEAST      FTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTS 1567 
sp|P04051|RPC1_YEAST      NCLUSTAL---------------------------------------------------- 1467 
                              . *  ..:::. .: ..:.::.. . ::.. :.::.: :.::.: :.::.: :.:: 
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Rpb2-Rpa2  
 
sp|P08518|RPB2_YEAST      MSDLANSE-KYYDEDPYGFEDESAPITAEDSWAVISAFFREKGLVSQQLDSFNQFVDYTL 59 
sp|P22138|RPA2_YEAST      MSKVIKPPGQARTADFRTLERESRFINPPKDKSAFPLLQEAVQPHIGSFNALTEGPDGGL 60 
                          **.: :.  :    *   :* **  *.. .. :.:. : .       .::::.:  *  * 
 
sp|P08518|RPB2_YEAST      QDIICEDS--TLILEQLAQHTTE----SDNISRKYEISFGKIYVTKPMVNE--SDGVTHA 111 
sp|P22138|RPA2_YEAST      LNLGVKDIGEKVIFDGKPLNSEDEISNSGYLGNKLSVSVEQVSIAKPMSNDGVSSAVERK 120 
                           ::  :*   .:*::  . :: :    *. :..* .:*. :: ::*** *:  *..* :  
 
sp|P08518|RPB2_YEAST      LYPQEARLRNLTYSSGLFVDVKKRTYEAIDVPGRELKYELIAEESEDDSESGKVFIGRLP 171 
sp|P22138|RPA2_YEAST      VYPSESRQRLTSYRGKLLLKLKWSVNN-----GEENLFEVRD-------------CGGLP 162 
                          :**.*:* *  :* . *::.:*  . :: . .*.*  :*:  ..:...:.:..   * ** 
 
sp|P08518|RPB2_YEAST      IMLRSKNCYLSEATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVFKKAAP 231 
sp|P22138|RPA2_YEAST      VMLQSNRCHLNKMSPYELVQHKEESDEIGGYFIVNGIEKLIRMLIVQRRNHPMAIIRPSF 222 
                          :**:*:.*:*.: :  :* : ** . ::*****:** **::     .  *   .: :.:  
 
sp|P08518|RPB2_YEAST      SPISHVAEIRSALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIFRALGI 291 
sp|P22138|RPA2_YEAST      ANRGASYSHYGIQIRSVRPDQTSQTNVLHYLNDGQVTFRFSWRKNEYLVPVVMILKALCH 282 
                          :  .   .  .   :. *  .* *.::    ...  *:: :    :  :*:*:*::**   
 
sp|P08518|RPB2_YEAST      IPDGEILEHIC-YDVNDWQMLEMLKPCVEDG----FVIQDRETALDFIGR--RGTALGIK 344 
sp|P22138|RPA2_YEAST      TSDREIFDGIIGNDVKDSFLTDRLELLLRGFKKRYPHLQNRTQVLQYLGDKFRVVFQASP 342 
                           .* **:: *   **:*  : : *:  :..       :*:*  .*:::*   * .  .   
 
sp|P08518|RPB2_YEAST      KEKRIQYAKDILQKEFLPHITQLEGFESRKAFFLGYMINRLLLCALDRKDQDDRDHFGKK 404 
sp|P22138|RPA2_YEAST      DQSDLEVGQEVLDRIVLVHLGKDG--SQDKFRMLLFMIRKLYSLVAGECSPDNPDATQHQ 400 
                          .:. :: .:::*:: .* *: :  . .. *  :* :**.:*   . .. . *: *   :: 
 
sp|P08518|RPB2_YEAST      RLDLAGPLLAQLFKTLFKKLTKDIFRYMQRTVEEAHDFNMK--------LAINAKTITSG 456 
sp|P22138|RPA2_YEAST      EVLLGGFLYGMILKEKIDEYLQNIIAQVRMDINRGMAINFKDKRYMSRVLMRVNENIGSK 460 
                          .: *.* * . ::*  :.:  ::*:  ::  ::..  :*:*        *    :.* *  
 
sp|P08518|RPB2_YEAST      LKYALATGNWGEQK-KAMSSRAGVSQVLNRYTYSSTLSHLRRTN-TPIGRDGKLAKPRQL 514 
sp|P22138|RPA2_YEAST      MQYFLSTGNLVSQSGLDLQQVSGYTVVAEKINFYRFISHFRMVHRGSFFAQLKTTTVRKL 520 
                          ::* *:***  .*.   :.. :* : * :: .:   :**:* .:  .:  : * :. *:* 
 
sp|P08518|RPB2_YEAST      HNTHWGLVCPAETPEGQACGLVKNLSLMSCISVG-TDPMPIITFLSEWGMEPLEDYVPHQ 573 
sp|P22138|RPA2_YEAST      LPESWGFLCPVHTPDGSPCGLLNHFAHKCRISTQQSDVSRIPSILYSLGVAPASHTFAAG 580 
                              **::**..**:*..***:::::  . **.  :*   * ::* . *: * .. ..   
 
sp|P08518|RPB2_YEAST      SPDATRVFVNGVWHGV--HRNPARLMETLRTLRRKGDINPEVSMIRDIREKELKIFTDAGRV 633 
sp|P22138|RPA2_YEAST      -PSLCCVQIDGKIIGWVSHEQGKIIADTLRYWKVEGKTPGLPIDLEIG----YVPPSTRGQ- 636 
 
 
sp|P08518|RPB2_YEAST      YRPLFIVEDDESLGHKELKVRKGHIAKLMATEYQDIEGGFEDVEEYTWSSLLNEGLVEYI 693 
sp|P22138|RPA2_YEAST      YPGLYLFGG---------HSRMLRPVRYLPLDK-----------------------EDIV 662 
                          *  *::. ...: . .. : *  : .: :. : :** * **:*   : ::  ...  ---   
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sp|P08518|RPB2_YEAST      DAEEEESILIAMQPEDLEPAEANEENDLDVDPAKRIRVSHHATTFTHCEIHPSMILGVAA 753 
sp|P22138|RPA2_YEAST      GPFEQVYMNIAVTPQEIQ-----------------------NNVHTHVEFTPTNILSILA 701 
                          -------  **: *::::.:.:..... . ..:.    :   ...** *: *: **.: * 
 
sp|P08518|RPB2_YEAST      SIIPFPDHNQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLK 813 
sp|P22138|RPA2_YEAST      NLTPFSDFNQSPRNMYQCQMGKQTMGTPGVALCHRSDNKLYRLQTGQTPIVKANLYDDYG 761 
                          .: **.*.****** **. ****:**.  .    * *.    *   *.*: .:.  :    
 
sp|P08518|RPB2_YEAST      FRELPAGQNAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITET 873 
sp|P22138|RPA2_YEAST      MDNFPNGFNAVVAVISYTGYDMDDAMIINKSADERGFGYGTMYKTEK-VDLALNRNRGDP 820 
                          : ::* * **:**: .*:**: :*:**:*:*: :**:  . ::::  . :   . .  :. 
 
sp|P08518|RPB2_YEAST      FEKPQRTNTLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTPISPDEEELGQRTAYHS 933 
sp|P22138|RPA2_YEAST      ITQHFGFGNDEWPKEWLEKLDEDGLPYIGTYVEEGDPICAYFDDT-------LNKTKIKT 873 
                          : :    .. .  :   :***:***   *. *---*-*-------------  ::*  :: 
 
sp|P08518|RPB2_YEAST      KRDASTPLRSTENGIVDQVLVTTNQDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGIT 993 
sp|P22138|RPA2_YEAST      YHSSEPAYIEEVNLIGDESNKFQE---LQTVSIKYRIRRTPQIGDKFSSRHGQKGVCSRK 930 
                           :.:...  .  * * *:   :.: : *: *.:: *  : *******:*******. . . 
 
 
sp|P08518|RPB2_YEAST      YRREDMPFTAEGIVPDLIINPHAIPSRMTVAHLIECLLSKVAALSGNEGDASPFT----D 1049 
sp|P22138|RPA2_YEAST      WPTIDMPFSETGIQPDIIINPHAFPSRMTIGMFVESLAGKAGALHGIAQDSTPWIFNEDD 990 
                          :   ****:  ** **:******:*****:. ::*.* .*..** *   *::*:     * 
 
sp|P08518|RPB2_YEAST      ITVEGISKLLREHGYQSRGFEVMYNGHTGKKLMAQIFFGPTYYQRLRHMVDDKIHARARG 1109 
sp|P22138|RPA2_YEAST      TPADYFGEQLAKAGYNYHGNEPMYSGATGEELRADIYVGVVYYQRLRHMVNDKFQVRSTG 1050 
                           ..: :.: * : **: :* * **.* **::* *:*:.* .*********:**::.*: * 
 
sp|P08518|RPB2_YEAST      PMQVLTRQPVEGRSRDGGLRFGEMERDCMIAHGAASFLKERLMEASDAFRVHICGICGLM 1169 
sp|P22138|RPA2_YEAST      PVNSLTMQPVKGRKRHGGIRVGEMERDALIGHGTSFLLQDRLLNSSDYTQASVCRECGSI 1110 
                          *:: ** ***:**.*.**:*.******.:*.**:: :*::**:::**  :. :*  ** : 
 
sp|P08518|RPB2_YEAST      TVIAKLN-----HNQFECKGCDN------------------------------------K 1188 
sp|P22138|RPA2_YEAST      LTTQQSVPRIGSISTVCCRRCSMRFEDAKKLLTKSEDGEKIFIDDSQIWEDGQGNKFVGG 1170 
                           .  :        . . *: *.                                       
 
sp|P08518|RPB2_YEAST      IDIYQIHIPYAAKLLFQELMAMNITPRLYTDRSRDF 1224 
sp|P22138|RPA2_YEAST      NETTTVAIPFVLKYLDSELSAMGIRLRYNVEPK--- 1203 
                           :   : **:. * * .** **.*  *  .: . .  
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Rpb2-Rpc2 
 
sp|P08518|RPB2_YEAST      ---MSDLANSEKYYDEDPYGFEDESAPI-----------TAEDSWAVISAFFREKGLVSQ 46 
sp|P22276|RPC2_YEAST      MVAATKRRKTHIHKHVKDEAFDDLLKPVYKGKKLTDEINTAQDKWHLLPAFLKVKGLVKQ 60 
                              :.  ::. : . .  .*:*   *:            *:*.* ::.**:: ****.* 
 
sp|P08518|RPB2_YEAST      QLDSFNQFVDYTLQDIICEDSTLILEQLAQHTTESDNISRKYEISFGKIYVTKPMVNESD 106 
sp|P22276|RPC2_YEAST      HLDSFNYFVDTDLKKIIKAN-------------QLILSDVDPEFYLKYVDIRVGKKSSSS 107 
                          :***** ***  *:.**  :                                    ..*. 
 
sp|P08518|RPB2_YEAST      GVTHALYPQEARLRNLTYSSGLFVDVKKRTYEAIDVPGRELKYELIAEESEDDSESGKVF 166 
sp|P22276|RPC2_YEAST      TKDYLTPPHECRLRDMTYSAPIYVDIEYTR-------GR----NIIMHKD--------VE 148 
                             :   *:*.***::***: ::**::          **    ::* .:.        *  
 
sp|P08518|RPB2_YEAST      IGRLPIMLRSKNCYLSEATESDLYKLKECPFDMGGYFIINGSEKVLIAQERSAGNIVQVF 226 
sp|P22276|RPC2_YEAST      IGRMPIMLRSNKCILYDADESKMAKLNECPLDPGGYFIVNGTEKVILVQEQLSKNRIIVE 208 
                          ***:******::* * :* **.: **:***:* *****:**:***::.**: : * : *  
 
sp|P08518|RPB2_YEAST      KKAAPSPISHVAEIRSALEKGSRFISTLQVKLYGREGSSARTIKATLPYIKQDIPIVIIF 286 
sp|P22276|RPC2_YEAST      ADEKK--GIVQASVTSS—THERKSKTYVITKNGK--------IYLKHNSIAEEIPIAIVL 257 
                           .   . ----*------------------*-------    *      * ::***.*:: 
 
sp|P08518|RPB2_YEAST      RALGIIPDGEILEHICYDVNDWQMLEMLKPCVEDGFVIQDRETALDFIGRRGTALGIKKE 346 
sp|P22276|RPC2_YEAST      KACGILSDLEIMQLVCGNDSSYQDIFAVNLEESSKLDIYTQQQALEYIGAKVKTMRRQKL 317 
                          :* **:.* **:: :* : ..:* :  ::   .. : *  :: **::** : .::  :*  
 
sp|P08518|RPB2_YEAST      KRIQYAKDILQKEFLPHITQLEGFESRKAFFLGYMINRLLLCALDRKDQDDRDHFGKKRL 406 
sp|P22276|RPC2_YEAST      TILQEGIEAIATTVIAHLTVEALDFREKALYIAMMTRRVVMAMYNPKMIDDRDYVGNKRL 377 
                          . :* . : : . .:.*:*       .**:::. * .*:::.  : *  ****:.*:*** 
 
sp|P08518|RPB2_YEAST      DLAGPLLAQLFKTLFKKLTKDIFRYMQRTVEEAH---DFNMKLAINAKT--ITSGLKYAL 461 
sp|P22276|RPC2_YEAST      ELAGQLISLLFEDLFKKFNNDFKLSIDKVLKKPNRAMEYDALLSINVHSNNITSGLNRAI 437 
                          :*** *:: **: ****:.:*:   :::.:::.:   :::  *:**.::  *****: *: 
 
sp|P08518|RPB2_YEAST      ATGNWGEQKKAMSSRAGVSQVLNRYTYSSTLSHLRRTNTPIGRDGKLAKPRQLHNTHWGL 521 
sp|P22276|RPC2_YEAST      STGNWS-LKRFKMERAGVTHVLSRLSYISALGMMTRISSQFEKSRKVSGPRALQPSQFGM 496 
                          :****.  *:   .****::**.* :* *:*. : * .: : :. *:: ** *: :::*: 
 
sp|P08518|RPB2_YEAST      VCPAETPEGQACGLVKNLSLMSCISVGTDPMPIITFLSEWGMEPLEDYVPHQSPDATRVF 581 
sp|P22276|RPC2_YEAST      LCTADTPEGEACGLVKNLALMTHITTDDEEEPIKKLCYVLGVEDITLIDSASLHLNYGVY 556 
                          :*.*:****:********:**: *:.. :  ** .:    *:* :    . .      *: 
 
sp|P08518|RPB2_YEAST      VNGVWHGVHRNPARLMETLRTLRRKGDINPEVSMIRDIREKELKIFTDAGRVYRPLFIVE 641 
sp|P22276|RPC2_YEAST      LNGTLIGSIRFPTKFVTQFRHLRRTGKVSEFISIYSNSHQMAVHIATDGGRICRPLIIVS 616 
                          :**.  *  * *::::  :* ***.*.:.  :*:  : ::  ::* **.**: ***:**. 
 
sp|P08518|RPB2_YEAST      DDESLGHKELKVRKGHIAKLMATEYQDIEGGFEDVEEYTWSSLLNEGLVEYIDAEEEESI 701 
sp|P22276|RPC2_YEAST      DGQSR------VKDIHLRKLLD-------------GELDFDDFLKLGLVEYLDVNEENDS 657 
                          *.:*       *:. *: **:               *  :..:*: *****:*.:**:.  
 
sp|P08518|RPB2_YEAST      LIAMQPEDLEPAEANEENDLDVDPAKRIRVSHHATTFTHCEIHPSMILGVAASIIPFPDH 761 
sp|P22276|RPC2_YEAST      YIALYEKDIVP------------------------SMTHLEIEPFTILGAVAGLIPYPHH 693 
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                           **:  :*: *                        ::** **.*  ***..*.:**:*.* 
 
sp|P08518|RPB2_YEAST      NQSPRNTYQSAMGKQAMGVFLTNYNVRMDTMANILYYPQKPLGTTRAMEYLKFRELPAGQ 821 
sp|P22276|RPC2_YEAST      NQSPRNTYQCAMGKQAIGAIAYNQFKRIDTLLYLMTYPQQPMVKTKTIELIDYDKLPAGQ 753 
                          *********.******:*.:  *   *:**:  :: ***:*: .*:::* :.: :***** 
 
sp|P08518|RPB2_YEAST      NAIVAIACYSGYNQEDSMIMNQSSIDRGLFRSLFFRSYMDQEKKYGMSITETFEKPQRTN 881 
sp|P22276|RPC2_YEAST      NATVAVMSYSGYDIEDALVLNKSSIDRGFGRCETRRKTTTVLKRYANHTQDIIGG-MRVD 812 
                          ** **: .****: **::::*:******: *.   *.     *:*.    : :    *.: 
 
sp|P08518|RPB2_YEAST      TLRMKHGTYDKLDDDGLIAPGVRVSGEDVIIGKTTPIS-PDEEELGQRTAYHSKRDASTP 940 
sp|P22276|RPC2_YEAST      ENGDPIWQHQSLGPDGLGEVGMKVQSGQIYINKSVPTNSADAPNPNNVNVQTQYREAPVI 872 
                                  ::.*. ***   *::*.. :: *.*:.* . .*  : .: ..  . *:*..  
 
sp|P08518|RPB2_YEAST      LRSTENGIVDQVLVTTNQDGLKFVKVRVRTTKIPQIGDKFASRHGQKGTIGITYRREDMP 1000 
sp|P22276|RPC2_YEAST      YRGPEPSHIDQVMMSVSDNDQALIKVLLRQNRRPELGDKFSSRHGQKGVCGIIVKQEDMP 932 
                           *..* . :***:::..::.  ::** :* .: *::****:*******. **  ::**** 
 
sp|P08518|RPB2_YEAST      FTAEGIVPDLIINPHAIPSRMTVAHLIECLLSKVAALSGNEGDASPFTDITVEGISKLLR 1060 
sp|P22276|RPC2_YEAST      FNDQGIVPDIIMNPHGFPSRMTVGKMIELISGKAGVLNGTLEYGTCFGGSKLEDMSKILV 992 
                          *. :*****:*:***.:******.::** : .*...*.*.   .: * . .:*.:**:*  
 
sp|P08518|RPB2_YEAST      EHGYQSRGFEVMYNGHTGKKLMAQIFFGPTYYQRLRHMVDDKIHARARGPMQVLTRQPVE 1120 
sp|P22276|RPC2_YEAST      DQGFNYSGKDMLYSGITGECLQAYIFFGPIYYQKLKHMVLDKMHARARGPRAVLTRQPTE 1052 
                          ::*::  * :::*.* **: * * ***** ***:*:*** **:*******  ******.* 
 
sp|P08518|RPB2_YEAST      GRSRDGGLRFGEMERDCMIAHGAASFLKERLMEASDAFRVHICGICGLMTVIAKLNHNQF 1180 
sp|P22276|RPC2_YEAST      GRSRDGGLRLGEMERDCVIAYGASQLLLERLMISSDAFEVDVCDKCGLMGYSG------- 1105 
                          *********:*******:**:**:.:* **** :****.*.:*. ****   .        
 
sp|P08518|RPB2_YEAST      ECKGCDNKIDIYQIHIPYAAKLLFQELMAMNITPRLYTDRSRDF 1224 
sp|P22276|RPC2_YEAST      WCTTCKSAENIIKMTIPYAAKLLFQELLSMNIAPRLRLEDIFQQ 1149 
                           *. *..  :* :: ************::***:***  :   :  
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Rpb11/AC19 
 
sp|P38902|RPBY_YEAST      ---------------------MNAPDRFELFLLGEGES---------KLKIDPDTKAPNA 30 
sp|P28000|RPC9_YEAST      MTEDIEQKKTATEVTPQEPKHIQEEEEQDVDMTGDEEQEEEPDREKIKLLTQATSEDGTS 60 
                                               ::  :. :: : *: *.         **  :. ::  .: 
 
sp|P38902|RPBY_YEAST      VVITFEKEDHTLGNLIRAELLNDRKVLFAAYKVEHPFFARFKLRIQTTEGYDPKDALKNA 90 
sp|P28000|RPC9_YEAST      ASFQIVEEDHTLGNALRYVIMKNPDVEFCGYSIPHPSENLLNIRIQTYGETTAVDALQKG 120 
                          . : : :******* :*  :::: .* *..*.: **    :::****     . ***::. 
 
sp|P38902|RPBY_YEAST      CNSIINKLGALKTNFETEWNLQTLAADDAF 120 
sp|P28000|RPC9_YEAST      LKDLMDLCDVVESKFTEKIKSM-------- 142 
                           :.:::  ..::::*  : :  : ::..:  
 
Rpb3/AC40  
 
sp|P16370|RPB3_YEAST      ----------------------MSEEGP------------QVKIREASKDNVDFILSNVD 26 
sp|P07703|RPC5_YEAST      MSNIVGIEYNRVTNTTSTDFPGFSKDAENEWNVEKFKKDFEVNISSLDAREANFDLINID 60 
                                                :*::.             :*:* . .  :.:* * *:* 
 
sp|P16370|RPB3_YEAST      LAMANSLRRVMIAEIPTLAIDSVEVETNTTVLADEFIAHRLGLIPLQSMDIEQLEYSRDC 86 
sp|P07703|RPC5_YEAST      TSIANAFRRIMISEVPSVAAEYVYFFNNTSVIQDEVLAHRIGLVPLK-VDPDMLTWVDSN 119 
                           ::**::**:**:*:*::* : * . .**:*: **.:***:**:**:::* : * :  .  
 
sp|P16370|RPB3_YEAST      FCED--HCDKCSVVLTLQAFGESE--------------STTNVYSKDLVIVSNLMGRNIG 130 
sp|P07703|RPC5_YEAST      LPDDEKFTDENTIVLSLNVKCTRNPDAPKGSTDPKELYNNAHVYARDLKFEPQGRQSTTF 179 
                          : :*  . *: ::**:*:.    :              ..::**::** : .:    .   
 
sp|P16370|RPB3_YEAST      HPIIQDKEGNGVLICKLRKGQELKLTCVAKKGIAKEHAKWGPAAAIEFEYDPWNKLKH-- 188 
sp|P07703|RPC5_YEAST      ADCPVVPADPDILLAKLRPGQEISLKAHCILGIGGDHAKFSPVSTASYRLLPQINILQPI 239 
                                  . .:*:.*** ***:.*.. .  **. :***:.*.:: .:.  *  :: :   
 
sp|P16370|RPB3_YEAST      ----------------------TDYWYEQDSAKEWPQSKNCEYEDPPNEGDPFDYKAQAD 226 
sp|P07703|RPC5_YEAST      KGESARRFQKCFPPGVIGIDEGSDEAYVKDARKDTVSREVLRYEEFADK---VKLGRVRN 296 
                                                :*  * :*: *:  . :  .**: .::.....     : 
 
sp|P16370|RPB3_YEAST      TFYMNVESVGSIPVDQVVVRGIDTLQKKVASIL-LALTQMDQDKVNFASGDNNTASN--- 282 
sp|P07703|RPC5_YEAST      HFIFNVESAGAMTPEEIFFKSVRILKNKAEYLKNCPITQMTEDIEQKKTATEVTPQEPKH 356 
                           * :****.*::. :::..:.:  *::*.  :   .:*** :*  :  :. : *..:    
 
sp|P16370|RPB3_YEAST      -MLGSNEDVMMTG---AEQDPYSNASQMGNTGSG--GYDNAW------------------ 318 
sp|P07703|RPC5_YEAST      IQEEEEQDVDMTGDEEQEEEPDREKIKLLTQATSEDGTSASFQIVEEDHTLGNALRYVIM 416 
                              .::** ***    *::*  :  :: . .:.  * . ::                   
 
sp|P16370|RPB3_YEAST      ------------------------------------------------------------ 
sp|P07703|RPC5_YEAST      KNPDVEFCGYSIPHPSENLLNIRIQTYGETTAVDALQKGLKDLMDLCDVVESKFTEKIKS 476 
                                                                                       
 
sp|P16370|RPB3_YEAST      - 
sp|P07703|RPC5_YEAST      M 47
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